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SUMMARY
Chapter 1 consists of a general description of the plant families Annonaceae, 
Piperaceae, Meliaceae, Rubiaceae and Euphorbiaceae, in particular in terms of their main 
secondary metabolites and their biological activity.
Chapter 2 presents a brief account of the biosynthetic pathways leading to the 
alkaloids, flavonoids and triterpenoids described in later chapters.
Chapter 3 describes the isolation of three novel methylated flavonoids from the 
bark of Desmos longiflorus (Annonaceae). The structures were determined largely by 
use of HMQC, HMBC and NOE difference techniques. Two other new compounds, a 
lanostane and a protoberberine alkaloid, were also obtained from the extract together with 
several known aporphine alkaloids, steroids, benzyl benzoate and the cyclohexane 
derivative, crotepoxide.
Chapter 4 concerns the structural elucidation, by 2D NMR methods, of a new 2- 
oxo-1 ip,16-epoxy-16-epicafestol derivative from Cojfea bengalensis (Rubiaceae).
Chapter 5 discusses the isolation of several isoquinoline alkaloids and the known 
sesquiterpenoid spathulenol from the Annonnaceous species Artabotrys odoratissimus.
Chapter 6 describes the isolation and characterisation of two new and one known 
bisdehydroaporphine alkaloids from the bark extract and a known aporphine alkaloid
from the leaf extract of Polyalthia bullata (Annonaceae) which is valued in Malaysia as 
an aphrodisiac (tonquat ali).
Chapter 7 gives an account of the isolation of the cyclohexene derivative zeylenol 
and two new pseudosugars from another Annonaceae, Annona roxburghiana.
In Chapter 8 the isolation of the known compounds, lupeol, lupeone, scopoletin 
and betulin 3 caffeate from Antidesma ghaesembilla (Euphorbiaceae) is discussed.
In Chapter 9 the isolation of one new and six known dammarane triterpenoids and 
the sesquiterpenoid viridiflorol from Amoora cucullata (Meliaceae) is discussed.
The final Chapter 10 gives an account of an investigation of Piper chaba 
(Piperaceae) which produced piperanine, 2,4-decadienoic acid piperidide, pellitorine and 
the lignan (-)-kusunokinin.
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CHAPTER 1
GENERAL INTRODUCTION
1
THE ANNONACEAE FAMILY
The Annonaceae is one of the largest of the plant families of the Magnoliales 
(Annonales, Ranales) which is considered to incorporate the most archaic order of extant 
dicotyledonous plants1. It is a large family comprising 2100 species and 120 genera and 
consisting of aromatic trees, shrubs or climbers2. The family is distributed throughout 
the tropics, occurring predominantly as trees or lianas in humid, lowland forest regions. 
The family is also found as trees or shrubs in the Neotropics, growing in drier and more 
open environments3.
ANNONACEAE OF ECONOMIC IMPORTANCE
The family Annonaceae contains a number of economically important genera, the 
most well known being Annona which is used as a source of edible fruits; the custard 
apple (Annona reticulata), sweetsop (A. squamosa), soursop (A. muricata) and 
cherrimoya (A. cherimola)4. The fruit pawpaw comes from Asimina triloba [pawpaw is 
also the fruit of Carica papaya (Papayaceae) which grows in the tropics] and the genera 
Cananga and Rollinia are also grown for their edible fruits5.
Some of the wood of Annonaceous plants is used for the production of alcohol6. 
The flowers of some of the Central American species are used as spice for flavouring 
chocolate and in cooking. The fragrant flowers of ylang-ylang (Cananga odorata), a 
native of Indo-China and Malaya, are used as an important raw material for perfumery7. 
The seed oils of some plants are used for the production of soap8 and edible oils9. 
Strong ropes are made from the bark of certain Brazilian species3.
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ANNONACEAE OF MEDICINAL SIGNIFICANCE
In developing countries herbal remedies are still extensively employed by ethnic
groups, despite the development of sophisticated synthetic drugs and medicine in the
West. Due to the abundance of Annonaceous plants throughout the tropical world, many
of these are documented as herbal remedies. In the Indo-Pak-Bangladesh subcontinent
many Annonaceous plants are used medicinally. Annona reticulata is used in dysentry,
Cananga odorata in gout and ophthalmia and Desmos chinensis in dysentry and
vertigo10. In Africa, Annonaceous plants are also used as herbal remedies. Annona
chrysophylla is used in snake bite, A. muricata in coughs, spasms and fevers,
Artabotrys brachypetalus in gonorrheoea and Uvaria leptoeladon in epilepsy11. In
Borneo the fruit of Neouvaria merrillii is used for treating fever and in the Philippines
12decoctions of all parts of Goniothalamus species are taken for fevers .
Chemical and pharmacological investigations of Annonaceous plants have 
intensified in the last two decades. The secondary metabolites of the Annonaceae show a 
wide variety of interesting biological and pharmacological activities. In most cases the 
Annonaceae produce alkaloids but a wide range of non-alkaloidal compounds belonging 
to various phytochemical groups is also found. Many of the alkaloidal and non-alkaloidal 
constituents are pharmacologically important.
Alkaloids isolated from Annonaceous plants have been found to exhibit cytotoxic, 
anti-tumour, antimicrobial, antifungal, antiviral and antibacterial activity13. Liriodenine 
(1) and other related oxoaporphines from Annonaceous plants show antitumour, 
antibacterial and antifungal activities14’15*16. Higenamine (2), from Annona squamosa, 
shows cardiovascular effects17. Liriodenine (1) and oxophoebine (3), from Xylopia 
aethiopica , and 10-methoxy liriodenine (4) and 10-hydroxy liriodenine (5), from Meliusa 
cf banacea , have been found to show DNA topoisomerase inhibitory activity18.
3
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In addition to liriodenine (1), lanuginosine (6) and lysicamine (7), from Rollinia 
papilionella19, and liridine (8) and atherospermidine (9), from Rollinia siricea20 have 
been found to exhibit cytotoxic activity. Asimicilone (10) and 6-cis-docosenamide (11),
H3CO,
h3c o
OCH
O
O
(9)
OCH
(8)
(H2C)
OCH
HO.
(11)
from Asimina parviflora21 > and annoretine (12) and argentinine (13) from Annona 
montana22 have also been found to exhibit cytotoxic activity. 3-(Y,Y~Dimethylallyl)- 
indole (14), from Monodora tenuifolia , shows antifungal and antibacterial activity23. 
Anticandidal activity has been observed for eupolauridine (15) and onychine (16) from
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Cleistopholis patens24. Norstephalagine (17) and atherospermidine (9), from Artabotrys 
maingaypS, exhibit muscle relaxation activity.
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The C-benzylated flavonoids, eg uvaretin (18) and isouvaretin (19) from Uvaria 
species, have been found to show cytotoxic and lyphocytic activity26’27. Pinocembrin
(20) and pinostrobin (21), also from Uvaria species are also cytotoxic28. Hufford et al 
have reported the antimicrobial activity for the C-benzylated flavonoids, from Uvaria 
chamae29'3®. The interesting tribenzylated flavonoid uvarinol (22), from the roots of U. 
chamae , has been found to show cytotoxicity and strong antimicrobial activity against 
various organisms31. Uvafzelin (23), an unusual methylated aromatic compound from 
U. afzelii, shows strong antimicrobial activity32.
HO.
HO. OH
(18)
HO OH
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.OH
(22)
8
o(23)
Terpenoids isolated from Annonaceous plants also exhibit cytotoxic, antibacterial 
and antimicrobial activity. These include the cytotoxic diterpenoids ent-kaur-16-en-19- 
oic acid (24) and gflM6P-hydroxy-19-kauranoic acid (25)33*34. The triterpenoid 
suberosol (26), from Polyalthia suberosa , exhibits anti-HIV replication activity35.
CH
COOH
(24) (25)
9
OH
HO
(26)
Goniotriol (27), and goniodiol (28), from Goniothalamus giganteus36,37, an(j 
goniodiol 7-monoacetate (29) and goniodiol 8-monoacetate (30), from G. amuyon38,39j 
have significant cytotoxicity against human tumours cells. The quinone, annoquinone-A 
(31), from Annona montana, demonstrated potent antimicrobial activity and cytotoxicity 
against KB tissue culture40 while melodorinol (32) and acetyl melodorinol (33), from 
Melodorum fruticosum , have cytotoxic activity41*42.
H
HQ
OH
OH
(27)
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H3CO,
O*
(31)
OR
(32) R=H
(33) R=Ac
The most interesting and the most active of the constituents of the Annonaceae are 
the acetogenins, which have cytotoxic, antitumor, antimalarial, antimicrobial,
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immunosuppressent, antifeedant and pesticidal activity43. The various structural types 
are illustrated by rollinone (34) from Rollinia papelionella44, bullatacin (35) and 
bullatacinone (36), from Annona bullata 45, and annomontacin (37), annonacinone (38) 
and annonacin (39), from A. montana 46. Trilobacin (40) , from Asimina triloba 
showed cytotoxic activity against human tumour cells47. Bullatacin (35) and bullatalicin
(41), from A. bullata , exhibit potent and selective cytotoxic activity48. Annomonicin
(42) and montanacin (43), from A. montana , have been found to show cytotoxicity 
against L-1210, P388 and MDA-MB231 cell lines49. Several other Annonaceous 
acetogenins have also been reported to have cytotoxic activity50’51’52’53.
,ch3
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R
O
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OH OH
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Goniothalamicin (44), from Goniothalamus giganteus 54 and bullatacin (35), 
from Annona bullata45 have been found to show insecticidal activity. Cherimoline (45) 
and its derivatives from Annona cherimolia 55, have been reported to have antimicrobial 
activity.
OH OH
H3C,
OH OH
(44)
OH
OH OHOH
(45)
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THE PIPERACEAE FAMILY
The plants of the family Piperaceae are small trees, shrubs and woody climbers. 
The family is pantropical in its distribution and inhabits mostly rain forest. The family 
consists of 5 genera and 2000 species56.
PIPERACEAE OF ECONOMIC IMPORTANCE
The main economic importance of the Piperaceae family is related to pepper. The 
species Piper nigrum is the source of pepper and the Polynesian beverage Kava is made 
from the roots of P. methysticum.. In India and Africa the leaves of Piper betle ere used 
as a masticatory57. Some species of Piper are also grown for their ornamental value.
PIPERACEAE OF MEDICINAL SIGNIFICANCE
Medicinally this family has great importance. In the Indian subcontinent, the 
plants of this family have various medicinal uses. Piper betle is used in snake-bite, P. 
cubeba in gonorrhea and cystitis, P. longum for colds and P. nigrum in cholera, 
malaria and skin diseases58. In Panama the leaves of Piper alleni and P. lucigauden 
are used as a snake-bite remedy by the Indians and the leaves of P. aequale are used in a 
decoction to cure rheumatism59. In the Philippines the leaves of P. albidirameum and 
P. penninerve are applied to ulcers and P. glabella is used as a remedy for conjunctivitis 
in Colombia59. The leaves of P. umbellata , the fruits of P. darienense and the 
decoction of roots , stem and leaves of P. alegreanum are used to relieve toothache60. 
Piper betle has been used in the treatment of diphtheria in Africa61.
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The most common constituents of the Piperaceae are the pepper alkaloids and 
phenylpropanoid derivatives. The alkaloid pipeline (46) from Piper longum, has a 
stimulatory action on the central nervous system62. Several piperamides from pepper, eg 
(47) and (48), showed larvicidal effects against the larvae of Toxocara cams®>. Isobutyl 
amides, eg pellitorine (see Chapter 10), have important insecticidal properties63*’636. 
The alkaloids N-(3-methoxy-4,5-methylenedioxydihydrocinnamoyl)-A3-pyridin-2-one 
(49), N-(3-methoxy-4,5-methylenedioxycinnamoyl)-A3-pyridin-2-one (50), piplartine
(51) and piplartine dimer (52), isolated from the leaves of P. aborescens , have been 
found to exhibit cytotoxic activity64.
O
N )v_y
(46)
O
(47)
o
(48)
o o
(49)
16
o o
(50)
(51)
OCH
OCH
OCH
(52)
3-(3,4-Dimethoxyphenyl)-propanoic acid (53) and 3-(3,4-dimethoxyphenyl)- 
propanamide (54), from P. arboricola, exhibit analgesic effects65. Strong antimicrobial 
activity has been observed for 4,5-dimethoxy-2,3-methylenedioxy-l-allylbenzene (55),
17
which was isolated from P. hispidum and P. aduncum66. Dihydrochalcones, for 
example piperaduncin A (56), from Piper aduncum have cytotoxic and antibacterial 
activity67.
0
COOH
N H
(53) (54)
HqCO
CH.
H3CO
(55)
H3COOC
H3CO
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THE MELIACEAE FAMILY
The Meliaceae is mainly a family of trees, restricted to tropical and subtropical 
regions. The family comprises about 50 genera and 550 species68. Most of the species 
are found in rain forests.
MELIACEAE OF ECONOMIC IMPORTANCE
This family has great importance economically. Timber is produced from 
Swietenia mahogani, Cedrela toona, Chukrasia tabularis and Chloroxylom swietenicfi®. 
The seed oil of Trichilea emetica is used for soap making68* The fruits of Aglaia and 
Lansium species are very important69. Some of the genera are used for ornamental 
purpose.
MELIACEAE OF MEDICINAL SIGNIFICANCE
Medicinally this family has some importance. In the Indo-Pak-Bangladesh 
subcontinent members of the Meliaceae have various medicinal uses. Cedrela toona. is 
used in dysentry and as an antiulcer, Melia azedarach as an anthelmintic and for nervous 
headaches, Carapa granatum and Naregamia alata for dysentry70. In the Philippines, 
the bark of Vavaea amicorwn and the leaves of Melia dubia have been used to relieve 
internal pain71. Insecticides have been isolated from Azadirachta and Melia species. 
Melia azaderach is used as an insecticide against flies72. In Africa the roots of 
Ekebergia species are used as a dysentry remedy while the roots of Turraea floribunda 
are used as an emetic in rheumatism, dropsy and heart disease73.
r
The Meliaceae family is a rich source of limonoids (tetran^triterpenoids). The 
most interesting limonoid is undoubtedly azadirachtin (57), from Azadirachta indica,
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which has potent antifeedent and insecticidal properties74. Other limonoids from the 
Meliaceae family have been found to exhibit antileukemic activity7^ . Limonoids from 
Azadirachta indica and Dysoxylum roseum have been found to exhibit cytotoxic activity 
against human cancer cells76’77. The pentacyclic triterpenoid katonic acid (58), from 
Sandoricum koetjape (syn S. indicum) shows cytotoxicity78.
HOCOOMe 
I ^OHCOO
OAc' OH
MeOOC O
(57)
HOOQ
(58)
2 0
Various triterpenoids from Melia azedarach are reported to have antiviral and 
antibacterial activity79*80’81. Antibacterial activity was also observed for mahmoodin 
(59), from Azadirachta indica, against various gram-positive and gram-negative 
organisms82. Gedunin (60), a metabolite of several Meliaceae species, exhibits 
antimalarial activity83 in vitro while alkanes of neem leaves are active against mosquito 
larvae84.
CHoOH
(59)
o
(60)
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THE RUBIACEAE FAMILY
The Rubiaceae is one of the largest plant families, consisting of 500 genera and 
about 7000 species. The family is mainly tropical and subtropical in its distribution but 
some species are also found in temperate and sub-arctic regions85. Members of the family 
found in tropical regions are trees or shrubs. Temperate ones are herbaceous85.
RUBIACEAE OF ECONOMIC IMPORTANCE
Some of the members of this family are very important in economic terms. The 
best known product of the Rubiaceae is coffee which comes from Coffea arabica , C. 
canephora and other species. Quinine is obtained from various Cinchona species86. 
Cephaelis species provides the drug ipecacuanha while the dyes madder and gambier are 
obtained from Rubia and Uncaria species85*87. Some of the Rubiaceae species are 
cultivated as ornamental plants and the best known one is Gardenia jasminoides.
RUBIACEAE OF MEDICINAL SIGNIFICANCE
Medicinally this family has great importance. The family Rubiaceae contains 
some important genera which are used as remedies for various diseases all over the 
world. In the Indian subcontinent Anthocephalus indicus is used in snake-bite, 
Cephaelis ipecacuanha in amoebic dysentry, Chassalia chartacea in pneumonia, 
Gardenia jasminoides in nervous disorder, Morinda umbellata in diarrhoea and 
dysentry and Ixora coccinea in dysentry88. Hintonia laliflora is used in malarial fever 
in Mexico and Hedyotis diffusa is used for stomach ulcers in Singapore while Contarea 
hexandra is used as a remedy for malaria all over the Latin America89. Mussaenda 
species are used in small-pox and Psychotria species are used in ulcers, T.B. and
2 2
internal pains. In Africa Rubia petiolaris is used for kidney diseases and Canthium 
inerme is used as a remedy for dysentry and diarrhoea^.
Morindaparvin-A (61), from Morinda parvifolicP1, tubulosine (62), from 
Pogonopus speciosus92 and tarennoside (63), geniposidic acid (64), geniposide (65), 
gardenoside (66) and genipin (67), from Genipa americana93, have all been found to 
exhibit cytotoxic and antitumour activity.
O
(61)
HN
OH
(62)
23
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(63) R=CHO
(64) R=COOH
(65) R=COOCH3
COoCH
OH
HO
(67)
Cyclic hexapeptides (as 68) from Rubia cordifolia and Rubia akane have been 
found to exhibit cytotoxicity and antitumour activity94*95*9^  Other cyclic hexapeptides 
and their glycosides from Rubia species also exhibit cytotoxic activity97*98 . Antiviral 
and antiinflammatory activity has been detected in the quinovic acid glycoside (69), from 
Uncaria tomentosa and Guettarda platypodd99*10° Anthraquinone glycosides, such as 
(70) from Rubia cordifolia , have been found to exhibit antibacterial activity101. An 
alkaloid , from Psychotria oleoides, has shown somatostatin antagonistic activity102.
24
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THE EUPHORBIACEAE FAMILY
The Euphorbiaceae is a large plant family consisting of some 300 genera and 
5000 species of dicotyledonous herbs, shrubs and trees. The genera Phyllanthus, 
Euphorbia, Croton and Acalypha are very large103 . The family is predominantly 
distributed in tropical regions but the genus Euphorbia is also found in extratropical 
regions like U. S. A., the MiddleEast, the Mediterranean basin and South Africa103. In 
South America, particularly in Brazil, about 300 Croton species are found.
EUPHORBIACEAE OF ECONOMIC IMPORTANCE
The Euphorbiaceae contains a large number of economically important genera. 
The most important is Hevea brasiliensis, the source of commercial rubber. Rubber is 
also obtained from the genus Manihot. The roots of Manihot esculentus (Manioc or 
Cassava) are used to prepare the food stuff tapioca104. Castor oil is obtained from 
Ricinus communis, tung oil from Aleurites fordii, croton oil from Croton tiglium and 
candlenut oil from Aleurites moluccana105. From Mallotus philippinensis a red dye is 
obtained while Chrozophora tinctoria produces purple and blue dyes. Some species 
also produce timber but this is restricted to the genus Ricinodendron106.
EUPHORBIACEAE OF MEDICINAL SIGNIFICANCE
Many of the Euphorbiaceous plants are documented as herbal remedies 
throughout the tropical world. In the Indo-Pak-Bangladesh subcontinent Acalypha 
indica is used in pneumonia and asthma, Croton tiglium in snake bite and fish poison, 
Euphorbia species in rheumatism, asthma, gout and neurological rheumatism, 
Homonoia riparia in gonorrhea and Jatropha multifida in scabies107. Many 
Euphorbiaceous genera are used to treat various diseases throughout the world. For
27
example the leaves of Breynia species are used in the Solomon islands to stop toothache 
and, in the Phillipines, the leaves of Glochidion species are applied to ulcers 108. In 
Mexico the caustic juice of Croton cortesianus is used to treat generalized skin 
diseases109.
The Euphorbiaceae produce a wide range of diterpenoids, usually as esters. 
Several ingenol derivatives from various Euphorbiaceous plants have been found to show 
high antitumour, cytotoxic and antileukemic activity110,111,112,113 Qne of these 
derivatives is ingenol 3,20-dibenzoate (71). Phorbol esters, for example 12-0- 
undecadienoylphorbol-13-acetate (72), from Euphorbiaceous plants have been reported 
to have cytotoxic activity114’115,116 but are also widely used in tumour promotion in 
medical research. Some diterpenoids from Euphorbiaceous plants have been found to 
have antileukemic activity117. Two acidic diterpenoids, (-)-hardwickiic acid (73) and 
3,4-secotrachylobanoic acid (74), from Croton sonderianus, have been found to exhibit 
antimicrobial activity118.
hUC
'"""CH
PhCOO
CH2OOCPh
(71)
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Phloroglucinol derivatives, eg mallotojaponin (75) from Mallotus japonicus , 
have been found to exhibit cytotoxic and antitumour activity119’12*1’121. Phyllanthostatin 
6 (76), an unusual compound from Phylanthus acuminatus , has been found to exhibit 
antineoplastic activity122. Some Euphorbiaceous plants also show antiviral activity12^ . 
Scopoletin (77) and umbelliferone (78), from Euphorbia humifusa, have shown 
antimicrobial activity124.
,CH
HO. OH
OH
OH
(75)
CH
HO OH
(76)
FL
(77) R= OMe
(78) R=H
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The furan derivative (79) and 2,4-dihydroxy-6-methoxy-3-methylacetophenone 
(80) from Euphorbia ebracteolata have been found to exhibit antituberculosis 
activity125.
CHO
OHC
(79)
OH O
CH
HO OCH
(80)
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CHAPTER 2
BIOSYNTHESIS OF ALKALOIDS, 
FLAVONOIDS AND TRITERPENOIDS
4 1
BIOSYNTHESIS OF ALKALOIDS
ALKALOIDS DERIVED FROM TYROSINE 
THE BENZYLISOQUINOLINE ALKALOIDS
The benzylisoquinoline alkaloids form the largest group of alkaloids of diverse 
structural types in the plant kingdom1. Tyrosine (3) is derived from chorismic acid (1) 
via p-hydroxyphenylpyruvic acid (2)2>3. Two molecules of tyrosine (3) form the 1- 
benzyltetrahydroisoquinoline (1-btiq) skeleton present in reticuline (15) and in coclaurine 
(12). At first it was thought that the formation of 1-btiq from tyrosine (3) occurred by 
the condensation of dopamine (6) and 3,4-dihydroxyphenylpyruvic acid (7) through 
Route A (Scheme 1). Thus the carboxylated intermediate would be the first 1-btiq (10) 
to be synthesized. Holland et al4 doubted the validity of this route when they observed 
that labelled DOPA (4) was mainly incorporated into the upper portion of 1-btiq molecule 
but tyrosine (3) was equally incorporated into both the upper and lower moieties, an 
observation that is at variance with the proposed mechanism in Route A. Recently 
Schumacher et afi and Zenk et afi have found that the enzyme (S)-norlaudanosoline 
synthase, isolated from the family Pavaveraceae, catalyses the condensation of dopamine 
(6) and 3,4-dihydroxyphenylacetaldehyde (8) following Route C (Scheme-1) to yield 
(S)-norlaudanosoline (11) as the initial 1-btiq alkaloid. (S)-reticuline (15) is formed by 
the methylation of (S)-norlaudanosoline6. However these authors also found that 3,4- 
dihydroxyphenylpyruvic acid (7) is not a substrate for this enzyme and have showed that 
Route A does not operate in the biosynthesis of isoquinolines. Herbert7 reported that the 
enzyme (S)-norlaudanosoline synthase accepted p-hydroxyphenylacetaldehyde (5) as an
4 2
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O COOH
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COOH
h° t w co°h
H O ^ x ^ ^  j  NH2
(4) f
H O ' ^ x ^  0
/  (6)
Route A x  hORoute B
/HO
x x v  -
/R ou te  C
(8) f
HO
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Scheme 1. Biosynthesis of benzylisoquinoline alkaloids.
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alternative substrate for condensation with dopamine (6) (Route B) to give (S)- 
norcoclaurine (9). This is further supported by Stadler et afi and Guinaudeae et aP who 
have reported that norcoclaurine (9) is formed by a stereospecific Pictet-Spengler 
condensation of dopamine (6) and p-hydroxyphenylacetaldehyde (5). Norcoclaurine (9) 
has been shown to be building block of many isoquinoline alkaloids1®. The common 
building block for the isoquinoline alkaloids, (S)-reticuline (15), is obtained from 
norcoclaurine via a sequence of O- and N-methylation as in coclaurine (12), N- 
methylcoclaurine (13) and (S)-3'-hydroxy-N-methylcoclaurine (14), stricdy governed 
by the sequential action of stereoselective enzymes. This view has been supported by 
extensive tracerexperiments8. Reticuline (15), on metabolism, gives rise to a series of 
isoquinoline alkaloids (Schemes 1, 2, 3, 4, 5, 6).
THE APORPHINE ALKALOIDS
That benzyltetrahydroisoquinoline acts as an intermediary in the formation of 
aporphines is well supported by a number of in vivo and in vitro studies11*12. The 
aporphines are the direct oxidative coupling products of reticuline (15, Scheme
2)1,11,13,14 The bis-dienone radicals (16a) or (16b), derived from reticuline (15), are 
likely to undergo ortho-ortho or ortho-para coupling giving 1,2,10,11-substituted (17) 
and 1,2,9,10-substituted (18) aporphines11*15.
Aporphines can be formed through proaporphine intermediates. Shamma et a/11 
reported that a trisubstituted 1-btiq, N-methyl coclaurine ortho-para diradical (19), 
derived from N-methylcoclaurine, undergoes cyclisation to give a known proaporphine 
glaziovine (20), which subsequently gives rise to the aporphines roemerine (22), lacking 
D-ring oxygenation and mecambroline (23), retaining oxygenation in D ring (Scheme
3). One of the intermediates of roemerine formation is the proaporphinol (21).
4 4
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Scheme 2 : Possible biosynthesis of aporphines via a bis-dienone radical.
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Scheme 3 : Routes to 1,2- and 1,2,9-substituted aporphines 
via a proaporphine intermediate.
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Scheme 4 : Possible route to tetrasubstituted aporphines from norprotosinomenine 
through neoaporphine intermediates.
Another proposed route1146 for the biosynthesis of tetrasubstituted aporphines 
(Scheme 4) involves the 1-btiq precursor norprotosinomenine (24), through the
4 7
intermediate neoproaporphines (25) and (26). It is assumed that neoproaporphine 
intermediates originate from para-ortho and para-para coupling between ring A and ring 
D radicals of norprotosinomenine (24). The direct transformation of (25) to 1,2,10,11- 
substituted aporphines and of (26) to 1,2,9,10-substituted aporphines has been 
considered to proceed via protonation and dienone-phenol rearrangement in a manner 
directly analogous to that for proaporphines. Besides these three proposed biogenic 
routes, it has been thought that aporphines can also be formed through protoberberineum 
salts15 but no hard evidence has been found for this route.
THE DEHYDROAPORPHINE, OXOAPORPHINE AND BISAPORPHINE 
ALKALOIDS
The biosynthetic studies of dehydroaporphine and oxoaporphines in vivo have 
not yet been carried out so far. Shamma et alu  have suggested a rational sequence of 
events (Scheme 5) involving the stepwise oxidation of an substituted aporphine (27) 
through the dehydroaporphine (28), and then 4,5,6a,7-tetradehydroaporphine (29). The 
4,5,6a,7-tetradehydroapophine would be susceptible to oxidation at C-7 leading to the 
generally unstable 7-oxo-N-methylquaternaryoxoaporphinium ion (30), which very 
readily loses the N-methyl group to form the oxoaporphine (31). It has been found that 
aporphines can undergo this process naturally on prolonged exposure to air17 and it must 
be considered that there is a possibility of dehydroaporphines and oxoaporphines 
formation without enzyme mediation. No in vivo biogenetic studies of bisaporphines 
have been carried out. However Shamma et fl/11 and Cave1** have proposed that 
bisaporphines can be formed from the oxidized monomeric derivatives like 
dehydroaporphine, tetradeohydroaporphine and oxoaporphine. This is further 
supported by the studies carried out by Guinadeau et al19.
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Scheme 5 : Possible biosynthesis of oxoaporphines from aporphines.
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THE PROTOBERBERINE ALKALOIDS
The protoberberine skeleton of the type (34) (Scheme 6) is the product of an 
oxidative ring closure of a 1-btiq precursor, eg reticuline (32). Tracer experiments 
established that the so-called "berberine bridge" (C-8) of the berberine group of alkaloids 
is derived in nature from N-methyl group of 1-benzyltetrahydroisoquinoline 
precursors2 *^21. The berberine bridge is formed by the oxidative cyclisation of the N- 
methyl group in a 1-btiq derivative (32) in a reaction which is very similar to that of 
methylenedioxy formation from an O-methyl group22. The mechanism involves 
oxidation of the 1-btiq (32) to the corresponding iminium intermediate (33), which can 
cyclise to form the tetrahydroprotoberberine nucleus of (34). Cyclisation of the O- 
methoxyphenoi to form a methylenedioxy group can finally yield (+)-sinactine (35).
It has been shown that (+)-(S)-reticuline (32) is preferred over the (-)-(R)-isomer 
as a substrate for berberine biosynthesis23*24. Bhakuni et aft5 reported that when doubly 
labelled (+)-reticuline was fed to the young cut branches of Cocculus laurifolius, labelled 
(+)-sinactine was isolated. Feeding of (+)-scoulerine (34) established its intermediacy in 
the biosynthesis of (+)-sinactine (35)26. A similar type of reaction pathway is followed 
in the biosynthesis of tetrahydropalmitine from (+)-(S)-reticuline27.
5 0
N
‘CHHO
OHHO
(32)
HO
OH
HO
(34)
(35)
Scheme 6 : Possible biogenesis of protoberberine alkaloids.
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BIOSYNTHESIS OF PIPERIDINE AMIDE ALKALOIDS
The alkamides are probably the condensation products of aromatic or long chain 
aliphatic acids with pyrrolidine, piperidine or isobutylamine moieties. Very little is 
known about the biosynthesis of alkamides. Leete28 has reported that the piperidine ring 
of coniine type alkaloids arises from acetate units. It has been shown, however, using 
labelled lysine (36)29, that the piperidine nucleus of sedamine and related alkaloids comes 
from lysine. Prabhu et a/30 have studied the possible biogenic pathways for the 
formation of the piperidine amide alkaloid, piperlongumine (38), in Piper longum., 
using labelled phenylalanine (37) and lysine (36) (Scheme 7) and have found that the 
C6-C3 moiety of piperlongumine (38) arises from phenylalanine while the piperidone 
ring is formed from lysine.
.COOH
*
COOHHoN
Scheme 7 : Possible biogenesis of piperidine amide alkaloids
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BIOSYNTHESIS OF FLAVONOIDS
The flavonoids comprise a large group of secondary metabolites. They are 
widely founds in higher plants and are responsible for much of the colouring of food and 
drink of plant origin. They are also responsible for the colour of the flowers and fruits. 
Many members are physiologically active. By 14C tracer studies it has been found that 
flavonoids are formed from a common C15 precursor, a chalcone31 (43), which is 
derived from the enzyme mediated condensation of an activated cinnamic acid (40) and 
three molecules of malonyl CoA (39). Malonyl CoA (39) is derived from acetate 
pathway and activated cinnamic acid (40) from the shikimic acid pathway32. Hahlbrock 
et a/33 have also proposed similar route for flavonoid biosynthesis. Subsequently the 
immediate product of the condensation reaction (41), and the enzyme chalcone synthase, 
responsible for this condensation, were identified34. Hahlbrock35 has pointed out that a 
central intermediate in the formation of all flavonoids is the chalcone (43) or the isomeric 
flavanone (42). The chalcone intermediate is then modified in a number of different 
ways by ring closure, oxidation or rearrangement to yield a range of flavonoid 
compounds eg (44), (45) and (46) (Scheme 8).
The nature of the biosynthetic precursors of the flavonoids may be reflected in the 
patterns of oxygenation in rings A and B. The meta-arrangements of the substituents 
arise from the malonyl origin of ring A, whereas ring B is derived from cinnamate.
5 3
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Scheme 8 : Biosynthesis of flavonoids.
BIOSYNTHESIS OF TRITERPENOIDS
The terpenoids represent a large diverse class of secondary metabolites. They are 
constructed from isoprene (2-methyl butadiene) units. Triterpenoids form a large group 
of secondary metabolites derived from squalene (47). There are more than 4000 
triterpenoids isolated so far and more than 40 skeletal types have been identified36. 
Biosynthetically squalene (47), or the 35 isomer of 2,3-epoxy-2,3-dihydrosqualene 
(48), is the immediate precursor of all triterpenoids37. Triterpenoids are formed by the 
cyclisation of these two precursors followed by rearrangement (Scheme 9). 3(5)-2,3- 
epoxy-2,3-dihydrosqualene (squalene-2,3-epoxide) undergoes cyclisation to give 3p- 
hydroxytriterpenoids which by oxidation and reduction can be transformed into 3a- 
hydroxytriterpenoids. In the bacterial cell free systems 3a-hydroxytriterpenoids are 
formed by the cyclisation of the 3R isomer of squalene-2,3-epoxide3^ ’39’40.
Cyclisation of squalene-2,3-epoxide in a chair-boat-chair-boat conformation 
leads to protosterol (49) or, by a subsequent sequence of rearrangements leads to 
lanosterol (50), cycloartenol (51) and cucurbitacin I41. Cyclisation of squalene-2,3- 
epoxide in the chair-chair-chair-boat conformation leads to the dammarane ring system 
(53). This cyclisation goes through a series of carbonium ion intermediates to a cation 
(52) from which dammaranes, euphanes and tirucallanes are thought to be derived. 
According to the scheme suggested by Eschenmoser et a/42, the transformation of the 
carbonium ion intermediates into euphol or tirucallol (54) occurs either by a concerted 
process or via the appropriate ethylenic intermediates. Triterpenoids containing a fifth 
ring can be formed by the reaction of the hypothetical cation with the terminal double 
bond of the side chain22. Then a number of hydrogen and methyl migrations occur. 
Triterpenoids of the lupane series (58) are most probably derived through the sequence 
of cations (55), (56) and (57).
5 5
Scheme 9 : Biosynthetic pathways of triterpenoids
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CHAPTER 3
CONSTITUENTS OF THE STEM BARK OF 
D E S M O S  L O N G I F L O R U S  (ROXB) SAFFORD
(ANNONACEAE).
60
INTRODUCTION
The genus Desmos (Annonaceae) comprises 30 species of shrubs and trees, 
distributed in tropical and subtropical regions1. Alkaloids have been isolated from 
Desmos tribaghienses2, D. dasymachalus3 and D. dumosus^- Flavanoids have been 
obtained from D. dumosus4, D. lawifi*6, D. cochinchinensis7 and D. chinensis8»9, 
aromatic acids and sterols fromZ). dasymachalus3 and cycloartanes from another Desmos 
species10.
Desmos longiflorus (Roxb) Safford (Annonaceae) is a shrub which is widely 
distributed in the hilly areas of Bangladesh. Several isoquinoline alkaloids were isolated 
from the stem bark11 and the antibacterial and antifungal activity of these alkaloids was 
studied12. Recently a lanostane derivative has been isolated from this plant13.
RESULTS AND DISCUSSION
Chromatography over silica gel of the ethyl acetate extract of the stem bark of D. 
longiflorus yielded five known compounds DL-1, DL-2, DL-3, DL-4, DL-5 which were 
subsequently identified as sitostenone (1), 4-stigmastene-3,6-dione (2), benzylbenzoate 
(3), crotepoxide (4) and N-benzoyl-0-(NT-benzoyl-L-phenylalanyl)-L-phenylalaninol 
(5) and five new compounds. The structures of four of them have been elucidated. 
These are DL-6, which is 15a-hydroxy-24-methylene-lanosta-7,9 (ll)-dien-3-one (6), 
DL-7, DL-8, and DL-9 which are the unusual C-methylated flavanoids (9), (10) and 
(11). DL-10 has not yet been identified. P-Sitosterol was also isolated from this plant.
Chromatography over silica gel of the methanol extract of the stem bark afforded 
six isoquinoline alkaloids DL-11, DL-12, DL-13, DL-14, DL-15 and DL-16. Five of
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them were identified as the known aporphine alkaloids oxocrebanine (12) (DL-11), 
buxifoline (15) (DL-12), oxobuxifoline (16) (DL-13), norstephalagine (17) (DL-14) and 
atherospermidine (18) (DL-15). The sixth alkaloid DL-16 is a new protoberberine 
alkaloid, 2-methoxy-3-hydroxy-9,10-methylenedioxytetrahydroprotoberberine (19).
DL-1 (1), C29H48O, Vmax 1680 (ketone), 1620 cm-1, was obtained as needles, 
mp 95°, [cx]d+810 (c, 1.00 in CHCI3) [lit.14 sitostenone, mp 95-96.5°. [oc]d +81.3° 
(c, 2.78 in CHCI3)]. Its mass spectrum [m/z 412 (M+), 397 (M+-15), 370 (C27H46+), 
327 (C27H39+), 289 (C2iH37+), 271 (C19H27O+), 149 (C nH i7+), 124 (C8H i20+, 
base peak)] indicated its steroidal nature. Its lH NMR spectrum shows two tertiary 
methyls [8h 0.67, 1.15], three secondary methyls [5h 0.78 (d, J 6.8 Hz), 0.88 (d, J 6.8 
Hz) and 1.10 (d, J 6.4 Hz)], a primary methyl [5h 0.96, t, J 6.5 Hz)] and an olefinic 
proton [8h 5.67 (sharp s)]. The unresolved protons appear as complex multiplets 
between 8h  1.28 and 2.60. These data suggested a steroidal enone with a sitosterol side 
chain. Comparison with published data15 led to the identification of DL-1 as sitostenone 
(1).
The 13C NMR spectrum of DL-1 readily supported structure (1). Thus it has six 
methyl groups [8c 11.8, 12.2, 17.2, 18.6, 18.9, 19.3] and an ap-unsaturated ketone 
[8c  199.6] with a trisubstituted double bond [8c  123.6 (d), 171.7 (s)]. In addition there 
are eleven methylenes, seven methines and two quaternary carbons. The 13C data for (1) 
so far have not been reported. The assignments (see Experimental) were made by 
comparison with 4-androsten-3-one16 and 24-ethyl-cholest-4-ene-3,6-dione17. This is 
the first report of the isolation of sitostenone from an Annonaceous plant
DL-2 (2), C29H46O2, vmax 1680 (ketone), 1617 cm-1, was obtained as crystals, 
mp 170°, [cc]d -60.0° (c, 1.00 in CHCI3) [lit.18 4-stigmastene-3-6-dione, mp 170-172°, 
[a]D -60.5° (c, 0.99 in CHCI3)] and has peaks in its mass spectrum at m/z 426 (M+), 
411 (M+-15), 285 [M+-CioH2i(side chain)], 243 (M+-Ci0H2i-42), 189 (Ci2H i30 2+), 
137 (C8H902+) and a base peak at m/z 43 (C3H7+). These indicated the steroidal nature 
of DL-2.
O
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The NMR spectrum shows two tertiary methyls [8h 0.71, 1.15], three 
secondary methyls [5h 0.78 (d, J 6.5 Hz), 0.84 (d, J 6.5 Hz), 0.87 (d, J 6.4 Hz)], a 
primary methyl [8h 0.95, t, J 6.4 Hz] and an olefinic proton [8h  6.16 (s)]. These data 
indicate a steroidal structure and comparison with published data18*19 readily led to the 
identification of DL-2 as 4-stigmastene-3,6-dione (2).
The 13C NMR spectrum of DL-2 (2) is in accord with the proposed structure. 
Thus it shows six methyl groups [8c  11.9, 12.0, 17.5, 18.7, 19.0, 19.8], a 
trisubstituted double bond [8c  125.4 (d), 161.l(s)] and two conjugated ketonic carbonyl 
[8c  197.6, 200.4], in addition to ten methylenes, seven methines and two quaternary 
carbons. Comparison with published data17 confirmed the identity of DL-2 as 4- 
stigmastene-3,6-dione (2).
DL-3 (3), C14H 12O2 was obtained as colourless oil, Xmax 228, 235, 260, 273, 
280, vmax 3020, 1722, 1603, 1585, 1498 cm-1. Its mass spectrum exhibits a molecular 
ion (M+) at m/z 212 corresponding to C14H 12O2 and a base peak at m/z 105 (PhCO+), 
together with fragments at m/z 107 (C7H7+) and 77 (Q>H5+). The JH NMR spectrum 
shows signals for ten aromatic protons [8h 8.07 (1H, m), 8.11 (1H, m) and 7.35-7.60 
(8H, m)] and a methylene singlet at 8h  5.38 (Ph-CHo-COl. The above data suggest that 
DL-3 is benzyl benzoate (3) and comparison with published data20 confirmed this..
(3)
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The 13C NMR spectrum of DL-3 shows the expected features. Thus it has an 
ester carbonyl [8c  166.4], ten aromatic doublets [8c  133.0, 129.7 (2), 129.2 (2), 128.6 
(2), 128.3, 128.1 (2)], two aromatic singlets [8c 136.0, 130.1] and a methylene [8c 
66.7]. The 13C data for (3) so far have not previously been reported. The assignments 
are given in the Experimental. The shifts of the CH2 0 0 CPh moiety were assigned by 
comparison with zeylenol2! and the shifts of the phenyl group by comparison with alkyl 
substituted benzenes22.
DL-4 (4), C i8H i8C>8, Amax 281, 273, 223 nm, was obtained as colourless 
needles, mp 152°, [(x]d+64.4° (c, 1.00 in CHCI3) [lit.23 crotepoxide, mp 152-153°, 
[oc]d +64.0° (c, 1.7 in CHCI3)] . It has esters [Vmax 1756 and 1732 cm-l], aromatic 
and C-O absorption in its IR spectrum (see Experimental). Its mass spectrum displays a 
molecular ion peak (M+) at m/z 362, a peak at m/z 303 [M+-CH3COO], a base peak at 
m/z 105 (Q>H5CO+), a peak at m/z 77 (C6H5+) and a peak at m/z 43 (C2H30+).
The *H NMR spectrum of DL-4 shows signals for five aromatic protons [8h 8.01 
(2H, m), 7.57 (lH,m), 7.44 (2H, m)] suggesting the presence of a benzoyl group, an 
AB quartet [8h 4.21, 4.55 (J 12.0 Hz)] indicative of an oxygenated methylene group,
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five oxygenated methines linked in a continuous chain [8h 3.05 (1H, dd, J 4.0, 1.5 Hz, 
H-4), 3.42 (1H, dd, J 4.0, 2.5 Hz, H-5), 3.65 (1H, d, J 2.5 Hz,H-6), 4.93 (1H, dd, J 
10.0, 1.5 Hz, H-3), 5.68 (1H, d, J 10.0 Hz, H-2)] and two acetyl groups [8H 2.00 (3H, 
s), 2.07 (3H, s)]. The chemical shifts of H-2 and H-3 indicate that they are attached to 
carbons bearing ester groups. The absence of hydroxyl absorption bands in the IR 
spectrum of DL-4 together with the 13C shifts of the oxygenated carbons (see below) 
indicated that the compound has two epoxide groups in addition to the three ester groups. 
Thus the three remaining protons at 8h 3.05 (H-4), 3.42 (H-5) and 3.65 (H-6) must be 
associated with the epoxides. In summary DL-4 is a hydroxymethyl cyclohexane 
derivative bearing two epoxides, two acetates and a benzoate. These features are 
reminiscent of crotepoxide (4) and comparison with published data23’24’25 confirmed the 
identification.
The 13C NMR spectrum of DL-4 shows the expected features for DL-4 (4). 
Thus it has an ester carbonyl [6c  165.5] and a phenyl ring [8c  133.4 (d), 129.7 (2xd),
129.0 (s), 128.5 (2xd)] associated with the benzoate, seven oxygenated carbons [8c 
70.3 (C-3), 69.4 (C-2), 62.4 (C-7), 59.4 (C-l), 53.7 (C-6), 52.5 (C-4), 48.0 (C-5)], 
two acetate methyl groups [8c  20.6 (2xq)] and two acetate carbonyls [8c 170.0, 169.5] 
associated with two acetyl groups. These data are consistent with the structure of 
crotepoxide (4). Comparison with published data26 again confirmed the identification of 
DL-4 as crotepoxide (4).
DL-5 (5), C32H30N2O4, was obtained as white crystals, mp 208-210°, [a]o  
-75° (c, 0.103 in EtOH) [lit.27 mp 210°, [a]D -78.7 (c, 0.14 in EtOH)]. It is UV active 
and has absorption bands at 215 and 230 nm. Its IR spectrum exhibits strong bands for 
NH (3340 cm-1), ester carbonyl (1750 cm-1), amide carbonyl (1640 cm-1) and aromatic 
ring (1600, 1580, 745, 694 cm-1) absorption. Its mass spectrum displays a molecular 
ion peak (M+) at m/z 506, corresponding to 032^ 0^ 04 , and other peaks at m/z 415 
(M + -P h C H 2), 385 (M +-PhC O N H 2), 294 (M +-PhC O N H 2-P hC H 2), 252
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[PhCH2CH(NHBz)=C=0]+, 224 (PhCH2CHNHBz)+ 105 (PhCO+), 91 (PhCH2+) 
and 77 (Ph+). These data are consistent with the presence of benzyl and benzamide 
functions. The peaks at m/z 252 and 224 are characteristic of an N- 
benzoylphenylalaninyl moiety.
NH
NH
The *H NMR spectrum of DL-5 shows the presence of a total of thirty protons. 
It reveals the presence of two NH groups as doublets at 8h 6.62 (J 6.6 Hz) and 6.72 (J 
8.2 Hz), twenty aromatic protons, incorporating two benzoyl and two benzyl groups, as 
multiplets at 8h 7.71 (4H) and 7.15-7.50 (16H), two benzyl methylenes at 8h 2.90 (1H, 
dd, J 13.6, 8.1 Hz) and 3.02 (1H, dd, J 13.6, 6.4 Hz) (2H-3) and at 8H 3.20 (1H, dd, J 
13.8, 7.0 Hz) and 3.32 (1H, dd, J 13.8, 6.6 Hz) (2H-3’), an esterified 
hydroxymethylene at 8h 4.05 (1H, dd, J 11.3, 4.2 Hz) and 4.57 (1H, dd, J 11.3, 3.3 
Hz) (2H-1) and two methines attached to NH at 8h  4.62 (1H, m, H-2) and 4.96 (1H, q, 
J 6.6 Hz, H-2'). These data indicate the presence of an ester grouping linking N- 
benzoylphenylalanyl and N-benzoylphenylalaninol residues. Comparison with published 
data27 confirmed the identity of DL-5 as N-benzoyl-0-(N’-benzoyl-L-phenylalanyl)-L- 
phenylalaninol (5).
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The structure was deduced in the following way. The COSY spectrum (Fig. 1) 
shows two coupled spin systems (a) and (b). System (a) consists of the methylene group 
at 5h 2.90 and 3.02 , the methine group at 5h 4.62, the esterified hydroxymethylene 
group at 8h 4.05 and 4.57 and the NH group at 8h  6.72 . System (b) consists of the 
methylene group at 8h 3.20 and 3.32 , the methine group at 8h  4.96 and the NH group 
at 8h  6.62.
NH NH
CH2— CH CH2~ 0  — CH2—CH-
(a) (b)
The 13C NMR spectrum shows the expected features for DL-5 (5). Thus it has 
two benzyl methylene carbons [8c  37.2 and 37.4 ], two deshielded methines [8c 54.5 
and 50.2 ], an ester methylene [8c  65.4 ], twenty aromatic methine carbons [8c  126.8 
(1C), 127.0 (2C), 127.1 (2C), 127.3 (1C) 128.4 (2C), 128.6 (4C), 128.8 (2C), 129.1 
(2C), 129.3 (2C), 131.4 (1C), 132.0 (1C)], four aromatic quaternary carbons [8c 
133.2, 134.1, 135.7, 137.1], two amide carbonyl carbons [8c  167.2, 167.4] and an 
ester carbonyl carbon [8c  171.9].
From the HMQC it was possible to identify all the aliphatic protonated carbons. 
The carbon at 8c  37.2 (t) has direct correlations with the methylene protons of 2H-3' [8h
2.90 (dd) and 3.02 (dd)] and the carbon at 8c  37.4 (t) has direct correlations with the 
methylene protons of 2H-3 [8h 2.20 (dd) and 3.32 (dd)]. The ester methylene protons 
of 2H-1 [8h 4.05 (dd) and 4.57 (dd)] correlate with the carbon at 8c  65.4 (t) while the 
methine protons H-2 [8h 4.62 (m)] and H-2’ [8h 4.96 (q)] correlate with the carbons at 
8c 50.2 (d) and 54.5 (d) respectively. These correlations assigned the carbons as
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Figure 
1. 
iH-lH 
COSY 
spectrum
 
of DL-5 
(5).
■r
i-1
^3
follows : 5C 37.2 (C-3'), 37.4 (C-3), 50.2 (C-2’), 54.5 (C-2) and 65.4 (C-l) 
respectively.
NH1
NH
(5a)
From the HMBC spectrum (Fig. 2) it was possible to obtain sufficient 
connectivity to elucidate the structure. The ester carbonyl carbon [5c 171.9 (s)] has 
correlations with the methylene protons 2H-1 [8h 4.05 (dd) and 4.57 (dd)], 2H-3' [8h
2.90 (dd) and 3.02 (dd)] and with the methine proton H-2' [8h 4.62 (m)], and is 
therefore C-l'. The amide carbonyl carbon at 5c 167.4 correlates with the methine 
proton H-2' [5h 4.62 (m)] and the another amide carbonyl carbon 5c 167.2 correlates 
with the NH [8h 6.62 (d)] and the aromatic protons [5h 7.71]. These and the other 
correlations shown in structure (5a) led to structure (5) for DL-5. This is the first report 
of its isolation from an Annonaceous plant.
DL-6 was obtained as colourless needles, mp 156-158°, [a]o +42.6° (c, 2.00 in 
CHCI3). The UV spectrum of DL-6 shows characteristic absorptions at A,max 252, 243 
and 236 nm, indicating the presence of a conjugated heteroannular diene system. The IR
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spectrum of DL-6 exhibits absorption bands at 3400 (hydroxyl), 1715 (ketonic C=0) and 
1640 (double bond) cm-1. The EIMS shows a molecular ion peak (M+) at m/z 452 and 
HREIMS confirmed the molecular formula as C31H48O2. Other mass peaks include m/z 
437 (M+-15), 419 (M+-15-18), 337 [M+-C9Hn(side chain)] and 125 (C9H17+ side 
chain). These data clearly indicate a triterpenoid with a conjugated diene system and an 
extra carbon in the side chain.
CH
28
(6) R=0; R =OH
(7) R=H,pOH; R’=H
(8) R=H,pOH; R=OH
The !H NMR spectrum of DL-6 reveals the presence of three secondary methyl 
groups [8h 0.88 (d, J 6.4 Hz, Me- 21), 1.00 and 1.03 (each d, J 6.8 Hz, Me-26,-27)], 
five tertiary methyl groups [5h 0.62, 0.91, 1.08, 1.11 and 1.18 (Me-18, -30, -29, -28, 
-19)], two olefinic protons of the conjugated diene system [8h 5.37 (d, J 6.0 Hz, H -ll) 
and 5.88(d, J 5.0 Hz, H-7)], an exomethylene group [5h 4.64 and 4.71 (each br s, Hz- 
31, He-31)], an oxygen-bearing methine [8h 4.27 (1H, dd, J 9.8, 5.6 Hz, H-15p)] and 
a deshielded proton [8h 2.75 (ddd, J 14.8, 14.5, 6.0 Hz)] suggestive of H-2p in a 3-oxo 
triterpenoid28. These data suggested a tetracyclic triterpenoid of the 24-methylene-
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7,9(1 l)-lanostadien-3-one type with additional secondary hydroxyl group. The 
attachment of the hydroxyl to C -l5 was deduced by comparison of the *H and 13C (vide 
infra) chemical shift data with those of ganoderiol B[15a,26,27-trihydroxy-7,9(ll),24- 
lanostatrien-3-one]28 and 24-methylene-7,9(l l)-lanostadien-3p-ol (7)29.
The 13C NMR spectrum contains signals for thirty one carbons including a keto 
group [5c 216.7, (C-3)], two trisubstituted double bonds [5c 121.6 (d) (C-7), 141.0 (s) 
(C-8), 144.7 (s) (C-9), 117.0 (d) (C-ll)], an exomethylene [5C 156.5 (s) (C-24), 106.1 
(t) (C-31)], a secondary alcohol [5c 74.6 (d), C-15] and eight methyl groups [5c 15.1 
(C-l8), 22.1 (C-19), 18.4 (C-21), 21.8 (C-26), 22.0 (C-27), 25.4 (C-28), 22.4 (C-29),
17.0 (C-30)], in addition to seven methylene, four methine and four quaternary carbons. 
The 13C resonances were readily assigned by comparison with those of ganoderiol B and 
24-methylene-7,9(ll)-lanostadien-3p-ol (7) [see Table 1] and confirmed the structure 
of DL-6 as 15a-hydroxy-24-methylene-7,9(ll)-lanostadien-3-one (6). The coupling 
constants of H-15 (J 9.8, 5.6 Hz) indicate its configuration as p. This was further 
confirmed by NOE difference experiments. Irradiation of H-15 (5h 4.27) gave a NOE 
(10%) at Me-18 (5h 0.62) while irradiation of Me-18 (5h 0.62) gave a NOE (7%) at 5h 
4.27 (H-15).
This is the first report of the isolation of triterpenoid (6). The corresponding 3P- 
hydroxy derivative suberosol (8)30 has recently been isolated from Polyalthia suberosa 
(Annonaceae) and is of particular interest in view of its reported anti-HIV activity. The 
15-deoxy analogue (7) of suberosol (8 ) has been isolated from A rtabotrys  
odoratissimupS, another member of the Annonaceae. Polycarpol (3p,15a-dihydroxy- 
7,9(ll),24-lanostatriene) has been found in several Annonaceae and is regarded as a 
useful chemotaxonomic marker29.
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TA BLE 1: 13C C hem ical Shifts Data o f  (6 ), G anoderiol B and (7).
Carbons
(6)
Compounds 
Ganoderiol B (7)
1 36.6 36.9
2 34.8 35.0
3 216.7 215.2
4 47.4 47.5
5 50.5 51.0
6 23.6 23.9
7 121.6 121.6
8 141.0 142.1
9 144.7 145.4
10 37.2 37.6
11 117.0 117.3
12 38.4 38.9
13 44.3 44.6
14 51.9 52.6
15 74.6 73.7
16 40.1 40.5
17 48.8 49.4
18 15.1 16.5
19 22.1 22.2
20 35.8 36.3
21 18.4 18.5
22 34.8 34.9
23 31.2 31.3
24 156.5 156.8
25 33.8 33.8
26 21.8 21.8
27 22.0 21.9
28 25.4 25.7
29 22.4 22.9
30 17.0 18.0
31 106.1 106.2
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DL-7 (9) was obtained as gum, [oc]d + 10.7 (c, 0.29 in CHCI3). It is UV active 
and has an absorption maximum at 250 nm [log e 3.45] suggesting a conjugated enone 
system. The IR spectrum exhibits hydroxyl (vmax 3620, 3450 cm-1) and unsaturated 
carbonyl (vmax 1649 cm-l) absorption. Additional bands at vmax 3020, 1620, 1570, 
1522, 1420 cm-l* indicate the presence of an aromatic ring. The EIMS shows a 
molecular ion peak (M+) at m/z 318 and HREIMS confirmed the molecular formula as 
C18H22O5. Other fragments in the mass spectrum include m/z 300 (M+-H20), 282 (M+- 
2H20 ), 267 (M+-2H20-CH3), 264 (M+-3H20), 105 (C6H5CO+), 104 (Q>H4CO+) and 
77 (C6H5+).
3’
PH
1'
V
2
PH
3
oOH
(9)
The lH NMR spectrum of DL-7 (9) shows the five aromatic protons [8h 7.30 
(m)] of a phenyl substituent, three tertiary methyl groups [8h 1.17 (s), 1.33 (s), 1.53 
(s)], three oxygenated methines [8h 5.10 (1H, dd, J 12.3, 2.2 Hz, H-2), 4.92 (1H, dd, 
J 10.1, 6.5 Hz, H-4), 3.92 (1H, s, H-7)], a methylene group [8h 2.45 (1H, ddd, J 
13.7, 6.5, 2.2 Hz, 3-Ha), 2.15 (1H, ddd, J 13.7, 12.3, 10.1 Hz, 3-Hb)] and three 
hydroxyl groups [8 h 4.65 (1H, s), 5.70 (1H, s), 2.75 (1H, s)]. Decoupling
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experiments readily established the coupled system -CH(0-)-CH2-CH(0-)- involving the 
protons at 8h 5.10 and 4.92 and the methylene group.
The 13C NMR spectrum of DL-7 (9) shows eighteen carbons including six 
aromatic carbons [8c 129.0 (d), 128.9 (2xd), 126.4 (2xd) 138.4 (s)], a ketonic carbonyl 
[8c 203.4], a tetrasubstituted enolic double bond [8c 111.0 (s), 170.7 (s)], four 
oxygenated carbons [8c 79.5 (d), 77.6 (d), 73.0 (s), 62.6 (d)], three methyl groups [8c 
24.5, 22.0, 19.6], a methylene [8c 36.8] and a quaternary carbon [8c 46.2]. The 
phenyl group, ketonic carbonyl and double bond account for six of the eight double bond 
equivalents of the molecule which must, therefore, have two additional rings. The lack 
of connectivity in the *H NMR spectrum necessitated recourse to a long range 8c/5h 
correlation experiment in order to find connectivity. In view of the small amount of 
material inverse detection was used, ie the HMBC experiment.
In the HMBC spectrum (Fig. 3) many correlations were observed and these are 
summerised in (9a) and in Table 5. The correlation of the tertiary methyl group protons 
were particularly helpful. The mutual correlations of the methyls at 8h 1-17 and 1.33
OH O
(9a)
74
9 6  [
0 8  t
0sr
o »  r
CfQ
a r t
80 (
3 6
88 O
03
OS
OE
az
revealed them as a geminal pair attached to the quaternary carbon at 6c 46.2. In addition 
both methyls showed 3Jch correlations to the unsaturated ketonic carbonyl group at 5c
203.4 and to the secondary oxygenated carbon at 6c 79.5 [associated with the singlet at 
5h 3.92]. The remaining methyl at 5h 1.53 is attached to a hydroxyl bearing carbon at 
6c 73.0 since it shows correlations to this carbon, in addition to 3Jch  correlations to the 
secondary oxygenated carbon at 6c 79.5 and to the strongly deshielded (enolic) p carbon 
of the unsaturated ketone system. These data lead unambiguously to part structure (9b) 
which is also supported by the correlations of the carbinol proton (5h 3.92) to all three 
methyl carbons and the two quaternary carbons at 5c 46.2 and 73.0.
OH
.OH
(9b)
Part structure (9b) can be extended in the following way. The allylic carbinol 
proton at 5h 4.92 correlates to both carbons of the conjugated double bond [5c 111.4 
and 170.7]. This carbinol proton, which forms part of the four-spin system discussed 
above, also shows a correlation to its neighbouring methylene group carbon. The 
lowfield methylene proton [5h 2.45] has strong correlation to the vinyl carbon at 5c
111.4 and to the remaining oxygenated methine at 5c 62.6. The attachment of the phenyl 
group to this oxygenated methine is revealed by correlation of its attached proton [5h 
5.06] to the aromatic carbons at 5c 126.4 (2d) and 138.4 (s). Thus the part structure can 
be extended to (9c).
75
OH
OH
OH
(9c)
Formation of a pyran ring completes the structure as in (9d). The correlation 
across the oxygen of the pyran from the methine to the lowfield vinyl carbon, absent in 
this case, is observed in a closely related compound (vide infra). Structure (9d) is novel 
and appears to have arisen from a flavonoid precursor by methylation of ring A.
OH
OH
OOH
(9d)
The relative stereochemistry of (9d) was investigated by NOE difference 
experiments. The results are given in Table 4. The methyl signals at 8h  1.17 and 1.53
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have a 1,3-diaxial relationship since each gives a strong NOE on irradiation of the other. 
The equatorial methyl at 8h 1.33 gives a reasonable NOE (4%) to the carbinol proton at 
8h 3.92. In related compounds (vide infra) the other two methyls also give NOEs to this 
carbinol proton which should therefore be equatorial. These results are accommodated 
by the stereochemistry shown in (9e).
OH
OH
.—•■mill
OH
(9e)
The relative stereochemistry of the pyran ring may be assigned on the basis of the 
coupling constants of the four spin system. The methine protons [8h 5.10 (dd, J 12.3, 
2.2 Hz, H-2); 4.92 (dd, J 10.1, 6.5 Hz, H-4)] each have a large coupling and are clearly 
axial in nature in a flavonoid half-chair conformation of the pyran ring. Irradiation of H- 
4 affords a NOE at H-3eq [8H 2.45 (ddd, J 13.7, 12.2, 6.5 Hz)]. Its geminal neighbour 
H-3ax [8h 2.15 (ddd, J 13.7, 12.3, 10.1 Hz)] is unaffected. The observation of a small 
NOE from the methyl group at 8h 1-53 to H-2 reveals the relationship between the rings. 
The relative stereochemistry is therefore assigned as in (9).
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TA BLE 2. tH  N M R  o f  C om pounds (9), (10) and (11).
Protons
(9) 8h , m, J (Hz)
Compounds 
(10) 8h , m, J (Hz) (11) 8h , m, J (Hz)
Ph 7.40, m 7.32, m 7.40, m
H-2 5.10, dd, 12.3, 2.2 5.40, t, 5.7 5.13, dd, 12.2, 2.5
H-3ax 2.15, ddd, 13.7, 2.40, t, 5.7 1.93, ddd, 14.7,
12.3, 10.1 12.2, 4.0
H-3eq 2.45, ddd, 13.7, 2.40, t, 5.7 2.17, dt, 14.7, 2.3
6.5, 2.2
H-4 4.92, dd, 10.1, 6.5 5.80, t, 5.7 4.65, dd, 4.0, 2.0
H-7 3.92, s 3.98, s 3.82, s
3H-9 1.33, s 1.29, s 1.31, s
3H-10 1.17, s 1.12, s 1.15, s
3H-11 1.53, s 1.55, s 1.53, s
OH 5.70, s 2.70, s 2.45, s
OH 4.65, br s 2.85, s 2.56, s
OH 2.75, s - 3.10, s
CH3CO - 1.61, s -
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TA BLE 3. 13C NM R o f  C om pounds (9), (10) and (11).
Carbons
(9)
Compounds
(10) (ID
C-2 79.5(d) 77.9(d) 76.5(d)
C-3 36.8(t) 33.4(t) 36.4(t)
C-4 62.6(d) 60.9(d) 58.6(d)
C-4a 111.4(s) 108.2(s) 111.3(s)
C-5 203.4(s) 198.6(s) 202. l(s)
C-6 46.2(s) 45.8(s) 45.9(s)
C-l 77.6(d) 77.2(d) 78.0(d)
C-8 73.0(s) 73.2(s) 73.2(s)
C-8a 170.7(s) 171.3(s) 170.3(s)
C-9 24.5 (q) 25.1(q) 24.5 (q)
C-10 19.6(q) 19.6(q) 19.5(q)
C -ll 22.0(q) 20.6(q) 22.2(q)
C -l’ 138.4(s) 138.9(s) 139.0(s)
C-2' 126.4(d) 125.2(d) 126.4(d))
C-3' 128.9(d) 128.6(d) 128.8(d
C-4’ 129.0(d) 128.0(d) 128.7(d)
C-5’ 128.9(d) 128.6(d) 128.8(d)
C-6 ' 126.4(d) 125.2(d) 126.4(d)
CH3CO - 20.6(q) -
CH3CO - 170.7(s) -
The next compound DL-8 was obtained as a gum, [cc]d  +5.0° (c, 0.65 in 
CHCI3), ^max 253 nm (log e 4.10). Its IR spectrum has bands at 3620, 3547, 1736, 
1655 and 1603 cm-1, indicating to presence of hydroxyl, ester and conjugated ketone 
moieties. The mass spectrum shows a peak at m/z 342, consistent with loss of water
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from C20H24O6. Other peaks include m/z 317 [M+-43(CH3CO)] , 300 [M+- 
60(CH3COOH)], 283 [M+-Q3H5L 282 [M+-60-H2O] and a base peak at 43 [CH3CO ]. 
The spectroscopic properties of DL-8 (see Tables) are very similar to those of DL-7 
suggesting a closely related structure. The *13 NMR spectrum shows resonances for a 
phenyl ring [8h 7.32 (5H, m)], three tertiary methyl groups [8h 1.12 (s), 1.29 (s) and 
1.55 (s)], another methyl at 8h  1.61 which turns out to be a shielded acetate {vide infra), 
two oxygen-bearing methines [8h 5.80 (t, J 5.7 Hz); 5.40 (t, J 5.7 Hz)] which both 
couple with a methylene group [8h 2.40 (2H, t, J 5.7 Hz)] whose protons are 
accidentally equivalent, a secondary carbinol [8h 3.98 (s)] and two hydroxyl protons [8h 
2.70 and 2.85]. These features differ from those of DL-7 only in the presence of acetate 
and the accidental equivalence of the methylene protons.
OH
OH
t mil
OAc
(10)
The 13C NMR spectrum (Table 3) confirmed the presence of the above 
functionality and, in particular, shows the presence of an a  P-un saturated ketone [8c
198.6 (s), 171.3 (s) and 108.2 (s)], a phenyl ring, three oxygenated methines [8c  60.9,
77.2, 77.9], an oxygenated quaternary carbon [8c 73.2 (s)], a quaternary carbon [8c  
45.8 (s)], a methylene carbon [8c  33.4 (t)], an acetate [8c  20.6 (q), 170.7 (s)] and three
8 0
tertiary methyls [6c  19.6 (q), 20.6 (q), 25.1 (q)]. The protonated carbons were assigned 
by a 2D 5c/6h direct correlation (HMQC) experiment (Fig. 4).
The structure of DL-8 as (10) was deduced largely on the basis of its HMBC 
spectrum (Fig. 5). The correlations are summarised in (10a) and in T able 5. The 
correlations of the methyl groups and the carbinol proton at 8h 3.98 reveal the same 
structure of ring A as in DL-7. The benzylic methine H-2 correlates to the phenyl ring as 
expected but, in addition, shows a correlation across oxygen to the p-carbon of the 
enone, thus establishing the pyran ring system. The acetate is attached to C-4 of the 
pyran since H-4 correlates to the acetate carbonyl at 6c 170.7.
n
( 1 0 a)
Two points about DL-8 (10) require comment. These concern the shielded nature 
of the acetate methyl and the accidental equivalence of the methylene protons. The phenyl 
ring will shield the acetate methyl if both are axial. However irradiation of H-2 affords a 
NOE at H-4 and vice versa suggesting that these protons are axial. Both of these 
situations can be accommodated if the pyran ring is undergoing rapid conformational
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inversion. The accidental equivalence of the diastereotopic methylene protons can also be 
explained in this way.
TA BLE 4. N O Es o f  C om pounds (9), (10) and (11).
Compounds
(9) ( 1 0 ) ( 1 1 )
Irradiation NOE (%) Irradiation NOE (%) Irradiation NOE (%)
1.17 1.53 (8) 1.12 1.55 (4.8) 1.15 1.53 (4.5)
1.33 3.92 (4) 1.29 (1.8) 1.31 3.82 (6)
1.53 1.17 (6) 3.98 (1.2) 1.53 1.15 (4.6)
5.10 (1.4) 1.29 1.12 (1.4) 3.82 (1.5)
- - 3.98 (6.1) 5.13(1)
3.92 1.33 (2.5) 1.55 1.12 (4.6) 1.93 4.65 (1.5)
4.65 (OH) 5.10 (2.3) 3.98 (0.9) 2.17 4.65 (1.7)
4.92 2.45 (2) 5.80 (1) 5.13 (2)
5.10 7.40 (1.8) 1.61 (Ac) 7.32 (1.3) 3.82 1.31 (4.5)
7.40 5.10 (3)
2.40
3.98 (0.6) 
5.40 (6.2) 
5.80 (8.1) 
7.32 (4.1)
4.65
5.13
1.93 (3)
2.17 (1.3)
2.17 (1.3) 
7.40 (2.7)
3.98 1.29 (3.4) 7.40 5.13 (4.3)
5.40 5.8o (1.5) 
2.40 (3.3) 
7.32 (4.0)
5.80 5.40 (1.3)
2.40 (3.5)
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TA BLE 5. L ong-range C orrelations o f  C om pounds (9), (10) and (11).
Carbon
(9)
Compounds
(10) (11)
2 H-3ax, Ar-H H-4, Ar-H H-3ax, Ar-H
3 H-4 H-2, H-4 -
4 H-2, H-3ax, H-3eq H-2, 2H-3 H-3eq
4a H-3eq, H-4 H-4, 2H-3 H-3eq, H-4
5 Me-9, Me-10 H-4, Me-9, Me-10 H-4, Me-9, Me-10
6 H-7, Me-9, Me-10 H-7, Me-9, Me-10 H-7, Me-9, Me-10
7 Me-9, Me-10, Me- 2H-3, H-4, Me-9, H-4, Me-9, Me-10,
11 Me-10, Me-11 Me-11
8 H-7, Me-11 H-7, Me-11 H-7, Me-11
8a H-3ax, H-4, Me-11 H-2, H-4, Me-11 H-4, Me-11
9 H-7, Me-10 H-7, Me-10 H-7, Me-10
10 H-7, Me-9 H-7, Me-9 H-7, Me-9
11 - H-7 H-7
1 ' H-2, H-3ax H-2, 2H-3 H-2, H-3ax
V H-2 H-2 H-2
3' - - -
4 ’ - - -
5 ’ - - -
6 ' H-2 H-2 H-2
CH3CO - - -
CH3CO - H-4, MeCO -
The relative stereochemistry of DL-8 as in (10) follows from NOE difference 
experiments (see T able 4). All the methyl groups in ring A afford NOEs to the
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secondary carbinol proton, indicating that both the secondary and tertiary hydroxyl 
groups must be a. The observation of a NOE from the C-8 methyl at 8h 1.55 to H-2 
confirms the relative stereochemistry of the pyran ring.
The third compound DL-9 was also obtained as a gum, [cx]d  +6.5° (c, 0.20 in 
CHCI3), Xmax 253 nm (log e 3.74), which showed hydroxyl (Vmax 3650, 3601, 3554 
cm-1) and conjugated ketone (vmax 1645 cm-1) absorption in its IR spectrum. As for 
DL-7 it also shows an (M+) peak at m/z 318 and HREIMS also confirmed the molecular 
formula as C18H22O5. Thus DL-9 is isomeric with DL-7 (9). Other mass peaks include 
m/z 300 [M+-H2O], 285 [M+-H2O-CH3], 282 [M+-2H20], 267 [M+-2H20-CH3] and 
105 [C6H5CO+]. The base peak in the mass spectra of both is at m/z 104, which arises 
from retro Diels Alder cleavage of the pyran ring.
The and 13C NMR spectroscopic properties of DL-9 are similar to those of 
DL-7 and DL-8 and the shifts are listed in Tables 1 and 2. The NMR shows the 
phenyl group [8h 7.40 (5H, m)], three tertiary methyls [5h 1.15 (s), 1.31 (s), 1.53 (s)], 
three oxygenated methines [8h 4.65 (dd, J 4.0, 2.0 Hz, H-4), 5.13 (dd, J 12.2, 2.5 Hz, 
H-2), 3.82 (s)], a methylene group [8H 2.17 (dt, J 14.7, 2.3 Hz), 1.93 (ddd, J 14.7,
12.2, 4.0 Hz)] which couples to two of the methines, and three hydroxyl groups [8h 
2.45, 2.56, 3.10 (each bs)]. The 13C NMR spectrum reveals an unsaturated ketone [8c 
202.1 (s), 170.9 (s), 111.3 (s)], a phenyl ring, three oxygenated methines [8c  78.0, 
76.4, 58.5], an oxygenated quaternary carbon [8c  73.2], a quaternary carbon [8c  45.9], 
a methylene group [8c 36.4 (t)] and three methyl groups [8c  19.6, 22.6, 24.5]. These 
data suggest that DL-9 has the same gross structure as DL-7 (9) but differs in the 
stereochemistry (vide infra) of at least one centre, in particular at C-4 since H-4 no longer 
has any large couplings.
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(11)
OH
OH O
(1 1 a)
The connectivity leading to structure (11) for DL-9 was derived from the HMBC 
spectrum (Fig. 6, 7) as above. The correlations are summerised in (11a) and in Table 5. 
The substitution pattern of ring A is readily revealed as in (11) by the correlations of the 
methyls and the carbinol proton H-7. The identity of H-4 is clearly established by its 
correlations to C-2, C-4a, C-5 and C-8a. The couplings of H-4 (J 4.0, 2.0 Hz) suggest 
that it is equatorial and this is confirmed by NOEs to both H-3ax and H-3eq. Irradiation 
of the axial H-2 gives, as expected, NOEs to the phenyl group and to H-3eq. The NOEs
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obtained for DL-9 are listed in Table 4 and lead to the relative stereochemistry as in 
(11). Thus DL-9 is the C-4 epimer of DL-7.
These methylated flavonoids are interesting new compounds. It is unfortunate 
that they were obtained in only small amounts. Other examples of methylated aromatic 
compounds have been reported from the Annonaceae (see Introduction).
DL-11 (12), C i9H i3N05 , was obtained as orange-red needles, mp 266-268° 
[lit.31 oxocrebanine, mp 265-269°]. It is UV active and shows absorption at A,max 250, 
275, 380 nm. It showed a Dragendorff positive spot on tic, indicating its alkaloidal 
nature, and its IR spectrum exhibits bands at Vmax 1665 (conjugated ketone), 3020, 
1603, 1579, 1520, 1468, and 1423 (aromatic) cm-1. Its mass spectrum shows a 
molecular ion (M+) at m/z 335 (base peak) together with fragments at m/z 320 (M+- 
CH3), 307 (M+-GO), 306 (M+-1-CO), 305 (M+-OCH2), 304 (M+-OCH3), consistent 
with an oxoaporphine system.
3 4
OCH 3
(12)
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The *H NMR spectrum of DL-11 reveals two pyridine protons [8h 7.64, 8.78 
(ABq, J 5.0 Hz, H-4, H-5)], an aromatic singlet [5h 7.03 (1H)], another aromatic AB 
quartet [8h 7.17, 8.31 (each 1H, J 9.0 Hz, H-10, H -ll)], a methylenedioxy group [8h
6.29 (2H, s)] and two methoxyl groups [8h 3.94 (3H, s), 4.00 (3H, s)]. These NMR 
data are consistent with an oxoaporphine nucleus with methylenedioxy and two methoxyl 
substituents. Comparison with published data confirmed the identity of DL-11 as 
oxocrebanine (12)32.
O
O
OCH
(14)
The 13C NMR spectrum is in accord with structure (12). It has a carbonyl 
resonance [8c  181.6], five aromatic methines [8c  101.9, 117.0, 123.7, 123.8, 144.1], a 
methylenedioxy group [8c  102.3], two methoxyl groups [8c 56.0, 61.0] and ten 
aromatic singlets [see Experimental]. The 13C NMR data for (12) have not been reported 
previously. The assignments (see Experimental) were made by comparison with the 13C 
NMR data of oxoputerine (13) and oxostephanine (14)33. This is the first report of the 
presence of oxocrebanine in the genus Desmos but it has been isolated previously from 
other Annonaceae32.
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DL-12 (15), C19H19NO4 was obtained as crystals, mp >297° [lit.34 buxifoline, 
mp >295°]. It is UV active and shows absorption bands at A,max 238, 280 nm. It 
showed Dragendorff positive spot on tic, indicating its alkaloidal nature. Its IR spectrum 
shows bands at vmax 3020, 1610, 1565, 1440 (aromatic) and 1030 (C-O) cm-1. Its 
mass spectrum shows a parent ion at m/z 325 and other peaks at 324 (M+-l), 310 (M+- 
15), 296 (M+-OCH), 295 (M+-OCH2), 294 (M+-OCH3), 279 (M+-CH20 2), 264 (M+- 
OCH3-OCH2) and 43 (base peak), consistent with an aporphine nucleus for DL-12.
OCH
NH
(15)
The *H NMR of DL-12 (15) shows a three spin system at 8h  7.94 (1H, d, J 8.5 
Hz, H -ll), 6.85 (1H, dd, J 8.5 Hz, H-10) and 6.80 (1H, d, J 2.5 Hz, H-8) associated 
with the aromatic ring D, a methylenedioxy group [8h 5.91, 6.05 (ABq, J 1.5 Hz)] and 
two methoxyls [5h 3.80 (s), 3.99 (s)]. These data are consistent with the aporphine 
alkaloid buxifoline (15) which has methoxyls at C-3 and C-9 and a methylenedioxy at C- 
1, C-2. Comparison with published data34 confirmed that DL-12 is buxifoline (15).
8 8
DL-13 (16), C19H 13N O 5 was obtained as crystals, mp 270° [lit.35 
oxobuxifoline, mp 268°]. It is UV active and shows absorption at Xmax 216, 252, 272, 
285 and 329 nm. It gave a positive Dragendorff spot on tic, indicating its alkaloidal 
nature. Its IR spectrum has bands at 1650 (C=0), 3020, 1600, 1580, 1460 (aromatic 
CH), 1220 and 1030 (C-O) cm-1 while its mass spectrum shows an [M++l] peak at m/z 
336 and a molecular ion (M+) at m/z 335 corresponding to C19H 13NO5. Other peaks 
include 334 (M+-H), 320 (M+-CH3), 304 (M+-OCH3), 307 (M+-CO), 306 (M+-CHO), 
305 (M+-CH2O), 292 (M+-CH3-CO), 290 (M+-CH3-OCH2), 276 (M+-OCH3 CO) and 
a base peak at m/z 28 (CO), consistent with an oxoapoiphine system.
OCH
(16)
The *H NMR of DL-13 reveals the presence of an AB quartet [8h 8.78, 8.13 
(each 1H, J 5.0 Hz, H-4, H-5)] in a pyridine ring and a three spin aromatic system [8h 
8.40 (1H, d, J 8.9 Hz, H -ll), 7.88 (1H, d, J 2.9 Hz, H-8, 7.22 (1H, dd, J 8.9, 2.9 
Hz, H-10)], in addition to a methylenedioxy group [8h 6.25 (s)] and two methoxyl 
groups [8h 3.91 (3H, s, MeO-9), 4.21 (3H, s, MeO-3)]. These data are consistent with
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an oxoaporphine alkaloid such as oxobuxifoline (16). The chemical shifts and coupling 
constants of H-4 and H-5 confirm the presence of a pyridine ring while the deshielded 
value of H-8 requires a C-7 carbonyl group. Comparison with published data35 
confirmed the identity of DL-13 as oxobuxifoline (16). There are slight differences in 
chemical shift because of solvent effects, since the original spectra were obtained in 
T F A 35.
Two further alkaloids DL-14 (17) (norstephalagine) and DL-15 (18) 
(atherospermidine) were also isolated. Their physical and spectroscopic properties were 
identical with those of norstephalagine (17) and atherospermidine (18), previously 
isolated from Artabotrys odoratissimus (see Chapter 5).
OCH
O
<o NH
(17)
OCH,
DL-16 (19) was obtained as orange-red crystals, mp >315°, [oc]d +34°  (c , 
0.032 in CHCI3). It is UV active and shows absorption at 240 (log e 4.37), 277 (log £ 
3.85), 287 (log e 4.08), 347 (log £ 3.73) and 360 (log £ 4.23) nm. Its IR exhibits bands 
at 3546 (hydroxyl), 3020, 1604, 1520, 1460, 1394, 1356, 1334 (aromatic) and 1030 
(C-O) cm-1. Its mass spectrum shows a molecular ion peak at m/z 325 and HREIMS
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confirmed its molecular formula as C19H19NO4. Other peaks include m/z 324 (M+-1), 
323 (M+-1-1), 310 (M+-15), 295 (M+-OCH2), 294 (M+-OCH3), 279 (M+-OCH3- 
CH3), 177 (C ioH hN 0 2 +) and 148 (C9Hg02 +). These data are consistent with a 
protoberberine alkaloid36. The appearance of peaks at m/z 177 and 148 suggests a 
berberine base containing hydroxy and methoxy groups in ring A and a methylenedioxy 
group in ring D36
HO.
14a
12a
(19)
11
The *H NMR of DL-16 shows four aromatic protons [5h 6.52-6.74 (4H, m)], a 
methylenedioxy [8h  5.91, 5.96 (ABq, J 1.4 Hz)], a methoxyl [8h  3.88 (3H, s)], four 
methylene groups [8h  4.10, 3.52 (ABq, J 15.3 Hz, H a -8 , H b-8), 3.26 (1H, dd, J 16.0, 
4.0 Hz, Ha -13), 2.81 (1H, dd, J 16.0, 11.0 Hz, HB-13), 2.61 (2H, m, 2H-5) and 3.08 
(2H, m, 2H-6)] and a methine proton [8h  3.58 (dd, J 11.0, 4.0 Hz, H-14)], confirming 
the deduction from the mass spectrum that the compound is a tetrahydroprotoberberine 
alkaloid with methylenedioxy, methoxy and hydroxy substituents. Unfortunately the 
aromatic protons of DL-16 are not well resolved. To avoid this problem the *H NMR 
spectrum was run in C6D6 as solvent. The *H NMR in C6D6 shows two aromatic 
singlets [SH 6.44 (1H, s, H-l), 6.79 (1H, s, H-4)] and an ABq [8H 6.66, 6.53 (each 
1H, J 8.0 Hz, H -ll, H-12)] in addition to a methylenedioxy [8h  5.34, 5.41 (ABq, J 1.4
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Hz)], the C-8 methylene [5h 4.15, 3.48 (ABq, J 15.2 Hz)], a methoxyl [5h 3.20 (3H, 
s)] and other aliphatic protons [8h  3.50 (2H, m, H-14, H b -5 ), 3.06 (2H, m, 2H-13), 
2.95 (2H, m, 2H-6) and 2.30 (1H, m, H a -5 )] . It seems likely that there are oxygen 
substituents at C-9/C-10 and C-2/C-3. The mass spectrum suggests that the 
methylenedioxy group is attached to ring D. To confirm this and to determine the 
relative positions of the methoxyl and phenolic hydroxy group and the methylenedioxy 
group we performed some NOE difference experiments. Irradiation of the methoxyl 
signal (8h 3.20) gave a NOE (10%) at H -1 (8 h  6.44) while irradiation at 8h 6.44 (H-l) 
gave a NOE (8%) at the methoxyl signal (8h  3.20) and additional NOEs at 8h  3.50 (H- 
14, 1%) and 8H 3.06 (2H-13, 2%). Irradiation of 8H 6.79 (H-4) gave a NOE (3%) at 8H
2.30 (H-5). These results confirm the position of the methoxyl group at C-2 and the 
hydroxyl at C-3. Irradiation of H-12 (8h  6.53) gave NOEs at 8h  6.66 (H-l 1) (5%) and 
at 8h 3.06 (2H-13) (2%). These results confirm the attachment of the methylenedioxy to 
C-9 and C-10.
The 13C NMR spectrum of DL-16 shows the expected features for a 
tetrahydroprotoberberine alkaloid. Thus it has four aromatic methines [8c  114.0 (C-l),
107.7 (C-4), 106.7 (C -ll), 120.9 (C-12)], a methylenedioxy [8c  101.1], a methoxyl 
[8C 56.0], four methylenes [8c  29.0 (C-5), 51.3 (C-6), 53.0 (C-8), 36.5 (C-13)] and a 
methine [8c  59.5 (C-14), in addition to eight aromatic singlets (see Table 6 ). 
Comparison of the 13C chemical shift data with those of descretanine37 (20) for the ring 
A carbons and stylophine38 (21) for rings B, C and D ring [see Table 6] confirms the 
structural assignments of DL-16 (19). There is a difference in the value of C-l which in 
our case is 8c 114.3 but is misassigned (8c 123.56) in the literature37. DL-16 (19) is a 
new natural product.
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HO.
OCH
(20)
OH
(21)
Q
O
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TA BLE 6 : 13C NM R o f  C om pounds (19), (20), (21).
Carbon
(19)
Compounds
(20) (21)
1 114.2 123.56
2 144.9* 146.05
3 145.2* 147.25
4 107.7 109.28
4a 129.0 128.36
5 29.0 29.6
6 51.3 51.2
8 53.0 52.9
8a 116.9 116.9
9 144.0* 146.2
10 143.3* 145.0
11 106.7 106.7
12 120.9 121.0
12a 127.4 128.8
13 36.5 36.5
14 59.5 59.8
14a 128.6 128.18
101.1 100.7
o c h 3 56.0 59.26
* Assignments may be interchangeable
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GENERAL EXPERIMENTAL
Melting points (mp) were determined on a Kofler hot-stage apparatus and are 
uncorrected. Infra-red (IR) spectra were recorded in CHCI3 solution (unless otherwise 
stated) on either a Perkin Elmer 580 or Philips 9800 FUR spectrometer. Ultra-violet 
(UV) spectra were measured for MeOH solutions (unless otherwise stated) using a 
Perkin-Elmer lambda 9 UV/Vis/NIR spectrometer. Low resolution mass spectra were 
determined using a VG updated MS 12 spectrometer while high resolution mass spectra 
were determined on a modified Kratos MS 9 instrument. Optical rotations were 
measured on an optical activity AA-100 polarimeter in CHCI3 solution at 20°C.
Unless otherwise stated, nuclear magnetic resonance (NMR) spectra were 
recorded at 298K and at 4.7T on Bruker WP 200SY and AM 200SY spectrometers (1H, 
200.132 MHz; 13C, 50.32 MHz). Higher field NMR spectra were recorded using either 
a Bruker AC 300 instrument (1H, 300.13 MHz; 13C, 75.47 MHz) at 7.05T or with a 
Varian VXR600S spectrometer (lH, 600 MHz; 13C, 150 MHz) at 14.IT. Spectra were 
recorded for CDCI3 solutions (unless otherwise specified) relative to CHCI3 at 8h  7.25 
and CDCI3 at 8c  77.00 and chemical shifts are recorded in ppm. Occasionally TMS was 
used as internal standard at 8 0.0. Tabulated *H NMR data have coupling constants (J) 
in Hz given in parenthesis. Signals indicated as m (multiplet) were unresolved or 
overlapping. *H NMR assignments are based on chemical shifts, correlation with 13C 
chemical shifts, homonuclear decoupling and NOE difference experiments and also on 
comparison with published data for similar compounds. 13C assignments are based on 
chemical shift, correlation with *H chemical shifts, multiplicities in DEPT or J. mod. 
13C spectra and comparison with published data for similar compounds. *H and 13C 
signals with similar chemical shifts and the same multiplicity are therefore interchangeable 
unless otherwise confirmed by 2D 8c/5h  and 8h /8h correlation experiments.
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Homonuclear proton NOE experiments were performed by selectively irradiating a single 
line of a multiplet for 3s and using a 90° observation pulse to minimise SPT effects. The 
NOEs reported are given as percentage saturation and are the result of scaling up the 
observed NOEs in inverse proportion to the degree of saturation in order to obtain values 
equivalent to the result of complete saturation. The HMQC (JH detected Heteronuclear 
Multiple Quantum Correlation)39 and HMBC (Heteronuclear Multiple Bond 
Correlation)40 experiments were performed on a Bruker AC 300 spectrometer (lH, 
300.13 MHz; 75.47 MHz) and are the inverse of the conventional chemical shift 
correlation experiments. In these techniques the couplings are observed from the
side of the much more sensitive proton which is detected during acquisition rather than 
the low y 13C nucleus and this greatly enhances the sensitivity of the NMR experiments. 
The pulse scheme for HMQC contains a BIRD pulse in order to remove large signals 
caused by protons not directly attached to 13C. Direct and long-range coupling constants 
have been chosen as 135.1 Hz and 7.1 Hz respectively for HMQC and HMBC 
experiments.
The solvents used were either of analytical grade or bulk solvents distilled before 
use. All plant material was air-dried, ground mechanically and extracted with EtOAc (in 
some cases by CHCI3 andEtOH) andMeOH. The crude extracts were then analysed by 
analytical tic and *H NMR. Extracts were then fractionated by flash column 
chromatography (FCC) over silica gel (Merck kieselgel GF254). Eluents for silica gel 
FCC were in most cases increasing percentages of EtOAc in petroleum ether (in some 
cases increasing percentage of CHCI3 in petroleum ether) followed by MeOH in EtOAc 
and finally MeOH. Each of the crude fractions was further purified by preparative thin- 
layer chromatography (PTLC) over silica gel (Merck kieselgel GF254,1mm thickness). 
Tic plates were developed using various solvent combinations in appropriate 
concentrations, the most commonly used solvent systems being EtOAc in petroleum 
ether, MeOH in CH2CI2 and MeOH in CHCI3. After each chromatographic separation 
the fractions were removed from PTLC plates or collected from columns were checked
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by analytical tic , *H NMR and sometimes NMR for their compositions. The total 
amount in each fraction was not always further chromatographed and therefore many of 
the actual yields are much greater than indicated in the experimental section.
All solvents were removed using a Buchi rotary evaporator and water aspirator. 
Petroleum ether refers to the fraction boiling between 40° and 60°. All reagents and 
solvents used in chemical reactions were purified according to literature methods. 
Analytical tic was over Merck precoated silica gel 60 F254 (0.25 mm thickness). 
Preparative and analytical plates were visualized under UV light (254 or 366 nm), by 
Dragendorff s reagent41, by adsorption of I2 vapour or by spraying with 25% H2SO4 
and heating.
C ollection and Identification  o f Plant M aterial
The plant material collected in Bangladesh was identified by Mr. A. Hasan, 
Department of Botany, University of Dhaka. Voucher specimens are deposited in the 
University Herbarium in Dhaka. Polyalthia bullata was collected by the botanist of the 
Forest Research Institute of Malaysia and a voucher specimen is deposited in the Institute 
Herbarium in Kepong near Kuala Lumpur.
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EXPERIMENTAL
Isolation. The plant material of Desmos longiflorus was collected from the 
district of Sylhet, Bangladesh. The dried ground stem bark (900g) was extracted 
successively with CHCI3 and MeOH. The CHCI3 extract (26g) was concentrated in 
vacuo and a portion (13g) was subjected to flash column chromatography over silica gel. 
The column was first eluted with petroleum ether, then increasing amounts of EtOAc in 
petroleum ether and finally MeOH, collecting 100ml fractions. Fractions were monitored 
by analytical tic. The early fractions contained mainly fat. The later fractions showed 
many spots on analytical tic. Multiple preparative tic using petroleum ether : EtOAc (85 : 
15), (88 : 12) and (97 : 3) of fractions 10, 13 and 7 respectively afforded DL-1 
(sitostenone, lOOmg), DL-3 (benzyl benzoate, 40mg), DL-6 (15a-hydroxy-24- 
methylene-lanosta-7,9(ll)-dien-3-one, 22mg), DL-2 (4-stigmastene-3,6-dione, 8.0mg) 
and DL-10 (unidentified, 10 mg). Multiple preparative tic of fractions 30, 38, 40 using 
petroleum ether: CH2CI2 : MeOH (14 : 85 :1) afforded DL-4 (crotepoxide, 60mg), DL-5 
[N-benzoyl-0-(N1-benzoyl-L-phenylalanyl)-L-phenylalaninol, 25mg], DL-7 (lOmg), DL- 
8 (22mg) and DL-9 (13mg).
The MeOH extract (lOg) was concentrated in vacuo and subjected to flash 
column chromatography over silica gel. The column was eluted with EtOAc, then 
increasing amounts of MeOH in EtOAc and finally with MeOH. Multiple preparative tic 
using CH2CI2 : MeOH (97 : 3), (94 : 6) and (90 : 10) of fractions 13, 15 and 16 afforded 
DL-12 (buxifoline, 3.0mg), DL-14 (norstephalagine, lOmg), DL-13 (oxobuxifoline, 
2.5mg), DL-11 (oxocrebanine, 26mg), DL-15 (atherospermidine, lOmg), and DL-16 (3- 
hydroxy-2-methoxy -9,10-methylenedioxytetrahydroprotoberberine, 15mg).
DL-1 (Sitostenone, 1), needles (MeOH), mp 95°, [a ]D + 8 1 .0 °  (c, 1.00 in 
CHCI3); IR vmax : 2960, 2850, 1680, 1620, 1410, 1380 cm-1; EIMS m/z (rel. int.) :
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412 (36), 397 (5), 370 (16), 327 (5), 289 (19), 271 (21), 269 (11), 230 (11), 229 (42), 
187 (11), 161 (13), 149 (26), 148 (16), 147 (30), 135 (27), 134 (13), 133 (20), 131
(13), 125 (14), 124 (100), 123 (25), 121 (27), 119 (20), 109 (27), 107 (30), 105 (28), 
97 (20), 95 (39), 93 (30), 91 (30), 83 (22), 81 (37), 79 (30), 69 (33), 67 (27), 57 (27), 
55 (64), 53 (66), 43 (40), 28 (46); lH NMR : 5H 0.67 (3H, s, Me-18), 1.15 (3H, s, 
Me-19), 0.78 (3H, d, J 6.8 Hz, Me-26), 0.88 (3H, d, J 6.8 Hz, Me-27), 1.10 (3H, d, J 
6.4 Hz, Me-21), 0.96 (3H, t, J 6.5 Hz, Me-29), 5.67 (1H, s, H-4), 1.28-2.60 (30H, 
m); J3C NMR : 5c 35.8 (C-l), 33.8 (C-2), 199.6 (C-3), 123.6 (C-4), 171.7 (C-5), 32.8 
(C-6), 31.9 (C-7), 34.5 (C-8), 53.7 (C-9), 38.5 (C-10), 21.0 (C-ll), 39.4 (C-12), 42.2 
(C -l3), 55.7 (C-14), 24.1 (C-15), 28.1 (C-16), 55.8 (C-17), 11.8 (C-18), 17.2 (C-19),
36.5 (C-20), 18.9 (C-21), 35.5 (C-22), 21.1 (C-23), 45.6 (C-24), 29.0 (C-25), 18.6 
(C-26), 19.3 (C-27), 22.9 (C-28), 12.2 (C-29).
DL-2 (4-Stigmastene-3,6-dione, 2), crystals (MeOH), mp 170°; [a]o -60.0° (c,
I.00 in CHC13); IR Vmax- 2960, 2870, 1680, 1617, 1520, 1464, 1380, 1334, 1269, 
1215, 930 cm-1; EIMS m/z (rel. int.) : 426 (1), 411 (2), 285 (6), 243 (5), 189 (3), 175 
(7), 149 (12), 137 (6), 123 (15), 121 (11), 109 (21), 107 (14), 105 (16), 97 (13), 93
(14), 91 (22), 83 (15), 81 (24), 77 (20), 71 (20), 69 (30), 57 (30), 55 (40), 43 (100); lH 
NMR : 5h 0.71, 1.15 (2x3H, 2xs, Me-18, Me-19), 0.78 (3H, d, J 6.5 Hz, Me-26),
0.84 (3H, d, J 6.5 Hz, Me-27), 0.87 (3H, d, J 6.4 Hz, Me-21), 0.95 (3H, t, J 6.4 Hz, 
Me-29), 6.16 (1H, s, H-4); ^ C  NMR : 8C 34.1 (C-l), 33.8 (C-2), 199.6 (C-3), 125.4 
(C-4), 161.1 (C-5), 202.4 (C-6), 46.8 (C-7), 34.2 (C-8), 50.9 (C-9), 39.8 (C-10), 20.8 
(C-ll), 39.1 (C-12), 42.5 (C-13), 55.8 (C-14), 25.0 (C-15), 28.0 (C-16), 56.7 (C-17),
II.9 (C-18), 17.5 (C-19), 36.0 (C-20), 18.7 (C-21), 34.5 (C-22), 23.0 (C-23), 45.7 
(C-24), 29.1 (C-25), 19.0 (C-26), 19.8 (C-27), 24.0 (C-28), 12.0 (C-29).
DL-3 (Benzyl benzoate, 3), oil, UV A,max Oog e ) : 228 (3.63), 235 (3.86), 260 
(3.55), 273 (4.13) , 280 (3.96) nm; IR vmax : 1722, 1603, 1585, 1520, 1498, 1450, 
1380, 1315, 1277, 1215, 1176, 1115,1072, 1027, 960, 930, 885 cm-1; EIMS m/z (rel.
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int.) : 212 (27), 109 (2), 108 (2), 107 (8), 106 (9), 105 (100), 93 (2), 91 (50), 90 (7), 
89 (5), 77 (35), 65 (14)), 51 (18), 28 (14); NMR : 5H 8.07 (1H, m), 8.11 (1H, m), 
7.35-7.60 (8H, m), 5.38 (2H, s); 13C NMR : 6c  136.0 (C-l), 129.7 (C-2’), 128.3 (C- 
3'), 133.0 (C-4’), 128.3 (C-51), 129.7 (C-6’), 166.4 (C-7), 130.1 (C-l’), 128.4 (C-2),
128.2 (C-3), 128.0 (C-4), 128.2 (C-5), 128.4 (C-6), 66.6 (C-71).
DL-4 (Crotepoxide, 4), needles (MeOH), mp 152°; [a]o +64.4° (c, 1.00 in 
CHC13); UV Xmax (log e) : 281 (3.54), 273 (3.43), 223 (4.30) nm; IR vmax : 3020, 
2960, 2930, 1756, 1732, 1690, 1602, 1151, 1456, 1372, 1260, 1235, 1210, 1154, 
1107, 1070, 1010, 980 cm-1; EIMS m/z (rel. int.) : 362 (1), 303 (1), 249 (1), 231 (2), 
227 (8), 207 (3), 185 (2), 163 (9), 157 (30), 138 (6), 125 (4), 115 (8), 106 (8), 105 
(100), 97 (100, 77 (23), 71(4); *H NMR : 6H 8.01 (2H, m), 7.57 (1H, m), 7.44 (2H, 
m), 5.68 (1H, d, J 10.0 Hz, H-2), 4.98 (1H, dd, J 10.0, 1.5 Hz, H-3), 3.05 (1H, dd, J
4.0, 1.5 Hz, H-4), 3.42 (1H, dd, J 4.0, 2.5 Hz, H-5), 3.65 (1H, d, J 2.5 Hz, H-6), 
4.21, 4.55 (2H, ABq, J 12.0 Hz, Ha-7, Hb-7), 2.00 (3H, s, CH3-CO-), 2.07 (3H, s, 
CH3CO-); 13C NMR : 8C 59.4 (C-l), 69.4 (C-2), 70.3 (C-3), 52.5 (C-4), 48.0 (C-5), 
53.7 (C-6), 62.4 (C-7), 129.0 (C-l’), 129.7 (C-2’), 128.5 (C-3’), 133.5 (C-4’), 128.5 
(C-51), 129.7 (C-6*), 170.0 (2-00£CH 3), 169.5 (3-00£CH3), 165.5 (CH20 £ 0 ) , 20.6 
(2xMeCO).
DL-5 [N-benzoyl-0-(N'-benzoyl-L-phenylalanyl)-L-phenylalaninol, 5], white 
crystals (EtOAc), mp 208-210°; [a]D -75° (c, 0.103 in EtOH); UV Xmax (log e ) : 215 
(4.03), 230 (4.35) nm; IR vmax (KBr) : 3340, 3025, 1750, 1640, 1600, 1580, 1530, 
1488, 1386, 1350, 1302, 1295, 1275, 1210, 1170, 1160, 1098, 1076, 1025, 1000, 
745, 710, 694 cm-1; EIMS m/z (rel. int.) : 506 (M+) (1), 415 (M+-PhCH2) (1), 385 
(M + -P h C O N H 2) (1), 294 (M + -P hC O N H 2-P h C H 2) (4), 269 (2), 252 
[PhCH2CH(NHBz)=C=0]+ (8), 224 (PhCH2CHNHBz)+ (9), 223 (2), 213 (2), 149 
(9), 148 (10), 147 (10), 146 [252-PhCHO+] (51), 133 (5), 119 (224-PhCO+) (8), 118 
(12), 109 (6), 107 (5), 106 (8), 105 (PhCO+) (100), 97 (9), 95 (7), 91 (PhCH2+) (32),
100
85 (7), 83 (10), 81 (10), 77 (Ph+) (38),71 (10), 57 (16), 55 (18), 43 (25), 28 (60); 1H 
NMR : 8h 7.71 (4H, m), 7.15-7.50 (16H, m), 6.72 (1H, d, J 8.2 Hz, NH), 6.62 (1H, 
dd, J 6.6 Hz, NH), 4.96 (1H, q, J 6.6 Hz, H-2), 4.62 (1H, m, H-2’), 4.57 (1H, dd, J
11.3, 3.3 Hz) and 4.05 (1H, dd, J 11.3, 4.2 Hz) [2H-1], 3.32 (1H, dd, J 13.8, 6.6 Hz) 
and 3.20 (1H, dd, J 13.8, 7.0 Hz) [2H-3'], 3.02 (1H, dd, J 13.6, 6.4 Hz) and 2.90 
(1H, dd, J 13.6, 8.1 Hz) [2H-3]; 13C NMR : 8C 65.4 (C-l), 54.5 (C-2), 37.2 (C-3),
171.9 (C-l’), 50.2 (C-2'), 37.4 (C-31), 126.8 (1C, d), 127.0 (2C, d), 127.1 (2C, d),
127.3 (1C, d), 128.4 (2C, d), 128.6 (4C, d), 128.8 (2C, d), 129.1 (2C, d), 129.3 (2C, 
d), 131.4 (1C, d), 132.0 (1C, d), 133.2 (1C, s), 134.1 (1C, s), 135.7 (1C, s), 137.1 
(1C, s), 167.2 (CONH), 167.4 (CONH). HREIMS : Found 506.2223; calculated for 
C32H30N2O4 506.2205.
DL-6 (15a-Hydroxy-24-methylenelanosta-7,9(ll)-dien-3-one, 6), colourless 
needles (MeOH), mp 156-158°; [cx]d +42.6°(c, 2.00 in CHCI3); UV Xmax (loge): 252 
(4.05), 243 (4.11), 236 (3.96) nm; IR vmax : 3400, 1715, 1640, 1462, 1380, 1217, 
1065, 1010, 890 cm-1; EIMS m/z (rel. int.) : 452 (M+, 100), 437 (M+-CH3) (13), 419 
(M+-CH3-H20 ) (11), 337 [M+-C9H i7(side chain)] (14), 285 (11), 271 (23), 199 (15), 
185 (25), 157 (29), 125 (C9H 17, side chain) (26), 123 (34), 119 (39), 105 (32), 95 
(38), 83 (47), 69 (76), 55 (91), 43 (82), 28 (59); *H NMR : 8H 0.62 (3H, s, Me-18),
0.88 (3H, d, J 6.8 Hz, Me-21), 0.91 (3H, s, Me-30), 1.00 (3H, d, J 6.8 Hz, Me-26),
1.03 (3H, d, J 6.8 Hz, Me-27), 1.08 (3H, s, Me-29), 1.11 (3H, s, Me-28),1.18 (3H, s, 
Me-19), 2.75 (1H, ddd, J 14.8, 14.5, 6.0 Hz, Hp-2), 4.27 (1H, dd, 9.8, 5.6 Hz, HP- 
15), 4.64, 4.71 (2xlH, 2xbr s, Hz -31, HE-31), 5.37 (1H, d, J 6.0 Hz, H -ll), 5.88 
(1H, d, J 5.0 Hz, H-7); 13C NMR (see Table 1). HREIMS : Found 452.3662; 
calculated for C31H48O2 452.3654.
DL-7 ( 9), a gum , [<x]D +10.7° (c, 0.29 in CHCI3); UV W  : 250 (log e 3.45) 
nm; IR vmax : 3620, 3450, 3020, 2966, 2936, 2872, 1649, 1620, 1570, 1522, 1420, 
1217, 1049, 930, 880 cm-*; EIMS m/z (rel. int.) : 318 (M+) (1), 300 (M+-H20) (1),
101
289 (8), 282 (M+-2xH20) (5), 271(22), 269 (10), 267 (2), 264 (1), 257 (10), 246 (31), 
245 (8), 244 (6), 239 (2), 230 (9), 229 (30), 228 (8), 220 (2), 202 (3), 196 (6), 185
(21), 175 (7), 173 (6), 167 (7), 161 (9), 159 (11), 147 (25), 145 (10), 142 (69), 140 
(4), 135 (21), 133 (14), 125 (13), 124 (100), 123 (5), 121 (12), 119 (4), 117 (5), 109 
(7), 105 (20), 104 (100), 103 (90), 99 (15), 81 (8), 79 (9), 78 (100), 77 (12), 72 (3), 69 
(12), 55 (16), 43 (44), 28 (50); >H NMR (see T a b le  2); 13c NMR (see T ab le  3). 
HREIMS : Found 318.1425; calculated for C18H22O5 318.1467.
DL-8 ( 10), a gum, [cc]D +5.0° (c, 0.65 in CHCI3); UV X.max (log e 4.10): 253 
nm; IR vmax : 3620, 3547, 3020, 2978, 2860, 1736, 1655, 1603, 1570, 1522, 1475, 
1425, 1335, 1211, 1047, 1030, 930, 875, 850 cm-1; EIMS m/z (rel. int.) : 342 (M+- 
H2O) (4), 324 (M+-2xH20) (2), 317 (18), 300 (7), 283 (4), 282 (15), 257 (16), 253
(2), 246 (9), 239 (6), 229 (9), 228 (90), 227 (4), 226 (7), 203 (7), 200 (4), 195 (5), 186 
(9), 185 (98), 184 (7), 168 (7), 158 (6), 157 (16), 156 (5), 155 (7), 153 (5), 143 (25),
142 (7), 135 (5), 131 (8), 129 (14), 128 (16), 127 (9), 117 (18), 116 (5), 115 (11), 107
(12), 105 (21), 104 (100), 103 (8), 99 (27), 95 (9), 91 (18), 83 (15), 81 (9), 79 (9), 78 
(7), 77 (12), 71 (11), 69 (17), 57 (8), 55 (16), 53 (6), 45 (6), 43 (70), 41 (15), 28 (25); 
•H NMR (see T a b le  2); 13c NMR (see T a b le  3). HREIMS : Found [M+-18] 
342.1480; calculated for C20H22O5 342.1467.
DL-9 (II), a gum, [<x]D +6.5° (c, 0.20 in CHCI3); UV W x  : 253 (log e 3.74) 
nm; IR vmax : 3650, 3601, 3454, 3020, 2957, 2872, 1647, 1625, 1570, 1560, 1522, 
1475, 1420, 1375, 1334, 1220, 1055, 1032.,1008, 964, 930 cm-1; EIMS m/z (rel. int.) 
; 318 (1), 300 (M+-H20 ) (3), 285 (M+-H2O-CH3) (1), 282 (M+-2xH20) (3), 267(1), 
257 (30), 246 (10), 240 (30, 239 (3), 228 (40), 220 (4), 202 (4), 187 (30, 186 (3), 185 
(12), 182 (6), 179 (8), 167 (6), 165 (60, 164 (16), 163 (8), 157 (5), 153 (5), 149 (10),
142 (37), 137 (8), 136 (6), 135 (11), 134 (5), 133 (9), 127 (9), 125 (8), 123 (16), 121
(12), 119 (8), 117 (8), 115 (8), 111 (9), 109 (17), 108 (9), 107 (17), 106 (7), 105 (29), 
104 (100), 103 (12), 99 (20), 97 (10), 95 (20), 93 (16), 91 (22), 85 (10), 83 (15), 81
102
(22), 79 (19), 78 (13), 77 (20), 71 (30), 69 (22), 67 (18), 57 (17), 55 (35), 53 (14), 43 
(90), 41 (45); >H NMR (see Table 2); NMR (see Table 3). HREIMS : Found 
318.1490; calculated for C18H22O5 318.1467.
DL-11 (Oxocrebanine, 12), orange-red needles (CHCI3), mp 266-268°; UV 
kmax (log e) : 250 (4.32), 275, (4.20) 380 (3.68) nm; IR vmax : 3020, 1665, 1603, 
1579, 1520, 1468, 1423, 1335, 1215, 1043, 1022,974, 927 cm-1; EIMS m/z (rel. in t.): 
335 (100), 320 (15), 307 (7), 306 (43), 305 (19), 404 (23), 292 (12), 276 (14), 265 
(71), 250 (30), 235 (8), 222 (13), 221 (9), 187 (10), 185 (9), 182 (12), 178 (20), 176
(12), 167 (24), 166 (22), 165 (15), 164 (19), 163 (18), 161 (15), 159 (17), 152 (13), 
151 (14), 149 (16), 139 (20), 137 (17), 123 (19), 111 (18), 109 (22), 107 (17), 105
(22), 104 (22), 95 (24), 91 (22), 77 (19); NMR : 8h  7.64, 8.78 (2H, ABq, J 5.0 
Hz, H-4, 5-H), 7.03 (1H, s, H-3), 7.17, 8.31 (2H, ABq, J 9.0 Hz, H-10, H -ll), 6.29 
(2H, s, CH2O2), 3.94 (3H, s, MeO-9), 4.00 (3H, s, MeO-8); NMR : 8c  145.5 (C-
1), 108.0 (C-la), 121.7 (C-lb), 151.7 (C-2), 101.9 (C-3), 135.4 (C-3a), 123.7 (C-4),
144.1 (C-5), 144.6 (C-6a), 181.6 (C-7), 126.4 (C-7a), 153.3 (C-8)*, 150.8 (C-9)*,
117.0 (C-10), 123.8 (C -ll), 128.6 (C -lla), 102.3 (CH2O2), 56.0 (OCH3), 61.0 
(OCH3). HREIMS : Found 335.0793; calculated for C19H13NO5 335.0794.
* Assignments may be interchangable.
DL-12 (Buxifoline, 15), crystals (MeOH); mp 292°; UV Xmax (log 6) : 238 
(4.21), 280 (3.92) nm; IR Vmax : 3020, 2960, 2836, 1610, 1565, 1440, 1240, 1030, 
980 cm-1; EIMS m/z (rel. int.) : 325 (26), 324 (44), 323 (21), 310 (9), 296 (11), 295
(15), 294 (11), 293 (8), 280 (9), 278 (10), 266 (11), 265 (14), 264 (7), 208 (10), 207 
(11), 180 (11), 178 (12), 165 (17), 164 (10), 163 (12), 153 (12), 152 (26), 151 (17), 
149 (19), 111 (10), 89 (12), 83 (200), 81 (16), 77 (13), 71 (20), 57 (47), 56 (17), 55 
(57), 44 (14), 43 (100), 28 (40); 1H NMR : 8H 7.94 (1H, d, J 8.5 Hz, H -ll), 6.85 
(1H, dd, J 8.5, 2.5 Hz, H-10), 6.80 (1H, d, J 2.5 Hz, H-8), 5.91, 6.05 (2H, ABq, J
1.5 Hz, CH2O2), 3.80 (3H, s, MeO-9), 3.99 (3H, s, MeO-3).
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DL-13 (Oxobuxifoline, 16) crystals (CHCI3), mp 270°; UV kmax Gog e) • 216 
(4.18), 252 (4.33), 272 (4.39), 285 (4.52), 329 (3.60) nm; IR vmax : 3020, 1650, 
1600, 1580, 1460, 1220, 1030 cm-1; EIMS m/z (rel. in t.): 335 (43), 334 (3), 320 (12), 
307 (10), 306 (30), 305 (5), 304 (15), 292 (16), 291 (8), 290 (10), 276 (12), 264 (12), 
263 (18), 234 (15), 206 (17), 205 (11), 178 (14), 177 (14), 176 (16), 164 (17), 163 
(24), 162 (13), 151 (15), 150 (15), 149 (14), 111 (6), 110 (10), 99 (9), 98 (10), 88
(13), 77 (9), 75 (15), 69 (15), 57 (20), 55 (30), 43 (33), 41 (26), 32 (19), 29 (26), 28 
(100); lH NMR : SH 8.78, 8.13 (2H, ABq, J 5.0 Hz, H-4, H-5), 8.40 (1H, d, J 8.9 
Hz, H -ll), 7.22 (1H, dd, J 8.9, 2.9 Hz, H-10), 7.88 (1H, d, J 2.9 Hz, H-8), 6.25 
(2H, s, CH2O2), 3.91 (3H, s, MeO-9), 4.21 (3H, s, MeO-3).
DL-16 (3-hydroxy-2-Methoxy-9,10-methylenedioxytetrahydroprotoberberine, 
19), orange-red crystals (MeOH), mp >315°» [(x]d +34.4°  (c , 0.032 in CHCI3); UV 
W x  (log e ) : 240 (4.37), 277 (3.85), 287 ( 4.08), 347 (3.73), 360 (4.23) nm; IR vmax 
: 3546, 3020, 2934, 2812, 1604, 1520, 1460, 1394, 1356, 1334, 1260, 1215, 1136, 
1107, 1055, 1030, 930, 875, 849, 790, 670 cm-1; EIMS m/z (rel. int.) : 325 (36), 324 
(20), 323 (16), 322 (21), 310 (3), 295 (2), 294 (2), 279 (4), 177 (20), 176 (16), 149
(23), 148 (100), 147 (10), 133 (6), 105 (6), 92 (7), 91 (22), 89 (13), 78 (6), 77 (8), 69 
(6), 57 (8), 43 (16); JH NMR (CDCI3) : 6H 6.52-6.74 (4H, m), 5.91, 5.96 (2H, ABq, 
J 1.4 Hz, CH2O2), 3.88 (3H, s, MeO-2), 4.10, 3.52 (2H, ABq, J 15.3 Hz, HA-8, HB- 
8), 3.26 (1H, dd, J 16.0, 4.0 Hz, HA-13), 2.81 (1H, dd, J 16.0 , 11.0 Hz, HB-13), 
2.61 (2H, m, 2H-5), 3.08 (2H, m, 2H-6), 3.58 (1H, dd, J 11.0, 4.0 Hz, H-14); JH 
NMR (C6D6) : SH 6.79 (1H, s, H-4), 6.66 (1H, d, J 8.0 Hz, H -ll), 6.53 (1H, d, J 8.0 
Hz, H -l2), 6.44 (1H, s, H-l), 5.34, 5.41 (2H, ABq, J 1.4 Hz, CH2O2), 4.15, 3.48 
(2H, ABq, J 15.2 Hz, HA-8, HB-8), 3.20 (3H, s, MeO-2), 3.50 (2H, m, H-14, HB-5),
3.06 (2H, m, 2H-13), 2.95 (2H, m, 2H-6), 2.30 (1H, m, HA-5); 13C NMR (see Table 
6). HREIMS : Found 325.1318; calculated for C19H19NO4 325.1315.
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CHAPTER 4
BENGALENSOL, A NEW 16-EPICAFESTOL 
DERIVATIVE, FROM THE LEAVES OF 
C O F F E A  B E N G A L E N S I S  ROXB. 
(RUBIACEAE).
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INTRODUCTION
The genus Coffea (Rubiaceae) comprises 20 species of shrubs, which are 
distributed in the tropics1. The furanoid diterpenoid cafestol (1) is a constituent of coffee 
(Coffea arabica )2*3 . Two related glycosides, mascaroside (2) and mozambioside (3) 
have been isolated from C. vianneyfi and C. arabica4, and C. pseudozanguebariae5 
respectively. Coffea bengalensis Roxb. is a shrub with horizontal slender branches 
which grows widely in Bangladesh, Asam, Nepal and Java island1. The fruits of this 
plant have been previously investigated6. We have investigated the leaves of C. 
bengalensis and have isolated7 a new cafestol type diterpenoid which we have named 
bengalensol. The evidence for the structure of bengalensol (4) is presented below.
RESULTS AND DISCUSSION
On chromatography over silica gel the ethanol extract of the leaves of C. 
bengalensis yielded one compound CB-1, bengalensol, which was subsequently 
identified as the new diterpenoid ertf-18(4—»19)-abeo-3,18;lla,16a-diepoxy-17- 
hydroxy-3,18-kauradien-2-one (4).
CB-1 (4) was isolated as a gum, C20H24O4, [oc]d  -286° (c, 0.103 in CHCI3). Its 
IR spectrum exhibits 3586 (hydroxyl), 3450 (hydroxyl), 1672 (conjugated ketone) and 
3020 and 1600 (aromatic) cm-1 absorption. Its mass spectrum displays an [M+] peak at 
m/z 328, together with fragments at m/z 310 [M+-18] and 239. The NMR spectrum 
(Fig. 8) of CB-1 shows resonances for a tertiary methyl group [8h  1.04 (d, J 1.0 Hz)], 
for protons attached to primary [8h  3.80 and 3.64 (ABq, J 11.6 Hz)] and secondary [8h  
4.43 (t, J 3.4 Hz)] oxygenated carbons, and a disubstituted furan ring [8h  6.41 and 7.58 
(both d, J 1.8 Hz)]. The 13C NMR spectrum (Fig. 9) of CB-1 (4)5>9 reveals a ketonic
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carbonyl [6c  184.7] in conjugation with the disubstituted furan [6c  146.3 (s), 141.3 (s),
148.0 (d), 110.1 (d)], primary [6c 65.8], secondary [5c 77.0]and tertiary [5c 89.2] 
oxygenated carbons and a methyl carbon [6c  16.6], in addition to six methylenes [8c 
53.7, 52.5, 43.3, 40.5, 36.1, 22.0], three methines [5C 55.7, 45.5, 41.8] and two 
quaternary carbons [6c  44.1,42.9]. The molecule is therefore a pentacyclic diterpenoid, 
in addition to the furan . One of these rings must be a cyclic ether since there are only 
two oxygens to share among three oxygenated carbons.
HO,
(2) R=OH; 17-O-P-D-glu
(3) R=H; 11-O-p-D-glu
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Acetylation of bengalensol (4) afforded a monoacetate (5), C22H2605* [m/z 
370.1757], as a gum. The IR spectrum of (5) reveals bands for conjugated ketone 
(Vmax 1687 cm-1) and acetate (vmax 1750 cm-1) absorption but lacks hydroxyl 
absorption. The downfield shift of the AB system (8h  4.33 and 4.14, J 11.7 Hz) 
relative to (4) indicates that the acetate is primary. The chemical shift (5h 4.45) of the 
proton attached to the secondary oxygenated carbon remains virtually unchanged.
12
20 '
1819
(4) R=H
(5) R=Ac
From the COSY (see Fig. 10) and HMQC (see Fig. 11) spectra of CB-1 it was 
possible to identify all the protons and the protonated carbons (see Experimental). The 
following spin systems were observed : 2H-1 (Jgem 16.0 Hz) with one of protons 
showing a long range coupling (J 1.0 Hz) with the methyl group 3H-20; H-5, 2H-6, 
2H-7; H-9, H -ll, H-12a , H-13, H-14R, H-14S; 2H-15 with the P proton coupled to 
H-14S. These data are consistent with a cafestol nucleus containing a 2-oxo group, an 
11,16 ether and a 17-hydroxyl function and lead to the gross structure (4) for CB-1 
(bengalensol). Confirmation of this structure and assignment of the non-protonated 
carbons were obtained from the HMBC spectrum. The principal correlations are listed in 
Table 7.
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T A BLE 7. L ong-range C orrelations o f  B engalensol (4)
Carbon Long-range correlations
1 3H-20
2 2H-1
3 H -la , H-18, H-19
4 H-18, H-19
5 H -la , 3H-20
6 -
7 H-15p
8 H-13, H-15a, H-14R
9 H-ip
10 2H-1, H-9, 3H-20
11 H-13, H-12a, H-9
12 H-9, H-14R
13 2H-17, H-15p, H-14R
14 H-12P
15 H-17 (5 3.64), H-14S
16 2H-17, H-12p, H-15p
17 H-13, H-15a
18 -
19 H-18
20 2H-1, H-9
Bengalensol has the same oxygenation pattern as the aglycone of mozambioside
(3), but the presence of the ether requires an inversion of configuration at C-16. A good 
example of this type of ether is provided by ercf-1 la,16a-epoxy-17-kauranol (6), from 
Rabdosia liangshanica^ , whose comparable *H and 13C shifts [8h4.43 (t, J 3.5 Hz, H-
11): 5c 76.7 (C-11), 89.6 (C-16) and 65.6 (C-17)] are virtually identical with those of
(4). Confirmation of the configuration at C-16 was obtained by NOE difference 
experiments. Thus separate irradiation of the primary alcohol 2H-17 protons afforded 
similar NOEs at H-13 (ca 6%) and at one H-15 (3%) [8h  1.38 (d, J 11.2 Hz)] which
112
must be H-15a since H-15p (8h  1.61) is a doublet of doublets (J 11.2, 3.5 Hz) with a 
W coupling to H-14S. Therefore the C-17 primary alcohol group must also be a  ie the 
configuration at C-16 is the opposite of that observed in the known compounds (1), (2) 
and (3). The normal kaurane relative stereochemistry of (4) is supported by a large
(6)
NOE from the C-20 methyl group to H-14S. Irradiation of the methyl group also affords 
NOEs at H -la  (H-lp has quartet splitting due to the W coupling with the methyl group) 
and H -lla . The C -ll oxygen function is therefore p (ent-a). Irradiation of H - lla  
results in a large NOE (10%) at H -la. The conformation of ring C is substantially 
chair-like since H-9 and H - lla  have only a very small vicinal coupling. H-13 appears as 
a triplet (J 6.5 Hz) and couples only with H-14R and H-12a. The absolute configuration 
of bengalensol (4) has not been rigorously established but its large negative rotation is 
consistent with ent stereochemistry6.
EXPERIMENTAL
Isolation. The leaves of Coffea bengalensis were collected at Savar and 
Kapashia in the Dhaka district of Bangladesh. Dried, powered leaves (500g) were 
extracted with EtOH in a Soxhlet extractor. The solvent was removed in vacuo and the
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residue subjected to flash column chromatography over silica gel using increasing 
amounts of EtOAc in petroleum ether. Ten fractions (100 ml) were collected and 
monitored by analytical tic. Early fractions contained only fat. Preparative tic of 
combined fractions 3-5 using acetone : toluene : AcOH (10 : 9 : 0.5) afforded crude 
bengalensol (4) (30mg) which was further purified by preparative tic using CH2CI2 : 
MeOH (98 :2).
The pure compound, ertf-18(4->19)-abeo-3,18;lla,16a-diepoxy-17-hydroxy- 
3,18-kauradien-2-one (4), was obtained as a gum , C20H24O4, [a]o -286° (c, 0.103 in 
CHCI3), IR Vmax : 3580, 3450, 3020, 1672, 1600 cm-1; EIMS m/z (rel. int.) : 328 
[M+] (40), 310 [ M+-18] (10), 239 (16), 161 (36), 149 (40), 147 (27), 121 (23), 107 
(20), 105 (30), 93 (22), 91 (50), 28 (100); *H NMR : 8H 2.39 (1H, dq, J 16.0, 1.0 Hz, 
H -lp), 2.69 (1H, d, J 16.0 Hz, H -la), 2.78 (1H, dd, J 12.2, 2.7 Hz, H-5), 1.90 (1H, 
m) and 1.50 (1H, m) (2H-6), 1.75 (1H, m) and 1.50 (1H, m) (2H-7), 1.95 (1H, br s, 
H-9), 4.43 (1H, t, J 3.4 Hz, H -lla ) , 2.02 (1H, d , J 11.6 Hz, H-12P), 1.83 (1H, m, 
H-12a), 2.55 (1H, t, J 6.5 Hz, H-13), 2.00 (1H, dd, J 12.0, 3.5 Hz, H-14S), 1.27 
(1H, ddt, J 12.0, 6.5, 2.3 Hz, H-14R), 1.38 (1H, d, J11.2 Hz, H-15a), 1.61 (1H, dd, 
J 11.2, 3.5 Hz, H-15P), 3.80 and 3.64 (both 1H, d, J 11.6 Hz, 2H-17), 6.41 (1H, d, J
1.8 Hz, H-18), 7.58 (1H, d, J 1.8 Hz, H-19), 1.04 (3H, d, J 1.0 Hz, Me-20); 13C 
NMR : 8c  53.7 (C-l), 184.7 (C-2), 146.3 (C-3), 141.3 (C-4), 45.5 (C-5), 22.0 (C-6),
36.1 (C-7), 44.1 (C-8), 55.7 (C-9), 42.9 (C-10), 77.0 (C -ll), 40.5 (C-12), 41.8 (C- 
13), 43.3 (C-14), 52.5 (C-15), 89.2 (C-16), 65.8 (C-17), 110.1 (C-18), 148.0 (C-19),
16.6 (C-20).
Acetylation of (4) (3mg) with AC2O in pyridine at room temperature overnight 
followed by the usual workup and purification by preparative TLC afforded the acetate
(5) as a gum, IR (CCI4) : 1750, 1687 cm '1; EIMS m/z (rel. int.) : 370 (22), 310 (74), 
295 (12), 282 (12), 239 (13), 161 (40), 147 (35), 121 (21), 105 (30), 91 (52), 77 (29), 
43 (100); !H NMR : 8h  2.38 (dq, J 16.1, 1.0 Hz, H-1P), 2.70 (d, J 16.1 Hz, H -la),
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2.79 (dd, J 12.1, 2.5 Hz, H-5), 4.45 (br t, H -ll), 2.48 (t, J 6.5 Hz, H-13), 1.48 (d, J
11.2Hz, H-15a), 1.76 (dd, J 11.2, 3.5 Hz, H-150), 4.14 and 4.33 (ABq, J 11.7 Hz, 
2H-17), 6.41 (d, J 1.7 Hz, H-18), 7.59 (d, J 1.7 Hz, H-19), 1.04 (d, J 1.0 Hz, 3H-20), 
2.10 (OAc). HREIMS : Found : m/z 370.1757; C22H26O5 requires m/z 370.1780.
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CHAPTER 5
ALKALOIDS AND TERPENOIDS FROM THE 
STEM BARK OF A R T A B O T R Y S  
O D O R A T I S S I M U S  R. BR. (ANNONACEAE).
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INTRODUCTION
The genus Artabotrys (Annonaceae) comprises over a hundred species of 
climbers and scandent shrubs, distributed in tropical Africa and Asia1. Different species 
of Artabotrys have been found to contain benzylisoquinoline, apoiphine, oxoaporphine 
and protoberberine alkaloids. The species are Artabotrys suaveolens2*3>4,5 A . 
lastourvellensi&l, A. venustus8, A. grandifolius9 , A. maingayi10 and A. uncinatusu . 
A. pierreanus contains tannins12. Sesquiterpenoids have been isolated from A. 
uncinatus13*14 and cyanogenic glucosides from A. suaveolens13.
Artabotrys odoratissimus R. Br. is a large climbing ornamental shrub native to 
Eastern Asia and it is widely distributed in Bangladesh15. A decoction of the leaves is 
given as a remedy for cholera in the Malay penisula15 and in the Indian subcontinent the 
flowers are used in Ayurvedic preparations for vomiting, biliousness, diseases of the 
blood and heart, itchiness, fevers, foul breath, leucoderma, headache, diseases of the 
bladder and erysipelas16. The fruits have been reported to contain fixed and volatile oil, 
cardiac glycosides and calcium and the extracts were found to exhibit hypotensive and 
spasmogenic effects17. A decoction of the leaves shows antifertility effects in rats18. 
Sterols and sterol glycosides were isolated from the fruit pulp19 and a lanosterol 
derivative from the stem bark20. Constituents of the stem bark include sterols, 
aporphine, oxoaporphine and benzylisoquinoline alkaloids and a sesquiterpenoid21’22.
RESULTS AND DISCUSSION
The ethyl acetate extract of the stem bark of A. odoratissimus yielded, on 
chromatography over silica gel, four compounds AO-1, AO-2, AO-3 and AO-4 which 
were subsequently identified as the known aporphine alkaloids norstephalagine (1),
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annonaine (2), isopiline (3) and oxoaporphine alkaloid liriodenine (4). The methanol 
extract, on concentration and chromatography over silica gel, gave AO-5 and AO-6 which 
were identified as the known oxoaporphine alkaloid atherospermidine (5) and 
benzylisoquinoline alkaloid N-methylcoclaurine (6). The ethyl acetate extract also gave a 
sesquiterpene AO-7, which was identified as the known compound spathulenol (7).
AO-1 was obtained as a yellowish amorphous solid, mp 93-94°, [oc]d -33° (c, 
0.90 in CHCI3) [lit.23 norstephalagine, mp 94-95°, [a]o -35° (c, 0.98 in EtOH)]. It is 
UV active and gave a single Dragendorff positive spot on tic (silica gel), indicating its 
alkaloidal nature. Its UV spectrum has A,max 243, 278 nm. The IR spectrum exhibits 
absorption bands at 3020, 1602, 1520, 1420, 1062 and 930 cm-1, indicative of its 
aromatic skeleton. The mass spectrum shows a molecular ion peak [M+] at m/z 295 
(C18H17NO3) and intense fragment ions at m/z 294 [M+-1], 280 [M+-15], 265 [M+-30] 
and 264 [M+-31], consistent with an aporphine nucleus for AO-1.
OCH 3
11
9
(1)
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The *H NMR spectrum of AO-1 shows a broad one proton doublet at 8h 8.01 (J
8.5 Hz) suggestive of proton H -ll of an aporphine nucleus, deshielded by an oxygen 
function at C-l, three other aromatic protons [8h 7.16-7.30 (m, H-8, H-9, H-10)], 
characteristic of the unsubstituted D ring of an aporphine, a methylenedioxy group [8h  
5.91, 6.06 (ABq, J 1.5 Hz)], and a methoxyl group [8h  4.02 (s)], indicating the fully 
substituted nature of ring A. The ring junction proton H-6a is visible as a double doublet 
at 8h  3.87 (J 13.5, 5.0 Hz) whereas the methylene protons are unresolved [8h  3.45 (1H, 
m), 2.70-3.60 (5H, m)]. The JH spectral data of AO-1 were compared with those of 
norstephalagine23*24’25 (1) and were found to be in close agreement.
The 13C NMR spectrum shows four aromatic methines [8c  128.0, 127.0, 126.8 
and 126.4], a methylenedioxy group [8c  100.7 (t)], a methoxyl group [8c  59.5] without 
neighbouring protons, an aliphatic methine [Sc 43.5 (d)], three methylene groups [8c
43.0, 37.0, 23.8] and eight aromatic singlets [8c  144.1, 140.4, 135.5, 135.1, 132.0,
129.0, 119.1, 110.7]. Comparison of these 13C spectral data with those of 
norstephalagine25 (1) confirmed this identity. Norstephalagine has been isolated 
previously from other Annonaceous plants23*24*25. This is the second report of its 
isolation from an Artabotrys species.
AO-2 was obtained as a colourless solid, mp 120-122°, [cx]d  -54° (c, 0.20 in 
CHCl3)[lit.26 annonaine, mp 123-124°, [a]d -56° (c, 0.15 in CHCI3)]. It is UV active 
and gave a single Dragendorff positive spot on tic (silica gel), indicating its alkaloidal 
nature. Its UV spectrum has ^max 230, 270, 318 nm. Its IR spectrum exhibits 
absorption bands at 3020, 1600, 1580, 1550,1460, 940 cm-1 indicative of its aromatic 
skeleton. The EIMS reveals a molecular ion peak [M+] at m/z 265 (C17H15NO2) and 
fragment ions at m/z 264 [M+-1], 250 [M+-15], 236 [M+-29] and 235 [M+-30], 
consistent with an aporphine nucleus for AO-2.
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The NMR spectrum has the characteristic deshielded H -ll signal of an 
aporphine at 5h 8.00 (br d, J 8.0 Hz). A sharp aromatic singlet at 5h 6.56 (H-3), three 
unresolved aromatic protons at 8h 7.12-7.30 (m, H-8, H-9, H-10), a methylenedioxy 
group at 8h 5.93 and 6.07 (ABq, J 1.5 Hz) and seven unresolved aliphatic protons at 8h
(2)
H
2.66-3.88 (m) readily revealed the substitution pattern of the aporphine nucleus. The lH 
spectral data of AO-2 were compared with those of annonaine26*27’28 and were found to 
be identical. Thus AO-2 is annonaine (2), previously isolated from other Annonaceae 
species27.
AO-3 was isolated as yellowish green solid, mp 150-152°, [a]o -52.5° (c, 0.30 
in CHCI3) [lit.29 iosopiline, mp 153°, [oc]d -55° (c, 1.06 in CHCI3)]. It is UV active 
and gave a single Dragendorff positive spot on tic (silica gel), indicating its alkaloidal 
nature. Its UV spectrum has A*max 220, 269, 305 nm and its IR spectrum shows 
phenolic absorption ( Vmax 3520, 3020, 1600, 1520, 1476, 1230 cm-1). The EIMS 
reveals a molecular ion [M+] peak at m/z 297 (C18H19NO3) and intense fragment ions at 
m/z 296 [M+-H], 282 [M+-CH3], 280 [M+-OH], 266 [M+-OCH3] and 235 [M+- 
C2H6Q2], again pointing to an aporphine nucleus.
1 2 1
/(3)
The NMR spectrum has a characteristic deshielded broad doublet at 8h 8.30 
(1H, J 8.0 Hz) suggestive of H-l 1, a three proton multiplet centered at 8h  7.25 (H-8, H- 
9, H-10) and two methoxyls [8h  3.87 (s) and 3.94 (s)], in addition to the usual 
unresolved methylene/methine resonances [8h  2.65-3.95, 7H, m]. These data 
suggested structure (3), which is isopiline, and comparison with published data29*30 
confirmed the identity. Isopiline has been previously isolated from other Annonaceae 
species29’30.
AO-4 was obtained as yellowish needles, mp 281-283° [lit31 liriodenine (4), mp 
280-282°]. It is UV active and gave a single Dragendorff positive spot on tic (silica gel), 
indicating its alkaloidal nature. Its UV spectrum has A,max 248, 268, 305 nm and its IR 
spectrum shows carbonyl (1655 cm-1) and aromatic (3020, 1601, 1525, 1465 cm-1) 
absorption. The EIMS reveals an [M++l] peak at m/z 276, a molecular ion peak [M+] at 
m/z 275 (C17H8NO3) and intense fragment ions at m/z 247 [M+-CO], 219 [M+-CO-CO] 
and 217[M+-C0-CH20], consistent with an oxoaporphine system.
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The !H NMR spectrum has a characteristic four spin system for the protons of 
ring D [8H 8.56, 8.42 (both dd, J 8.0, 0.8 Hz, H -ll, H-8), 7.73 and 7.52 (both, dt, J
8.0, 1.5 Hz, H-9, H-10)], an aromatic singlet [8h  7.17 (H-3)], an AB system [8h  8.70, 
7.80 (both d, J 5.0 Hz, H-4, H-5)] and a methylenedioxy group [8h  6.31 (2H, s)]. The 
chemical shifts and coupling constant of H-4 and H-5 are consistent with the presence of 
a pyridine ring while the deshielded value of H-8 requires a C-7 carbonyl group. Thus 
structure (4) is assigned to AO-4. This is the structure of liriodenine (4) and comparison 
with published data31*32 confirmed the identity.
3 4
11a
9
(4)
The 13C NMR is in accord with structure (4) and has a carbonyl resonance [8c 
183.3], seven aromatic methines [8c  144.5, 135.0, 129.0, 128.8, 128.1, 125.6, 103.6], 
a methylenedioxy group [8c  100.8] and eight aromatic singlets [8c 153.0, 151.7, 149.7,
145.0, 136.9, 133.7, 131.2, 123.7]. The assignments are given in the Experimental. 
Our chemical shift values (CDCI3-CD3OD) differ slightly from the published data33 for 
liriodenine (TFA) because of different solvents.
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AO-5 was obtained as a yellowish needles, mp 282-284° [lit.34 
atherospermidine, mp 283-285°]. Again it is UV active and gave a single Dragendorff 
positive spot on tic (silica gel), indicating its alkaloidal nature. Its UV spectrum has 
^max 247, 279, 310 nm. Its IR spectrum exhibits bands at 1650 (conjugated ketone) 
and 3025, 1602, 1518 (aromatic) cm-1. The mass spectrum shows an [M++l] peak at 
m/z 306, a molecular ion peak at m/z 305 (C18H11NO4) and intense fragment ions at m/z 
290 [M+-CH3], 277 [M+-CO], 275 [M+-CH20], 274 [M+-OCH3] and 262 [M+-CH3- 
CO], again consistent with an oxoaporphine.
OCH
0
O
In agreement with this the *H NMR reveals pyridine protons [5h 8.09 and 8.87 
(ABq, J 5.4 Hz, H-4, H-5)], a characteristic ring D four spin system with H-8 and H-l 1 
deshielded [5H 8.46 (1H, dd, J 8.0, 0.9 Hz, H -ll), 8.52 (1H, dd, J 8.0, 0.9 Hz, H-8),
7.65 (1H, dt, J 7.6, 1.5 Hz, H-9), 7.45 (1H, dt, J 7.6, 1.5 Hz, H-10)], a 
methylenedioxy group [8h 6.28 (s)] and a methoxyl group [5h 4.27 (s)]. It is clear from 
these data that AO-5 is closely related to AO-4 (4) but has ring A fully substituted. The 
H NMR data (CDC13) are consistent with structure (5) which is atherospermidine but 
differ slightly from published values35*36 (TFA) because of solvent effects.
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OCH
HoCO.
(11)
As expected the 13C NMR is consistent with structure (5). Thus it has a 
conjugated carbonyl [5c 182.4], six aromatic methines [5c 143.2, 134.0, 128.0, 127.3, 
126.3, 119.6], a methylenedioxy [5c 102.3], a methoxyl [5c 59.7] and nine aromatic 
singlets [5C 150.0, 143.8, 136.5, 135.8, 132.9, 130.5, 129.6, 127.4, 122.3]. The 13C 
NMR data of atherospermidine have not been reported previously. The assignments 
(experimental) are based on the comparison of the 13C NMR data with those of liridine 
(II)37 (for B, C and D ring carbons) and of norstephalagine ( l)25 (for A ring carbons).
AO-6 was obtained as white needles mp 182-184°, [a]o -93° (c, 1.00 in CHCI3) 
[lit.3® N-methylcoclaurine (6), mp 181-183°, [a]D -94.7° (c, 11.8 in CHCI3)]. It is UV 
cCtive and gave a single Dragendorff positive spot on tic (silica gel), indicating its 
dkaloidal nature. Its UV spectrum has A.max 225, 281 nm and the IR spectrum has 
fhenolic absorption [vmax 3680, 3595, 3020, 1600, 1520, 1210 cm-1]. The EIMS 
{hows a molecular ion [M+] peak at m/z 299 (C18H21NO3), an [M+-1] peak at m/z 298,
<. base peak at m/z 192, corresponding to an N-methyl isoquinolium cation with methoxyl
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and hydroxyl substituents and arising by the loss of a hydroxybenzyl fragment (C7H7O), 
and a prominent peak at m/z 177 [base peak-15]. The fragmentation pattern is consistent 
with that of a benzylisoquinoline alkaloid.
5 4
H3CO
HO
8
c h 3
2'
3'
9
1'
6’
HO
5’
(6)
The *H NMR spectrum shows an AA'BB' system [8h  6.95 and 6.60 (Jab+Jab'
8.5 Hz), two aromatic singlets [8h 6.53, 6.36], a methoxyl [5h 3.83 (s)], an N-methyl 
[5h 2.46 (s)], a deshielded methine [8h 3.74 (t, J 6.1 Hz)] and six methylene protons 
[8h 2.51-3.35 (m)]. The above data are consistent with a coclaurine (6) nucleus. To 
assign some of the *H resonances and to ascertain the substitution pattern NOE difference 
experiments were carried out. Irradiation of the aromatic singlet at 8h  6.53 (H-5) affords 
a strong NOE (10%) at the methoxyl group (8h 3.87) while irradiation of the other 
aromatic singlet at 8h 6.36 (H-8) affords a NOE (6%) at the H-l methine at 8h  3.74. 
The reverse experiments gave similar results. These results permit the assignment of H-5 
(8h 6.53) and H-8 (8h 6.36) and the position of the methoxyl group at C-6. These data 
lead to structure (6 ) for AO-6. Comparison with published data for N- 
methylcoclaurine38’39 confirmed the identity.
126
The 13C NMR of AO-6 has resonances for the methines of a p-disubstituted 
benzene [8c 130.5 (C-2', C-6'), 115.2 (C-3', C-5')], two other aromatic methines [8c
114.3 (C-5), 111.0 (C-8)], a methoxyl [8c  55.6], an N-methyl [8c  40.8], a methine [8c
65.5 (C-l)] and three methylenes [8c  45.4, 39.8 and 23.3 (C-3, C-9, C-4)], in addition 
to six aromatic singlets [8c  155.3, 146.5, 143.7, 128.4, 126.1 and 122.3(C-6, C-7, C- 
4’, C-8a, C-l', C-4a)]. Comparison with the reported 13C NMR data of coclaurine40for 
the coclaurine nucleus and the N-methyl carbon of annonelliptine4! for the N-methyl 
group confirmed the identity of AO-6 as N-methylcoclaurine (6).
AO-7 was obtained as oil [<x]d  +54° (c, 1.00 in CHCI3) [lit42 spathulenol, [cx]d 
+56° in CHCI3]. The IR spectrum shows hydroxyl (Vmax 3605 cm-1) and 
exomethylene (Vmax 1635, 895 cm-1) absorption. The EIMS reveals a molecular ion 
peak [M+] at m/z 220 (C15H24O) and a fragment peak at m/z 177 [M+-C3H7]. Thus 
AO-7 is a tricyclic sesquiterpenoid alcohol. The lH NMR spectrum shows a two proton
HO
(7)
multiplet at 8h  4.67 indicative of an exomethylene group, three methyl groups [8h  1.27 
(Me-15), 1.04 and 1.02 (Me-13 and Me-12)], one (Me-15) of which is attached to a 
carbon bearing a hydroxyl group, and two cyclopropyl protons [8h  0.62 (m, H-6, H-7)].
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An aromadendrane nucleus seemed a likely possibility for AO-7. Comparison of the *H 
NMR data with those of spathulenol (T)42*43*44 established the identity.
The 13C NMR spectrum has the expected resonances for structure (7). Thus 
there are signals for an exomethylene [(8c 106.2 (t) (C-14), 153.4 (s) (C-10)], three 
methyl groups [8c 28.7 (C-12), 26.1 (C-15), 16.7 (C-l3)], a tertiary carbinol [8c 81.0 
(C-4)], a cyclopropane ring [8c 29.9 (C-6), 27.5 (C-7), 20.3 (C-ll)] , four methylenes 
[8c 41.7, 38.8, 26.7, 24.8] and two methines [8c 54.3, 53.4]. The l3C NMR shifts of 
AO-7 are identical with those published for spathulenol45 (7).
In addition to the above compounds we have also isolated the alkaloid asimilobine 
(8), the triterpenoid 24-methylene lanosta-7,9(ll)-dien-3p-ol (9) and p-sitosterol (10), 
previously reported from this plantl9*20*2!.
(8)
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EXPERIMENTAL
Isolation. The plant material of Artabotrys odoratissimus R. Br. was collected 
from the Dhaka University campus, Dhaka, Bangladesh. The ground stem bark (800g) 
was extracted in a Soxhlet apparatus successively with EtOAc and MeOH. The EtOAc 
extract (6g) was concentrated in vacuo and was subjected to flash column 
chromatography over silica gel. The column was eluted first with petroleum ether and 
then increasing amounts of EtOAc in petroleum ether and MeOH in EtOAc collecting 50 
ml fractions. Fractions were monitored by analytical tic. The early fractions contained 
mainly fat. The later fractions showed many spots on analytical tic. Multiple preparative 
tic using CH2CI2 : MeOH (97 : 3), (95 : 5) and (92 : 8) afforded the compounds 
norstephalagine, AO-1(1) (12.0mg), annonaine, AO-2 (2) (3.0mg), isopiline, AO-3 (3) 
(3.0mg), liriodenine, AO-4 (4) (20mg) and asimilobine (8) (40 mg). Preparative tic of 
fraction 18 using petroleum ether : EtOAc (92 : 8) afforded AO-7, spathulenol (7) 
(16.4mg) and 24-methylenelanosta-7,9 (11)- dien-3p-ol (9) (20mg) and fraction 15 
afforded p-sitosterol (10) (17mg).
The MeOH extract was concentrated in vacuo and subjected to flash column 
chromatography over silica gel. The column was eluted with EtOAc then increasing 
amounts of MeOH in EtOAc and finally with MeOH. Multiple preparative tic using 
CHCI3 : MeOH (90 : 10) and (88 : 12) afforded atherospermidine, AO-5 (5) (14.5mg) 
and N-methylcoclaurine, AO-6 (6) (20mg).
AO-1 (Norstephalagine, 1) , yellow amorphous solid (ether), mp 93-94°; [oc]d 
-33° (c, 0.90 in CHCI3); UV Xmax (log e ) : 243 (4.33), 278 (4.46) nm; IR vmax : 3020, 
2401, 1602, 1520, 1420, 1224, 1062, 930, 850, 736, 625 cm-1; EIMS m/z (rel. int.) : 
295 (31), 294 (53), 280 (8), 266 (17), 265 (24), 264 (30), 236 (9), 206 (12), 177 (13), 
165 (18), 43 (77), 18 (100); lH NMR : SH 8.01 (1H, br d, J 8.5 Hz, H -ll), 7.16-7.30
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(3H, m, H-8, H-9, H-10), 5.91, 6.06 (2H, ABq, J 1.5 Hz, CH2O2), 4.02 (3H, s, 
CH30-3), 3.87 (1H, m, H-6a), 3.45 (1H, m, H-5a), 2.70-3.60 (5H, ra, 2H-4, 2H-7, 
H-5b); 13C NMR : 8c  144.1 (C-l), 110.7 (C-la), 129.0 (C-lb), 135.1 (C-2), 140.4 (C- 
3), 119.1 (C-3a), 23.8 (C-4), 43.0 (C-5), 53.5 (C-6a), 37.0 (C-7), 135.5 (C-7a), 128.0 
(C-8), 127.0 (C-9), 126.8 (C-10), 126.4 (C -ll), 132.0 (C-lla), 100.7 (CH2O2), 59.5 
(CH3O-3).
AO-2 (Annonaine, 2 ) , colourless solid (acetone-hexane), mp 120-122°; [<x]d  
-54° (c, 0.20 in CHCI3); UV Xmax (log e ) : 230 (3.89), 270 (4.15), 318 (3.75) nm; IR 
Vmax : 3020, 1600, 1580, 1550, 1460, 1045, 940, 800 cm-1; EIMS m/z (rel. in t.): 265 
(11), 264 (14), 250 (8), 236 (12), 235 (7), 132 (5), 77 (9), 28 (100); •H NMR : SH
8.00 (1H, br d, J 8.0 Hz, H -ll), 7.12-7.30 (3H, m, H-8, H-9, H-10), 6.56 (1H, s, H- 
3), 5.93, 6.07 (2H, ABq, J 1.5 Hz, CH2O2), 2.66-3.88 (7H, m, 2H-4, 2H-5, H-6a, 
2H-7).
AO-3 (Isopiline, 3), yellowish green solid (ether), mp 150-151°; [oc]d -52.5° (c,
0.30 in CHCI3); UV Xmax (log e ) : 220 (4.20), 269 (4.02), 305 (3.56) nm; IR vmax : 
3520, 3020, 2401, 1600, 1520, 1476, 1230, 930 cm-1; EIMS m/z (rel. in t.): 297 (46), 
296 (55), 282 (17), 280 (28), 268 (14), 266 (16), 235 (12), 177 (12), 165 (15), 151 
(11), 149 (25), 43 (100); ^  NMR : 8H 8.30 (1H, br d, J 8.0 Hz, H -ll), 7.25 (3H, m, 
H-8, H-9, H-10), 3.94 (3H, s, CH30-3), 3.87 (3H, s, CH3O-2), 2.65-3.95 (7H, m, 
2H-4, 2H-5, H-6a, 2H-7).
AO-4 (Liriodenine, 4), yellowish needles (CHCI3), mp 281-283°; UV ^max (log 
e) : 248 (3.83), 268 (4.12), 305 (3.67) nm; IR vmax : 3020, 2395, 1655, 1601, 1525, 
1465, 1050, 965, 615 cm-1; EIMS m/z (rel. int.) : 276 (11), 275 (100), 248 (4), 247
(24), 246 (15), 219 (15), 217 (8), 191 (17), 190 (16), 189 (24), 188 (35), 163 (16), 
162 (25); iH NMR : 8H 8.70, 7.80 (each 1H, ABq, J 5.0 Hz, H-4, H-5), 7.73, 7.52 
(each 1H, dt, J 8.0, 1.5 Hz, H-9. H-10), 8.56, 8.42 (each 1H, dd, J 8.0, 0.8 Hz, H-8,
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H -ll), 7.17 (1H, s, H-3), 6.31 (2H, s, CH20 2); 13C NMR (CDCI3/CD3O D ): 5c 151.7 
(C-l), 123.7 (C-la), 136.9 (C-lb) 153.0 (C-2), 103.6 (C-3), 145.0 (C-3a) 125.6 (C-4),
144.5 (C-5), 149.7 (C-6a), 183.3 (C-7), 131.2 (C-7a), 128.8 (C-8), 129.0 (C-9), 135.0 
(C-10), 128.1 (C -ll), 133.7 (C-lla), 100.8 (CH20 2). HREIMS : Found 275.0545; 
calculated for C17H9NO3 275.0582.
AO-5 (Atherospermidine, 5) , yellowish needles (CHCI3), mp 282-284°; UV 
A-max (log e): 247 (4.43), 279 (4.60), 310 (3.82) nm; IR vmax : 3025, 2380, 1650, 
1602, 1518, 1223, 923, 849, 767 cm-1; EIMS m/z (rel. in t.) : 306 (23), 305 (86), 290
(25), 277 (10), 276 (26), 275 (100), 274 (23), 266 (16), 262 (13), 234 (12), 206 (11), 
204 (9), 177 (5), 176 (17), 175 (5), 149 (22); [H NMR : 5H 8.87, 8.09 (each 1H, ABq, 
J 5.4 Hz, H-4, H-5), 7.65, 7.45 (each 1H, dt, J 7.6, 1.5 Hz, H-9, H-10), 8.52, 8.46 
(each 1H, dd, J 8.0, 0.9 Hz, H-8, H -ll), 6.28 (2H, s, CH20 2), 4.27 (3H, s, CH3O-3); 
13C NMR (CDCI3/CD3O D ); 5c 143.8 (C-l), 122.3 (C-la), 127.4 (C-lb), 135.8 (C-2),
136.5 (C-3), 129.6 (C-3a), 119.6 (C-4), 143.2 (C-5), 150.0 (C-6a), 182.4 (C-7), 130.5 
(C-7a), 127.3 (C-8), 126.3 (C-9), 134.0 (C-10), 128.0 (C -ll), 132.9 (C-lla), 102.3 
(CH20 2), 59.7 (CH3O-3); HREIMS : Found 305.0672; calculated for C18H 11NO4 
305.0688.
AO-6 (N-methylcoclaurine, 6) ,  white needles (CHCI3), mp 182-184°; [cc]d -93° 
(c, 1.00 in CHCI3); UV Xmax (log e ) : 225 (4.25), 281 (3.83) nm; IR vmax : 3680, 
3595, 3020, 2920, 2850, 2390, 1600, 1520, 1210,930 cm-1; EIMS m/z (rel. in t.): 299 
(1), 298 (1), 192 (100), 178 (8), 177 (34), 144 (9), 107 (8), 91 (4); !H NMR : 5H
6.95, 6.60 (each 2H, AA'BB', Jab+JaB' 8.5 Hz, H-3’, H-5’, H-2', H-6’), 6.53 (1H, s, 
H-5), 6.36 (1H, s, H-8), 3.83 (3H, s, CH3O-6), 2.46 (3H, s, N-CH3), 3.74 (1H, t, J
6.1 Hz, H-l), 2.51-3.35 (6H, m, 2H-2, 2H-3, 2H-9); 13C NMR : 5c 65.5 (C-l), 45.4
(C-3), 23.3 (C-4), 122.3 (C-4a), 114.3 (C-5), 155.3 (C-6), 146.5 (C-7), 110.8 (C-8),
128.4 (C-8a) 39.8 (C-9), 126.1 (C-l'), 130.5 (C-2', 6’), 143.7 (C-4'), 115.2 (C-3', 
5’), 55.6 (CH3O-6), 40.8 (N-CH3).
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AO-7 (Spathulenol, 7) , oil, [a]o  +54° (c, 1.0 in CHCI3); IR Vmax : 3605, 
3080, 2980-2860, 1635, 1450, 1375, 1095, 915, 895 cm-1; EIMS m/z (rel. int.) : 220 
(3), 205 (2), 177 (3), 124 (22), 95 (28), 81 (30), 69 (38), 57 (51), 55 (72), 43 (100), 41 
(56); lH NMR : SH 4.67 (2H, m, 2H-14), 1.27 (3H, s, CH3-15), 1.04 (3H, s, CH3- 
13), 1.02 (3H, s, CH3- I2), 0.62 (2H, m, H-6, H-7), 0.72-2.45 (11H, m, H-l, 2H-2, 
2H-3, H-5, 2H-8, 2H-9, OH); ^ C  NMR : 6C 53.4 (C-l), 26.7 (C-2), 41.7 (C-3), 81.0 
(C-4), 54.3 (C-5), 29.9 (C-6), 27.5 (C-7), 24.8 (C-8), 38.8 (C-9), 153.4 (C-10), 20.3 
(C-ll), 28.7 (C-12), 16.7 (C-13), 106.2 (C-14), 26.1 (C-15).
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CHAPTER 6
CONSTITUENTS OF THE STEM BARK AND 
LEAVES OF P O L Y A L T H I A  B U L L  A T  A  BL.
(ANNONACEAE).
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INTRODUCTION
The genus Polyalthia (Annonaceae) comprises 120 shrubs and trees which are 
distributed in tropical and subtropical regions1. The chemical work on this genus up to 
1981 has been reviewed2. There have been many publications on constituents which 
include alkaloids from Polyalthia suaveolens3»4, P. beccarifi, P. longifolia6»7»8*9, P. 
longifolia var pendula6, P. acuminata10, P. cauliflora*1, P. macropoda and P. 
sten o p e ta la 12, P. nitidissima1^ , and P. suberosa14, diterpenoids from P. 
longifolia15'16'12, P. macropoda18 and P. viridis19, triterpenoids from P. suberosa20 and 
P. longifolia21, sesquiteipenoids from P. suaveolens22 , steroids from P. cerasoides and 
P. suberosa23 and P. longifolia24 and flavonoids from P. longifolia2^ . Polyalthia bullata 
is a tree which grows widely in the Indian subcontinent and Malay penisula. Thus far no 
work has been carried out on this plant. It is valued in Malayasia as 1 tonquat ali", an 
aphrodisiac.
RESULTS AND DISCUSSION
On chromatography over silica gel the ethyl acetate extract of the stem bark of P. 
bullata yielded PB-1, PB-2 and PB-3 which were subsequently identified as the known 
bisdehydroaporphine, urabaine (1 ), and two new alkaloids, bis-O- 
methyldehydroisopiline (2) and 7-dehydronomuciferinyl-7'-dehydro-0-methylisopiline 
(3). The ethyl acetate extract of the leaves of P. bullata yielded, upon chromatography 
over silica gel, PB-4, a known oxoaporphine, liridine (4).
PB-1 (1) was obtained as green crystalline powder, mp >282° [lit.26 urabaine, 
mp >280°]. It showed a single spot under UV light and gave a Dragendorff positive spot 
on tic (silica gel), indicating its alkaloidal nature. The UV spectrum shows absorption
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maxima at 209 [log e 4.10], 256 [log e 4.32], 260 [log £ 4.43] and 328 [log e 4.00] nm, 
indicating a dehydroaporphine system with substitution at the C-7 position27. The IR 
spectrum has bands at 3404 (NH), 3020, 1600, 1523, 1420, 930 (aromatic CH), 2940, 
2840 (aliphatic CH) and 1020 (C-O) cm-1. The mass spectrum of PB-1 exhibits a 
molecular ion peak [M]+ at m/z 556 corresponding to C36H32N2O4 and an [M/2+H]+ 
peak at m/z 279 corresponding to C18H 17NO2. The absence of any other significant 
peak in the region rn/z 556-279 suggests a symmetrical dimeric structure for (1).
NH
11a
11a’
6a; OCH
OCH3a’
The NMR spectrum of PB-1 is remarkably simple in keeping with its 
symmetrical nature. Thus it has signals for four (x2) contiguous aromatic protons, one 
of which is highly deshielded [8H 9.65 (br d, J 8.6 Hz, H -ll, H -ll'), 7.35 ( dt, J 8.5, 
1.8 Hz, H-10, H-10'), 7.24 (dt, J 8.0, 1.4 Hz, H-9, H-9’), 7.15 ( dd, J 8.2, 1.6 Hz, H- 
8, H-8')], an isolated aromatic proton (x2) [8h 7.12 (s, H-3, H-3')], two methoxyl 
groups (x2) [8h 3.99 (s) and 4.06 (s)] and four (x2) aliphatic protons [8h 3.15-3.42 
(m)]. These data, in conjunction with the mass spectroscopic results, led quickly to a 
7,7'-bisdehydroaporphine structure for (1). The chemical shift of H -ll, H -ll ' is 
particularly characteristic of the system with an oxygen at C-l. Comparison with
139
published data28 identified PC-1 as urabaine (1), which has isolated previously from 
Oxandra cf major (Annonaceae)29.
The 13C NMR spectrum of PB-1 readily accords with structure (1). Thus its 
monomeric unit has five aromatic doublets [5c 111.8, 128.0, 127.4, 123.8, 123.1], nine
NH
11a
9
(5)
aromatic singlets [5C 151.6, 145.7, 139.2, 133.4, 129.9, 125.8, 125.7, 118.1, 118.1], 
two triplets [5c 41.2, 31.9] and two methoxyl carbons [5c 59.9, 56.5]. The chemical 
shifts of the methoxyls show that one of them [5c 59.9] has no proton neighbour. The 
absence of a doublet at 5c 103.2 [C-7 of the monomer, dehydronomuciferine3^  (5)] and 
appearance of a singlet at 5c 118.1 are consistent with the dimeric nature of (1) (see 
Table 8). Comparison with the published data for urabaine29 confirmed its identity. 
This is the first report of urabaine in the genus Polyalthia.
PB-2 was obtained as yellowish brown microcrystals, mp 268-270°. It gave a 
single Dragendorff positive spot on tic (silica gel), indicating its alkaloidal nature. Its UV 
spectra has maxima at ^max 213 [log 8 4.53], 265 [log 8 4.62] and 323 [log e 4.02] nm,
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characteristic of a dehydroaporphine system with substitution at C-7 position27. The IR 
spectrum has bands at 3390 (NH), 3020, 1600, 1560, 1420, 930 (aromatic C-H), 2936, 
2856 (aliphatic C-H) and 1020 (C-O) cm-1- The mass spectrum shows a molecular ion 
peak [M]+ at m/z 616, corresponding to C38H36N2O6, and an [M/2+H]+ peak at m/z 
309, corresponding to C19H 19NO3, equivalent to the [M+l]+ peak for O-methyl 
dehydroisopiline31 (6). This suggests a symmetrical dimeric structure (2) for PB-2 .
OCH
NH
(6)
It was apparent from the iH NMR spectrum of PB-2 that it is closely related to 
urabaine (1). Thus its monomeric unit has a strongly deshielded proton [8h 9.60 (dd, J 
8.6, 0.6 Hz, H -ll, H -ll'] which forms part of a four spin aromatic system [5h 7.15 
(dd, J 8.2, 1.5 Hz, H-8, H-8'), 7.23 (dt, J 8.2, 1.4 Hz, H-9, H-9’), 7.37 (dt, J 8.4, 1.8 
Hz, H-10, H-10')]. The lack of any further aromatic protons and the appearance of a 
three methoxyl signals [8h 4.14 (s), 4.06 (s), 4.00 (s)] indicates that the second aromatic 
ring is fully substututed. The aliphatic methylene resonances appear as a complex 
multiplet between 8h 3.15 to 3.37. Thus PB-2 is a 7,7'-bisdehydroaporphine with three 
methoxyls in ring A, ie a dimer (2) of O-methyldehydroisopiline (6). Comparison with
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the published data for urabaine ( l )28 and O-methyldehydroisopiline (6)32 support this 
conclusion.
The 13C NMR spectrum of PB-2 shows the expected features of a 
bisdehydroaporphine with ring A fully substituted. Thus the monomeric unit has four 
aromatic doublets at [5c 127.2, 126.8, 123.8, 123.1], ten quaternary carbons [5c 151.1,
148.5, 146.7, 139.5, 132.5, 125.5, 122.5, 121.8, 121.8, 120.1], two methylenes [5c
40.5, 23.8] and three methoxyl carbons [5c 61.3, 60.9, 60.4]. The chemical shifts of 
the methoxyl-bearing carbons indicate the lack of neighbouring protons. These data lead 
to the conclusion that PB-2 (2) is a dimer of O-methyldehydroisopiline (6) . Comparison
OCH
NH
HoCO*
OCH
HN
OCH
with the monomeric unit of urabaine ( l )28 for the carbons of C and D rings and with O- 
methyldehydroisopiline (6)33 for the carbons of rings A and B confirm this conclusion 
(see Table 8). PB-2 (2) is a new natural product.
142
PB-3 was obtained as yellowish brown microcrystals, mp >310°. It gave a 
single Dragendorff positive spot on tic (silica gel), indicating its alkaloidal nature. It is 
UV active with bands at Xmax 210 [log e 3.82], 255 [log e 4.26], 261 [log e 4.38] and 
327 [log e 3.76] nm, characteristic of a dehydroaporphine system with substitution at the 
C-7 position27. The IR spectrum exhibits absorption bands at 3391 (N-H), 3020, 1600, 
1560, 1522, 1456, 930 (aromatic C-H), 2937, 2853 (aliphatic C-H) and 1020 (C-O) 
cm-1. The mass spectrum shows a molecular ion [M]+ peak at m/z 586 (C37H34N2O5), 
with major fragments at m/z 309 (C19H19NO3) and m/z 279 (C18H17NO2), suggesting 
that PB-3 has a dimeric structure formed from two different monomers.
The presence in the *H NMR spectrum of PB-3 of two highly deshielded protons 
at 8h 9.65 (br d, J 8.5 Hz, H -ll) and 9.58 (br d, J 8.1 Hz, H -ll'), an aromatic proton 
singlet at 5h 7.12 (H-3), six other aromatic protons between 8h 7.10-7.40 (m), five 
methyl groups [8h  4.13 (s), 4.06 (s), 4.05 (s), 3.99 (x2) (s)] and eight aliphatic protons 
between 8h 3.15-3.43 (m) readily led to the conclusion that the two monomeric units are 
dehydronomuciferine and O-methyldehydroisopiline. Thus PB-3 has the structure (3).
OCH3
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The 13C NMR spectrum is entirely consistent with structure (3). The assignments of 
both and 13C resonances, made by comparison with the appropriate 
monomers28-29’32, are listed in the Experimental and in Table 8  (13C). PB-3 (3) is a 
new natural product.
T A B L E  8 . 13C N M R  C hem ical Shifts o f C om pounds (1), (2) and (3)
Carbon (1) (2) (3) Carbon (1) (2) (3)
1 145.7(s) 148.5(s) 145.7(s) 7 ' 118. l(s) 120. l(s) 120.2(s)
r 145.7(s) 148.5(s) 148.7 7a 133.4(s) 132.5(s) 133.3(s)
la 125.7(s) 125.6(s) 125.8(s) 7’a 133.4(s) 132.5(s) 132.4(s)
l ’a 125.7(s) 125.6(s) 125.6(s) 8 128.0(d) 127.2(d) 128.0(d)
lb 118.1 (s) 121.8(s) 118.l(s) 8 ' 128.0(d) 127.2(d) 127.3(d)
l 'b 118.1 (s) 121.8(s) 121.7(s) 9 127.4(d) 126.8(d) 127.4(d)
2 151.6(s) 146.7(s) 151.6(s) 9 ' 127.4(d) 126.8(d) 126.9(d)
2 ’ 151.6(s) 146.7(s) 146.8(s) 10 123.8(d) 123.8(d) 123.6(d)
3 111.8(d) 151.l(s) 111.8(d) 10’ 123.8(d) 123.8(d) 124.0(d)
3' 111.8(d) 151. l(s) 151. l(s) 11 123.1(d) 123.1(d) 123.0(d)
3a 129.9(s) 121.8(s) 130.0(s) 11' 123.1(d) 123.1(d) 123.5(d)
3'a 129.9(s) 121.8(s) 121.7(s) 11a 125.8(s) 122.5(s) 125.8(s)
4 31.9(t) 23.8(t) 30.7 (t) l l ’a 125.8(s) 122.5(s) 122.4(s)
4' 31.9(t) 23.8(t) 23.6(t) MeO-1 59.9(q) 60.4(q) 59.9(q)
5 41.2(t) 40.5(t) 41.1(t) MeO-T 59.9(q) 60.4(q) 60.4(q)
5' 41.2(t) 40.5(t) 40.7 (t) MeO-2 56.5(q) 60.9(q) 56.5(q)
6a 139.2(s) 139.5(s) 139.3(s) MeO-2’ 56.5(q) 60.9(q) 60.9 (q)
6'a 139.2(s) 139.5(s) 140.0(s) MeO-3 - 61.3(q) -
7 118.1 (s) 120.1(s) 118. l(s) MeO-3* - 61.3(q) 61.3(q)
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PB-4 was obtained as yellow crystals mp 186° [lit.34 liridine, mp 188°]. It is 
UV active and has absorption maxima at Xmax 234 (log £ 4.25) and 271 (log £ 4.36) 
nm. The IR spectrum exhibits absorption bands 1702 (C=0), 3020, 1620, 1572, 1480, 
1324, 930 (aromatic) and 1020 (C-O) cm-1. The mass spectrum displays an [M+] peak 
at m/z 321 (C19H15NO4) together with fragments at m/z 306 [M+-15], 291 [M+-15-15], 
278 [M+-15-28] and 263 [M+-15-15-28], consistent with an oxoaporphine alkaloid.
The lH NMR of PB-4 shows a double doublet at 8H 9.02 (1H, J 8.4, 0.6 Hz, 
H -ll) which is part of an aromatic spin spin system with three other protons resonating 
at 5h 7.68 (dt, J 7.5, 2.0 Hz, H-10), 7.46 (dt, J 7.5, 1.9 Hz, H-9) and 8.48 (dd, J 7.6,
1.6 Hz, H-8), an AB system [8h  8.87 and 8.14 (each d, J 5.4 Hz, H-4, H-5)] and three 
methoxyl signals [8h  4.06 (s), 4.09 (s), 4.17 (s)]. Comparison with published data34 
readily led to the identification of PB-4 as liridine (4).
OCH3
10
8
9
(4)
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The 13C NMR of PB-4 is in accord with the structure (4) and has a carbonyl 
resonance [8c  182.5], six aromatic doublets [5c 144.6, 134.4, 129.0, 128.2, 127.6, 
119.2], nine aromatic singlets [5c 156.5, 148.5, 147.2, 145.5, 134.5, 131.4, 131.1, 
122.8, 115.6] and three methoxyl carbons [5c 61.8, 61.5, 61.0]. The assignments are 
given in the Experimental. Comparison with published data35 confirmed the identity of 
PB-4 as liridine (4).
EXPERIMENTAL
Isolation. The plant material of Polyalthia bullata was collected in Malayasia. 
The dried stem bark (400g) and leaves (350g) were extracted in a Soxhlet apparatus with 
EtOAc. The EtOAc extracts of the stem bark (3.6g) and leaves (3.0g) were concentrated 
in vacuo and fractionated by flash column chromatography over silica gel, eluting with 
petroleum ether, increasing amounts of EtOAc in petroleum ether and finally with MeOH 
(50 ml fractions). The fractions were monitored by analytical tic. Early fractions 
contained only fat Multiple preparative tic, using petroleum ether: EtOAc [(80 :20), (88 
: 12) and (85 : 15)] of the stem bark fractions gave the following results :- fraction 15 
gave PB-1 (17mg), fraction 8 PB-2 (55mg) and fraction 10 PB-3 (21mg). Similarly 
preparative tic, using CH2CI2 : MeOH (98 : 2), of the fraction 19 of the leaf extract 
afforded PB-4 (lOmg).
PB-1 (1), green crystalline powder (MeOH), mp > 282°; UV Xmax • 209 (log e 
4.10), 256 (log e 4.32), 260 (log e 4.43), 328 (log e 4.00) nm; IR vmax : 3404 (NH), 
3020, 2940, 2840, 1523, 1420, 1020, 930 cm-1; EIMS m/z (rel. int.) : 556 [M]+ (100), 
279 [M/2+H]+ (44), 264 [279-CH3]+ (14), 248 [279-OCH3]+ (7), 233 (9), 217 (8); JH 
NMR : 5h 9.65 (br d, J 8.6 Hz, H -ll, H -ll'), 7.35 (dt, J 8.5, 1.8 Hz, H-10, H-10’), 
7.24 (dt, J 8.0, 1.4 Hz, H-9, H-9’), 7.15 (dd, J 8.2 , 1.6 Hz, H-8, H-8’), 7.12 (s, H-3, 
H-3’), 3.15-3.42 (m, 2H-4, 2H-4\ 2H-5, 2H-5’), 3.99 (s, CH30-1, CH30-1’), 4.06
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(s, CH3O-2, CH3O-2') ; 13c NMR (see T ab le 8); HREIMS : Found [M]+ 
C36H32N2O4 556.2349; requires 556.2362; found [M/2+H]+ C19H17NO2 279.1248; 
requires 279.1259.
PB-2 (2), yellowish brown microcrystals (MeOH), mp 268-270°; UV A,max : 
213 (log e 4.53), 265 (log e 4.62), 323 (log e 4.02) nm; IR vmax : 3390 (NH), 3020, 
2936, 2856, 1600, 1560, 1420, 1020,930 cm-1; EIMS m/z (rel. in t.): 616 [M]+ (100), 
309 [M/2+H]+ (35), 294 [309-CH3]+ (9), 278 [309-CH3O]+ (10), 263 (13); >H NMR : 
8h  9.60 (dd, J 8.6, 0.6 Hz, H -ll, H - ll’), 7.37 (dt, J 8.4, 1.8 Hz, H-10, H-10’), 7.23 
(dt, J 8.2, 1.4 Hz, H-9, H-9'), 7.15 (dd, J 8.2, 1.5 Hz, H-8, H-8'), 3.15-3.37 (m, 2H- 
4, 2H-4’, 2H-5, 2H-5'), 4.00 (s, CH3O-I, CH3O-I’), 4.06 (s, CH3O-2, CH3O-2 ') 
4.14 (s, CH3O-3, CH3O-3'); 13C NMR (see T a b le  8); HREIMS : Found [M]+ 
C38H36N2O6 616.2510; requires 616.2502; found [M/2+H]+C19H19NO3 309.1345; 
requires 309.1330.
PB-3 (3), yellowish brown microcrystals (MeOH), mp >310°; UV /-max : 210 
(log e 3.82), 255 (log e 4.26), 261 (log e 4.38), 327 (log e 3.76) nm; IR Vmax : 3391 
(NH), 3020, 2937, 2853, 1600, 1560, 1522, 1456, 1020, 930 cm-1; EIMS m/z (rel. 
int.) : 586 [M]+ (100), 309 [M-278+HJ+ (22), 279 [M-308+H]+ (30); 'H  NMR : 8H
9.65 (br d, J 8.5 Hz, H -ll), 9.58 (br d, J 8.1 Hz, H -ll'), 7.12 (s, H-3), 7.10-7.40 (m, 
H-8, H-8', H-9, H-9', H-10, H-10', H -ll, H - l l ’), 3.15-3.43 (m, 2H-4, 2H-4', 2H-5, 
2H-5'), 3.99 (s, CH3O-I, CH3O-I'), 4.06 (s, CH30-2), 4.05 (s, CH30-2'), 4.13 (s, 
CH3O-3'); 13C NMR (see Table 8); HREIMS : Found [M]+ C37H34N2O5 586.2468; 
requires 586.2474.
PB-4 (4), yellow crystals (MeOH), mp 186°; UV Xmax : 234 (log e 4.25), 271 
(log e 4.36) nm; IR vmax : 3020, 1701 (0=0), 1620, 1572, 1480, 1324, 1020, 930 cm- 
!; EIMS m/z (rel. in t.): 321 [M]+ (100), 306 [M+-15] (61), 291 [M+-15-15] (22), 278 
[M+-15-28] (44), 263 [M+-15-15-28] (53), 248 (26), 235 (30), 220 (54), 192 (23), 164
147
(40), 137 (28); lH NMR : SH 9.02 (dd, J 8.4, 0.6 Hz, H -ll), 8.87, 8.14 (each, d, J 5.4 
Hz, H-4, H-5), 8.48 (dd, J 7.6, 1.6 Hz, H-8), 7.68 (dt, J 7.5, 2.0 Hz, H-10), 7.46 (dt, 
J 7.5, 1.9 Hz, H-9), 4.17 (s, CH30-2), 4.09 (s, CH30-3), 4.06 (s, CH30-1); 13C 
NMR : 8c  145.5 (C-l), 115.6 (C-la), 122.8 (C-lb), 147.2 (C-2), 148.5 (C-3), 131.1 
(C-3a), 119.2 (C-4), 144.6 (C-5), 156.5 (C-6a), 182.5 (C-7), 131.4 (C-7a), 128.2 (C- 
8), 127.6 (C-9), 134.4 (C-10), 129.0 (C -ll), 134.5 (C-lla), 61.8 (CH30-1), 61.5 
(CH30-2), 61.0 (CH30-3).
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CHAPTER 7
ZEYLENOL AND TWO NEW PSEUDOSUGARS 
FROM THE STEM BARK OF A N N O N A  
R O X B U R G H I A N A  L. (ANNONACEAE).
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INTRODUCTION
The genus Annona (Annonaceae) consists of about 120 species of trees, shrubs 
and herbs. They are widely distributed in the tropics and the neotropics and to a lesser 
extent in Africa1. Annona roxburghiana is a shrub of 2-4 ft in height and is distributed 
through out Bangladesh. So far no work has been carried out on this plant. The 
chemical work on this genus up to 1981 has been reviewed2. Recently alkaloids have 
been isolated from A. montona?A,5, A. crassifloraP, A. glabra1, A. elliptical, A . 
hayesift, A. paludosa10, A. spraguei11 and A. salzmanii12. The existence of acetogenins 
in this genus has been reviewed13. Further reports of acetogenins from A. montana14, A. 
densicoma15, A. muricata and A. cherimolia16 have appeared. Monoterpenoids and 
sesquiterpenoids have been isolated from A. atemoya11 »18 and diterpenoids from A. 
bullata19.
RESULTS AND DISCUSSION
On chromatography over silica gel, the chloroform extract of the stem bark of A. 
roxburghiana yielded AR-1, subsequently identified as the known cyclohexene 
derivative, zeylenol (1). The sticky methanol extract was acetylated and 
chromatographed over silica gel to yield AR-2 and AR-3 which were identified as two 
new acetylated isomeric cyclitol (pseudosugar) derivatives with the gross structure (2). 
The stereochemistry of AR-2 is tentatively assigned as in (4).
AR-1 was obtained as colourless needles, m p 132-134°, [cc]d + 1 1 3 °(c, 0 .50 in 
CHC13) [lit.20 zeylenol, m p 132-133°, [ot]D +113.5° (c, 0.60 in CHCI3) ]. It was UV
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active [^max 230 (log e 4.53) nm] and gave a single spot. Its IR spectrum showed 
hydroxyl (3450 cm-1), ester (1718,1275 cm-1), alkene and aromatic (3020,1600,1585, 
1490, 710 cm-1) absorption. The mass spectrum of AR-1 displayed an [M+] ion at
m/z 384, an [M+-OH] peak at m/z 367 and intense fragments ions at m/z 262 [M+- 
PhCOOH], 245 [M+-PhCOOH-OH] and 244 [M+-PhCOOH-H20]. The base peak at 
m/z 105 is suggestive of the PhCO+ ion which loses 28 mass unit (CO) to give m/z 77.
HOi
u o  7 CH2OOCPh
3 OOCPh
(1)
The iH NMR spectrum of (1) shows signals for ten aromatic protons [8h  8.02- 
7.95 (4H, m), 7.54 (2H, m) and 7.38 (4H, m)] suggestive of the presence of two 
slightly different benzoyl groups, an AB quartet [8h  4.89 and 4.73 (J 12.3 Hz)] 
indicative of a benzoyloxymethylene group, two vinyl protons on a cis disubstituted 
double bond [8H 6.00 (ddd, J 10.1, 3.7, 1.8 Hz, H-5); 5.85 (ddd, J 10.1, 2.5, 1.0 Hz, 
H-4)] associated with two allylic oxygenated methines [8h  4.32 (dd, J 3.7, 1.0 Hz, H- 
6); 5.69 (dddd, J 6.1, 2.5,1.8,1.2 Hz, H-3)]. H-3 has vicinal coupling to H-4 and H-2 
[8h  4.25 (d, J 6.1 Hz)], an allylic coupling (1.8 Hz) with H-5 and a homoallylic 
coupling (1.0 Hz) with H-6. The attachment of the second benzoate group to C-3 is 
revealed by the downfield shift of H-3. These data are consistent with structure (1) 
which is zeylenol, previously isolated from Uvaria zeylanica (Annonaceae)21. 
Comparison with published data20*21 confirmed the assignment
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The 13C NMR spectrum of (1) showed the expected features. Thus it has two 
ester carbonyls (8c  167.9, 167.2) and two phenyl rings [8c  133.5, 133.4, 129.8, 
128.5, 128.4 ( all d), 129.4 (s)], associated with the two benzoates. The olefinic 
carbons appear at 8c  126.9 (d) and 129.5 (d), while the oxygenated carbons resonate at 
8c  68.9, 70.9, 74.3 (all d), 66.8 (t) and 76.0 (s). These values compare well with the 
published data for zeylenol2!. This is the second report of the isolation of zeylenol from 
the Annonaceae and the first from the genus Annona.
AR-2 was obtained as a gum. Its IR spectrum exhibits ester carbonyl (1745, 
1700 cm-l), double bond (3020, 1500, 1425, 1370, 1225 cm-1) and C-0 (1025 cm-l) 
absorption. The 13C DEPT spectrum indicated the molecular formula C12H22O10. Thus 
it has five acetate groups [8C 20.9 (2), 20.8 (2), 20.7 (CH3), 170.3, 170.2, 170.1, 
170.0, 169.9 (C=0)], a trisubstituted double bond [8c  133.7 (s), 126.3 (d)], four 
oxygenated methines [8c  69.4, 69.3, 67.8, 67.2] and an oxygenated methylene [8c 
63.3]. Thus the molecule is monocarbocyclic. Its mass spectrum shows an M+-60 peak 
at m/z 326 and other peaks at m/z 266 (M+-60-60), 224 (M+-60-60-42), 207 (M+-60- 
60-59), 182 (M+-60-60-42-42), 140 (182-42) and a base peak at 122 (140-18).
AcO
OAcAcO
OAc
(2)
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The *H NMR of AR-2 shows an AB system at 8h 4.45 (d, J 13.6 Hz) and 4.63 
(d, 13.6 Hz) and five deshielded methines [8h  5.29 (dd, J 6.7, 2.7 Hz, H -2), 5.35 (dd, 
J 4.9, 2.7 Hz, H-3), 5.48 (dd, J 6.3, 1.7 Hz, H-l) , 5.51(br d, J 4.9 Hz, H-4) and
5.92 (br d, J 3.0 Hz, H-7)], the last associated with the vinyl proton H-7, in addition to 
the expected resonances for five acetates [5h 2.05, 2.06, 2.07, 2.09, 2.10]. These data 
indicate that AR-2 is the pentaacetate of a hydroxymethylcyclohexene tetrol ie a cyclitol or 
pseudosugar as in (2).
From the ^ ^ H  COSY (Fig. 12) it was possible to establish the proton-proton 
connectivity. The primary acetate protons 2H-6 are allylic and show allylic coupling to 
the vinyl proton H-7 [8h  5.92]. The sequence H-6—» H -1 [8 h  5.48]-»H-2 [8h  
5.29] —»H-3 [8h  5.35]—>H-4 [8h  5.51] is readily apparent, confirming the assignments 
of the protons in (2). There are also some indications of homoallylic coupling of H-l 
and the methylene protons 2H-6.
H
OH
H
OH
AcOHoC
AcO
(3)
OAc
AcO OAc
HOH2C
HO
"iiiOH
OH
(4) (5)
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Figure 12. !H -lH COSY spectrum o f  AR-2 (4).
In the absence of independent evidence, eg NOEs, for the conformation of the 
cyclohexene ring it is difficult to assign the relative stereochemistry. A tentative 
stereochemistry may be suggested on the basis of a half chair conformation (3) as 
follows. The allylic proton H-l is pseudoaxial and couples with the axial H-2 (6.7 Hz). 
All other couplings are small and must involve equatorial protons . H-4 shows no allylic 
coupling to the vinyl proton and should be more or less in the plane of the double bond. 
Thus AR-2 has the relative stereochemistry as in (4).
AR-2 appears to be a new cyclitol. The only free cyclitol to have been reported is 
streptol (5)22 from Streptomyces sp. The structure and stereochemistry of streptol have 
been confirmed by synthesis23. Cyclitols often contain amino functions and form part of 
larger antibiotic molecules.
The next compound AR-3 was also obtained as a gum, Vmax 3020, 1745, 1700, 
1500, 1045 cm-1 . It is clear from its 13C NMR spectrum that it is another cyclitol 
derivative. It has five acetates [6c  20.9 (2), 20.7 (2), 20.4, 170.3, 170.1, 169.9, 169.8, 
169.7], a trisubstituted double bond [6c  133.6 (C-5), 125.5 (C-7)], four oxygenated 
methines [5c 70.7, 69.2, 68.4, 67.0] and an acetoxymethylene [6c  62.7 (C-6)]. Thus it 
has the same gross structure (2) as AR-2.
Its mass spectrum also shows an (M+-60) peak at m/z 326 and other major peaks 
at m/z 266 (M+-60-60), 224 (M+-60-60-42), 206 (M+-60-60-60), 182 (224-42), 140 
(182-42) and a base peak at m/z 122 (140-18). Its *H NMR shows an AB system at 8h 
4.43 (1H, d, J 13.5 Hz) and 4.70 ( 1H, d, J 13.5 Hz), three one proton double doublets 
at 8H 5.21 (1H, dd, J 8.0, 2.1 Hz), 5.62 (1H, dd, J 3.6, 1.9 Hz) and 5.63 (1H, dd, J
3.8, 1.5 Hz), a broad doublet at 5.74 (1H, br d, J 1.3 Hz) and another broad doublet at 
5.85 (1H, br d, J 8.0 Hz)]. The five acetate methyl groups appear at 8h  2.02, 2.04,
2.06, 2.07 and 2.14 .
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The fH ^H  COSY, though limited in quality because of the small sample 
provided some connectivity. The narrow doublet at 8h  5.74 shows coupling to the 
acetoxymethylene protons and apparently to two other protons [8h  5.85 and 5.60]. The 
lowest field signal [8h  5.85] has a large coupling (J 8.0 Hz) to the proton at 8h  5.21 
which in turn couples to the proton at 8h 5.60. This proton appears to couple to both 
the narrow doublet at 8h 5.74 and to the doublet of doublets at 8h 5.63 . Not all the 
couplings are visible in the COSY spectrum since the proton at 8h 5.63 shows no further 
correlations. Since it is difficult to decide which proton is the vinyl proton the assembly 
of a rational coupled system is not possible. Until the more material is available the 
detailed structure of AR-3 must remain undetermined. There is no doubt, however, that 
it is a new cyclitol.
This is the first report of the isolation of cyclitols from the Annonaceae. In 
addition, sorbitol acetate (6) and sucrose acetate (7) were also isolated.
OAc [ O
AcOCH2 OA;
CH2OAc
J— O
CH2OAc
I
H— C—OAc
AcO—C—H
H— C—OAc
H— C—OAc
CH2OAc CH2OAc
OAc
(6)
(7)
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EXPERIMENTAL
The plant material of Annona roxburghiana was collected from the district of 
Comilla, Bangladesh. The ground stem bark (175g) was extracted successively, in a 
Soxhlet apparatus, with CHCI3 and MeOH. Following concentration in vacuo, the 
CHCI3 extract (450mg) was fractionated by flash column chromatography over silica gel, 
eluting with petroleum ether, petroleum ether and increasing amounts of CHCI3 and 
finally MeOH (50 ml fractions). Multiple preparative tic of fraction 6 [CHCI3 : MeOH 
(98 : 2) afforded AR-1 (12mg) (1).
AR-1 (zeylenol, 1)) was obtained as colourless needles (MeOH), mp 132-134°, 
[a]D +113° (c, 0.50 in CHCI3) ; UV Xmax (MeOH): 230 (log e 4.53) nm ; IR vmax : 
3450 3020, 1715, 1600, 1585, 1490, 1450, 1372, 1278, 1175, 1115, 1070, 1010, 970, 
710 cm-1; EIMS m/z (rel. in t.): 384 [M+] (1), 367 [M+-OH] (1), 262 [M+-PhCOOH]
(1), 245 (3), 244 (4), 231 (2), 215 (3), 203 (4), 190 (2), 163 (3), 123 (8), 122 (20), 
110 (5), 106 (12), 105 (100), 99 (10), 77 (52); lH NMR : 8H 8.02-7.95 (4H, m, H-2’, 
H-2"), 7.54 (2H, m, H-4’, H-4”), 7.38 (4H, m, H-3', H-3"), 6.00 (1H, ddd, J 10.1,
3.7, 1.8, H-5), 5.85 (1H, ddd, J 10.1, 2.5, 1.0 Hz, H-4), 5.69 (1H, dddd, J 6.1, 2.5,
1.8, 1.2 Hz, H-3), 4.89, 4.73 (2H, ABq, J 12.3Hz, 2H-7), 4.32 (1H, dd, J 3.7, 1.0 
Hz, H-6), 4.25 (1H, d, J 6.1 Hz, H-2); i3C NMR 8C: 76.0 (C-l), 68.7 (C-2), 74.3 (C- 
3), 126.9 ( C-4), 129.5 (C-5), 70.0 (C-6), 66.7 (C-7), 128.5 (2x C-3'), 128.4 (2x C- 
3"), 129.8 (2xC-2\ 2xC-2"), 133.5 (C-4'), 133.4 (C-4"), 129.4 (C-l’, C-l"), 167.9 
(C-7'), 167.2 (C-7").
The methanol extract was concentrated in vacuo to give a sticky mass (1.2g) 
which was acetylated under standard conditions with acetic anhydride and pyridine 
overnight. The acetylated extract was fractionated by flash column chromatography 
using CHCI3 and increasing amounts of MeOH (50 ml fractions). Multiple preparative
159
tic [ petroleum ether : EtOAc (65: 35)] of fractions 6 and 7 afforded AR-2 (4) (5.0mg) 
and AR-3 (2) (4.5mg). In addition fraction 7 afforded sorbitol acetate (6) (5.0mg) and 
fraction 8 sucrose acetate (7) (12.0mg).
AR-2 (4), gum, IR vmax : 3020, 1745, 1700, 1500, 1425, 1370, 1225, 1025 
cm-1; EIMS m/z (rel. in t.): 326 [M+-60] (1), 266 [M+-60-60] (1), 224 [M+-60-60-42]
(19), 223 (5), 206 [M+-60-60-60] (2), 183 (10), 182 [M+-60-60-42-42] (94), 164 (17), 
153 (21), 145 (8), 140 (182-42) (80), 139 (12), 124 (9), 123 (30), 122 [140-18] (100), 
115 (14), 111 (26), 103 (14), 98 (22), 95 (15), 94 (40), 81 (9); *H NMR : 6H 4.45 , 
4.63 (2H, ABq, J 13.6 Hz, 2H-6), 5.29 (1H, dd, J 6.7, 2.7 Hz, H-2), 5.35 (1H, dd, J
4.9, 2.7 Hz, H-3), 5.48 (1H, dd, J 6.3, 1.7 Hz, H-l), 5.51 (1H, br d, J 4.9 Hz, H-4),
5.92 (1H, d, J 3.0 Hz, H-7); 13C NMR : 5C 20.9 (2) , 20.8 (2) , 20.7 (all q), 170.3, 
170.2, 170.1, 170.0, 169.9 (all s), 133.7 (s), 126.3 (d), 69.4 (d), 69.3 (d), 67.8 (d),
67.2 (d), 63.3 (t).
AR-3 (2), gum, IR vmax : 3020, 1745, 1700, 1500, 1430, 1370, 1220, 1045 
cm-1; EIMS m/z (rel. in t.): 326 [M+-60] (1), 266 [M+-60-60] (1), 224 [M+-60-60-42] 
(8), 223 (3), 206 [M+-60-60-60] (3), 183 (3), 182 [224-42] (28), 164 (9), 153 (9), 145
(2), 141 (8), 140 [182-42] (20),139 (4), 124 (5), 123 (19) 122 [140-18] (100), 115 (4), 
111 (9), 103 (10), 98 (7), 95 (13), 94 (11), 81 (7); lH NMR : 5H 4.43, 4.70 (2H, ABq, 
J 13.5 Hz, 2H-6), 5.21 (1H, dd, J 8.0, 2.1 Hz), 5.60 (1H, dd, J 3.6, 1.9 Hz), 5.63 
(1H, dd, J 3.8, 1.5 Hz), 5.74 (1H, br d, J 1.3 Hz), 5.85 (1H, br d , J 8.0 Hz); 13C 
NMR : 8C 20.9 (2), 20.7 (2), 20.4 [all q], 170.3, 170.1, 169.9, 169.8, 169.7 (all s),
133.6 (s), 125.5 (d), 70.7 (d), 69.2 (d), 68.4 (d), 67.0 (d), 62.7 (t).
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CHAPTER 8
THE CONSTITUENTS OF THE STEM BARK OF 
A N T I D E S M A  G H A E S E M B I L L A  GAERTN 
(EUPHORBIACEAE).
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INTRODUCTION
The genus Antidesma (Euphorbiaceae) comprises 60 species of trees or shrubs 
which are distributed throughout tropical Asia, Africa, Australia and the Pacific1. 
Triterpenoids have been isolated from several species including Antidesma bunius2, A. 
pentandrunfi and A. menasu*'5. A. ghaesembilla is a tree which is widely distributed in 
Bangladesh. The bark of this plant is considered an astringent and tonic in Indochina6. 
Thus far no phytochemical work has been done on this plant.
RESULTS AND DISCUSSION
On chromatography over silica gel the EtOAc extract of the stem bark of A. 
ghaesembilla yielded four compounds AG-1, AG-2, AG-3 and AG-4 which were 
subsequently identified as the triterpenoids lupeol (1) and lupeone (2), the coumarin 
scopoletin (3) and the ester betulin 3-caffeate (4).
AG-1 (1) was isolated as white crystals, mp 210-212°, [cc]d  +30.4° (c, 0.58 in 
CHCI3) [lit7 lupeol, mp 212°, [cc]d +32° (c, 0.50 in CHCI3)]. Its IR spectrum exhibits 
hydroxyl [ vmax 3615, 1030 cm-1] and exomethylene [Vmax 3070, 1638, 887 cm-1] 
absorption. Its mass spectrum displays an [M+] peak at m/z 426 (C30H50O) together 
with fragments at m/z 411 [M+-15] and 408 [M+-18] and a base peak at m/z 43 
[(C3H7)+].
The JH NMR spectrum reveals signals for six tertiary methyls [8h 0.74, 0.77, 
0.81, 0.93, 0.94 and 1.01], a vinyl methyl [5h 1.66 (br d, J 0.5 Hz)], a secondary 
carbinol [8h 3.20 ( dd, J 9.6, 6.2 Hz)] and an exomethylene group [8h 4.58 (1H, d, J 
0.4 Hz) and 4.65 (1H, dq, J 0.4, 0.5 Hz)]. These data indicated a pentacyclic
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triterpenoid of the lupeol type and comparison with published d a ta ^  confirmed the 
identity of AG-1 as lupeol (1).
HoC19V 9Q
11 13 17
V 26
V .14
(1) R= H, POH
(2) R= O
The 13C NMR spectrum of AG-1 (1) shows seven methyl groups [8c  28.0,
19.3, 18.0, 16.1, 15.9, 15.4, 14.5], an exomethylene group [8c 150.8 (C-20), 109.3
(C-29)] and a secondary hydroxyl bearing carbon [8c  78.9 (C-3)], in addition to ten
methylene, five methine and five quaternary carbons. These data (see Experimental) are 
-t*
identical those of lupeol ( l)10’11./>
AG-2 (2) was obtained as crystals mp 166-168°, [a ]o  +60° (c, 0.52 in CHCI3) 
[lit.12 lupeone, mp 166-168°, [a]D +60.6° (c, 0.50 in CHCI3)]. Its IR spectrum 
exhibits ketonic carbonyl [Vmax 1701 cm-1] and an exomethylene group [Vmax 3070, 
1640, 887 cm-1]. Its mass spectrum suggests it is a pentacyclic triterpenoid [m/z 424 
(M+, C3oH480); 409 (M+-15); 394 (M+-15-15); 381 (M+-15-28); 43 (C3H7+, base 
peak)]] and this was confirmed by the !H and 13C NMR spectra (see Experimental)
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which show inter alia six tertiary methyls [8h 0.73, 0.86, 0.89, 0.96, 1.00 (6H, s ) , 
8c  26.6, 21.0, 18.0, 15.9, 15.7, 14.4], a vinyl methyl [8h 1.61 (3H, br d, J 0.5 Hz, 
Me-30) , 8c  19.3 (C-30)], a ketonic carbonyl group [8c 218.3 (C-3)] and an 
exomethylene group [8h 4.51 (1H, d, 0.4 H z), 4.62 (1H, dq, J 0.4, 0.5 H z), 8c  150.9 
(C-20), 109.4 (C-29)]. Comparison with published data12*1® readily led to the 
identification of AG-2 as lupeone (2).
Compound AG-3 (3) was obtained as needles, mp 204° [lit.13 scopoletin, mp 
202-203°]. On tic it showed as a single blue fluorescent spot under UV light and has 
characteristic hydroxy-coumarin absorption in the UV (Xmax 342, 297, 260, 251 and 
225 nm) and IR [vmax 3530 (OH), 1720 (C=0), 3020, 1604, 1583 (aromatic) cm-l]. 
The mass spectrum indicates a molecular formula C10H8O4 [m/z 192] with fragments at 
m/z 177 [M+-15] and 161 [M+-31]. The coumarin nature of AG-3 was readily deduced 
from its !H NMR spectrum which shows a characteristic ring A AB quartet [8h 6.28 
and 7.59 (each d , J 9.5 Hz, H-3 and H-4)], two aromatic singlets [8h 6.91 and 6.84 
(both s, H-5, H-8)] and a methoxyl group [8h 3.95, s]. These data can be 
accommodated by
structures (3), scopoletin, or (5), isoscopoletin. The identity of AG-3 as scopoletin (3) 
was confirmed by comparison with published data13’14.
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AG-4 (4) was isolated as an amorphous solid, [<x]d +33.2° (c, 0.50 in CHCI3) 
[lit.15 betulin 3-caffeate, [a]o  +33.6° (in CHCI3)]. It is UV active and shows 
absorption at ^max 221, 234, 246, 295 and 350 nm. The IR spectrum has bands at 
3550 (OH), 1710 (conjugated ester), 1637, 1604, 1522 and 929 (aromatic and vinyl) 
cm-1. The mass spectrum has an [M+] ion at m/z 604, with additional fragments at m/z 
589 [M+-15], 434 [M+-170], 163 [C9H7C>3+ (base peak)] and 161 [C9H50 3+].
'CHoOH
HO.
(4)
The ^  NMR spectrum shows signals for an isopropenyl group [8h 4.66 and
4.56 (1H each, br s ) and (1.66, 3H, s)], five tertiary methyl groups [5h 0.99, 0.96, 
0.89, 0.86, 0.84], a secondary ester function (8h 4.56, 1H, m, H-3), a primary alcohol 
[8h 3.80 and 3.36 (ABq, J 11.0 Hz, 2H-28)] and an allylic proton [8h 2.36 (1H, m, H- 
19)]. These data are consistent with the presence of a lupeol type triterpenoid skeleton 
with a hydroxyl at C-28. The appearance of signals at 8h 6.24 (1H, d, J 15.8 Hz, H- 
8'), 6.85 (1H, d, J 7.8, H-5’), 6.96 (1H, br d, J 8.3 Hz, H-6'), 7.08 (1H, br s, H-2’) 
and 7.53 (1H, d, J 15.8 Hz, H-7') indicates the presence of a 3',4'- 
dihydroxycinnamoyloxy moiety. Thus AG-4 is most likely to be betulin 3-caffeate (4) 
and comparison with published data15 confirmed this conclusion.
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The 13C NMR spectrum of AG-4 is also in accord with this proposal. Thus it 
has five methyls [5c 28.1, 16.6, 16.2, 16.1, 14.6], an isopropenyl group [5c 150.3 (s),
109.7 (t), 19.0 (q)], a primary alcohol [5c 60.5], a secondary ester [5c 81.2] and ten 
other methylenes, five methines and five quaternary carbons (see Experimental). The 
appearance of three aromatic methines [5c 122.1, 115.3, 114.1], two olefinic methines 
[5c 144.8, 115.7], three aromatic singlets [5c 146.8, 144.3, 127.2] and an ester 
carbonyl [5c 167.8] confirms the 3’,4'-dihydroxycinnamoyloxy moiety. Comparison 
with published data15 again confirmed the structure of AG-4 as betulin 3-caffeate (4).
EXPERIMENTAL
Isolation. The plant material of A. ghaesembilla was collected from the Khulna 
district of Bangladesh. The stem bark (500g) was extracted in a Soxhlet apparatus with 
EtOAc. The EtOAc extract (8.0g) was concentrated in vacuo and a portion (4.0g) was 
fractionated by flash column chromatography over silica gel, eluting with petroleum 
ether, increasing amounts of EtOAc in petroleum ether and finally with MeOH (100ml 
fractions). The fractions were monitored by analytical tic . The early fractions contained 
only fat. Fraction 7 gave AG-1 (lOOmg) and fraction 5 gave AG-2 (25mg) upon multiple 
preparative tic using petroleum ether : EtOAc [(90 : 10) and ( 96 : 4)]. Similarly , 
preparative tic of fraction 15 [petroleum ether : EtOAc (75 : 25)] afforded AG-4 (20mg) 
and of fraction 18 [CH2CI2 : MeOH (98 : 2)] gave AG-3 (8.0mg).
AG-1 (1), lupeol, white crystals (MeOH), mp 210-212°; [a]o +30.4° (c, 0.58 
in CHCI3); IR vmax : 3615, 3070, 3020, 1638, 1520, 1380, 1217, 1030, 887 cm1; 
EIMS m/z (rel. int.) : 426 [M+] (2), 411 [M+-CH3] (3), 408 [M+-H20] (3), 218 (5), 
207 (6), 189 (58), 163 (80), 135 (57), 107 (68), 105 (55), 79 (54), 43 (100); lH NMR : 
5h 0.74, 0.77, 0.81, 0.93, 0.94, 1.01 ( Me-28, Me-23, Me-24, Me-25, Me-26, Me- 
27), 1.66 (3H, br d, J 0.5 Hz, Me-30), 3.20 (1H, dd, J 9.6, 6.2 Hz, Ha-3 ), 4.58 (1H,
168
d, J 0.4 Hz, Ha-29), 4.65 (1H, dq, J 0.4, 0.5 Hz, Hb-29) ; 13c NM R: 5c 38.7 (C- 
1), 27.4 (C-2), 78.9 (C-3), 38.8 (C-4), 55.3 (C-5), 18.3 (C-6), 34.2 (C-7), 40.8 (C-8), 
50 4 (C-9), 37.1 (C-10), 20.9 (C-ll), 25.1 (C-12), 38.0 (C-13), 42.8 (C-14), 27.4 (C- 
15), 35.5 (C-l6), 42.9 (C-17), 48.2 (C-18), 47.9 (C-19), 150.8 (C-20), 27.8 (C-21),
40.0 (C-22), 28.0 (C-23), 15.4 (C-24 ), 16.1 (C-25), 15.9 (C-26), 14.5 (C-27), 18.0 
(C-28), 109.3 (C-29), 19.3 (C-30).
AG-2 (2) , lupeone, crystals (MeOH), mp 166-168°; [a]D +60° (c, 0.52 in 
CHC13); IR vmax : 3070, 3018, 1701 (C=0), 1640, 1460, 1350, 887 cm-l; EIMS m/z 
(rel. int.) : 424 [M+] (8), 409 [M+-CH3] (9), 394 (10), 381 (13), 313 (12), 218 (22), 
205 (52), 189 (28), 149 (28), 135 (35), 121 (57), 107 (68), 105 (44), 95 (82), 81 (88), 
79 (56), 55 (72), 43 (100); lH NM R: 5H 0.73, 0.86, 0.89, 0.96 (4xMe), 1.00 (6H, s, 
2xMe), 1.61 ( 3H, br d, J 0.5 Hz, Me-30), 4.51 (1H, d, J 0.4 Hz, Ha-29), 4.62 (1H, 
dq, J 0.4, 0.5 Hz, Hb-29); 13c NM R: 8C 39.5 (C-l), 34.1 (C-2), 218.3 (C-3), 47.3 
(C-4), 54.8 (C-5), 19.6 (C-6), 33.5 (C-7), 40.7 (C-8), 49.7 (C-9), 36.8 (C-10), 21.4 
(C -ll), 25.1 (C-12), 38.1 (C-13), 42.8 (C-14), 27.4 (C-15), 35.5 (C-16), 42.9 (C-17),
48.2 (C-18), 47.9 (C-19), 150.9 (C-20), 29.8 (C-21), 39.9 (C-22), 26.6 (C-23), 21.0 
(C-24), 15.7 (C-25), 15.9 (C-26), 14.4 (C-27), 18.0 (C-28), 109.4 (C-29), 19.3 (C- 
30).
AG-3 (3), scopoletin, needles (EtOAc-petroleum ether), mp 204°; UV Xmax 0og 
e) : 342 (3.62) 297 (4.05), 260 (3.75), 251 (3.82), 225 (3.90) nm; IR vmax : 3530, 
2932, 2856, 1720, 1604,1583, 1560, 1518, 1422, 1388, 1262, 1218, 1140, 1017, 930, 
850 cm-l; EIMS m/z (rei. in t.): 192 [M+] (27), 177 (26), 163 (10), 161 (30), 149 ( 36), 
121 (33), 109 (22), 107 (25), 105 (21), 95 (32), 81 (41), 79 (36), 69 (65), 53 (63), 43 
(100); lH NMR : 8H 6.28 and 7.59 (ABq, J 9.5 Hz, H-3, H-4), 6.91 (1H, s, H-5), 
6.84 (1H, s, H-8), 3.95 (3H, s, CH3O-6).
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AG-4 (4), betulin 3-caffeate, amorphous solid, [oc]d  +33.2° (c, 0.50 in CHCI3); 
UV Xmax (log e) : 221 (4.21), 234 (4.03), 246 (3.86), 295 (3.69), 350 (3.95) nm; IR 
Vmax : 3550 (OH), 1710 (C=0), 1637, 1604, 1522,929 (C=CH2) cm-1; EIMS m/z (rel. 
int.) : 604 [M+] (1), 589 [M+-CH3] (2), 434 [M+-170] (4), 189 (13), 180 (18), 164
(11), 163 (C9H703+) (100), 161 (C9H50 3+) (10), 147 (13), 145 (12), 135 (30), 134
(20), 133 (16), 129 (13), 123 (14), 121 (27), 119 (15), 112 (16), 109 (15), 107 (34), 
105 (29), 95 (21), 93 (39), 91 (25), 89 (13), 84 (19), 81 (19), 79 (15), 77 (21), 69 
(28), 55 (40), 43 (22); !H NMR : 8H 7.53 and 6.24 (ABq, J 15.8 Hz, H-7’, H-8'),
7.08 (1H, br s, H-2'), 6.96 (1H, br d, J 8.3 Hz, H-6'), 6.85 (1H, d, J 7.8 Hz, H-2’), 
4.66, 4.56 (each 1H, br s, Ha-29, Hb-29), 1.66 (3H, s, Me-30), 0.99 (3H, s, Me-26),
0.96 (3H, s, Me-27), 0.89 ( 3H, s, Me-24), 0.86 (3H, s, Me-23), 0.84 (3H, s, Me-25),
4.56 (1H, m, H-3), 3.80 and 3.36 (ABq, J 11.0 Hz, H-28), 2.36 (1H, m, H-19); 13C 
NMR : 8C 38.4 (C-l), 23.8 (C-2), 81.2 (C-3), 38.0 (C-4), 55.4 (C-5), 18.2 (C-6), 33.9 
(C-7), 40.6 (C-8), 50.3 (C-9), 37.1 (C-10), 20.8 (C -ll), 25.3 (C-12), 37.0 (C-13), 
42.4 (C-14), 26.9 (C-15), 29.5 (C-16), 46.9 (C-17), 50.3 (C-18), 49.2 (C-19), 150.3 
(C-20), 29.6 (C-21), 33.9 (C-22), 28.1 (C-23), 16.6 (C-24), 16.2 (C-25), 16.1 (C-26), 
14.6 (C-27), 60.5 (C-28), 109.7 (C-29), 19.0 (C-30), 127.2 (C -l’), 115.3 (C-2’), 
144.3 (C-3'), 146.8 (C-4’), 114.1 (C-5'), 122.1 (C-6’), 144.8 (C-7'), 115.7 (C-8'),
167.8 (C-9’).
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CHAPTER 9
CONSTITUENTS OF THE STEM BARK OF 
A M O O R A  C U C U L L A T A  ROXB. 
(MELIACEAE).
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INTRODUCTION
The genus Amoora (Meliaceae) comprises 16 species of trees which are 
distributed in the Indian subcontinent, Malay penisula and Australia1. Limonoids have 
been isolated from the species Amoora grandifolia^A  and A. rohituka56 J $ ,9,10 ? 
sesquiterpenes from A. grandifolia11 and sterols from A. rohituka12.13 a . 
wallichii14. Amoora cucullata Roxb. is a tree which grows widely in the coastal forest 
of Bangladesh. It has been reported that bruised leaves are applied to remove 
inflamation15. Thus far no phytochemical work has been carried out on this plant.
RESULTS AND DISCUSSION
The EtOAc extract of the stem bark of A. cucullata yielded, upon chromatography 
over silica gel, seven known compounds AC-1, AC-2, AC-3, AC-4, AC-5, AC-6 and 
AC-7 which were subsequently identified as dammara-20,24-dien-3-one (1), 20(S)- 
hydroxydammar-24-en-3-one (2), cabraleone (3), cabraleadiol (4), cabralealactone (5), 
viridiflorol (6) and isofouquierone (7) and a new compound AC-8 was identified as 
20(S), 24- dihydroxydammaran-3-one (8).
AC-1 ,C3oH480 , was obtained as crystals, mp 76°, [a]o  +91.2° (c, 1.0 in 
CHCI3) [lit.16 dammara-20,24-dien-3-one, mp 75° , [oc]d+91.6 (c, 1.02 in CHCI3)], 
Vmax 3050,1701 (ketone), 1630, 980, 880 cm-1, whose mass spectrum [m/z 424 [M+], 
409 (M+-15), 315 [M+-CgHi3 (side chain)], 109 [base peak, C8H 13 (side chain 
cleavage)] indicates its triterpenoid nature. The !H NMR of AC-1 shows five quaternary 
methyls [5h 0.85, 0.94, 0.99, 1.02 and 1.06], two vinyl methyls [8h 1.60 and 1.66], an
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exomethylene [8h  4.70 (2H, m)] and a vinyl proton [5h 5.12 (m)]. These data revealed 
a tetracyclic triterpenoid structure. Comparison with published data16 led to the 
identification of AC-1 as dammara-20,24-dien-3-one (1).
The 13C NMR spectrum of AC-1 readily agreed with structure (1). Thus it has 
seven methyl signals [5c 15.3, 15.7, 16.1, 17.7, 21.0, 25.7 and 27.0], a trisubstituted 
double bond [5c 124.4 (d) and 131.4 (s)], an exomethylene [5c 107.5 (t) and 152.5 (s)] 
and a ketonic carbonyl group [5c 218.1], in addition to ten methylene, four methine and 
four quaternary carbons. The 13C NMR data for (1) have not previously been reported. 
The assignments (see Experimental) were made by comparison with 20(S)- 
hydroxydammar-24-en-3-one17 for the 3-oxodammarane nucleus and with dammara- 
20,24-dien-3(3-ol18 for the side chain.
AC-2, C30H50O2, was obtained as white crystals, mp 134-136°, [oc]d +66° (c,
1.0 in CHCI3) [lit.19 20(S)-hydroxydammar-24-en-3-one, mp 135-136°, [oc]d +65° (in 
CHCI3)], vmax 3600 (hydroxyl), 1698 (ketone) cm-1, whose mass spectrum [m/z 427
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(M+-15), 424 (M+-18) and 315 (M+-sidechain)] again indicated a triterpenoid, probably 
a dammarane. The NMR spectrum of AC-2 shows eight tertiary methyls [8h  0.87, 
0.93, 0.98, 1.02, 1.08, 1.13, 1.61 and 1.68] and a vinyl proton [8h  5.11 (m)]. These 
spectral data suggested a 3-oxodammarane nucleus with an uncyclized side chain 
containing a hydroxyl function at C-20 and a A24»25double bond. Comparison with the 
published data20 for 20-hydroxydammar-24-en-3-one confirmed the identity of AC-2 as
(2 ).
HQ
The 13C NMR spectrum is in agreement with this structural proposal and has 
signals for eight methyls [8c  15.2, 16.0, 16.3, 17.7, 21.0, 25.4, 25.7.and 26.6], a 
tertiary carbinol [8c  75.3], a trisubstituted double bond [8c  124.6 (d) and 131.6 (s)] and 
a ketonic carbonyl [8c  218.1], in addition to ten methylene, four methine and four 
quaternary carbons. The 13C data of AC-2 were identical with published values17 for 
20(S)- hydroxydammar-24-en-3-one (2), thus confirming its identity. The 13C NMR 
chemical shifts of selected carbons provide a method for distinguishing between the R21
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and S17 configurations at C-20. The chemical shifts of the two series (20R : 20S) are as 
follows : C-16 (5C 23.5, 24.8), C-17 (5c 49.4, 49.7), C-21 (5c 25.2, 25.4), C-22 (5C
41.8, 40.4).
AC-3, C30H50O3, was isolated as needles, mp 163°, [a]o  +60° (c, 1.10 in 
CHCI3) [lit.22 cabraleone, mp 163-166.5°, [a]D +60° (c, 1.20 in CHCI3)], vmax 3446 
(OH), 1697 (ketone) cm-1, whose mass spectrum did not show a molecular ion. The 
highest detectable peak is at m/z 443, evidendy resulting from the loss of 15 mass units 
(Me-group) from m/z 458, the presumed molecular ion C30H50O3. Other major 
fragments include peaks at 428 [M+-15-15], 399 [M+-59], 315 [M+-CgHi502+ (side 
chain)], 143 [C8H i502+ ( side chain)], 125 [C8H i502+-18] and 59 [(CH3)2COH]+ The 
NMR spectrum of AC-3 shows the presence of eight tertiary methyls [Sh  0.87,0.93, 
1.00, 1.03, 1.07, 1.10, 1.14 and 1.18] and an oxygenated methine [5h  3.65 (dd, J  7.0,
6.2 Hz, H-24)]. Comparison with published data22*23.24 confirmed the identity of AC-3 
as cabraleone (3).
OH
(3) R=0
(4) R=H, a  OH
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The 13C NMR spectrum reveals the presence of a ketonic carbonyl [6c  218.1], 
three oxygenated carbons [6c  70.1(s), 86.3(d), 86.2(s)] and eight methyls [15.0, 16.0,
16.1, 20.8, 23.9, 26.6, 27.0, 27.6], in addition to ten methylenes, four methines and 
four quaternary carbons. AC-3 is therefore a tetracarbocyclic triterpenoid ketone with a 
side chain containing a cyclic ether and a tertiary hydroxyl. These data readily led to 
structure (3) for AC-3 which is cabraleone. Comparison with published data24*25 
confirmed its identity.
AC-4, C30H52O3, was obtained as needles, mp 175° [(x]d +18.2° (c , 1.00 in 
CHCI3) [lit.23 cabraleadiol, mp 175-176°, [a]o +18° (c, 1.00 in CHCI3) ] , Vmax 3618 
(hydroxyl), 3586 (hydroxyl), 1460, 1060 cm-1 and has peaks in its mass spectrum at m/z 
460 [M+], 445 (M+-15), 427 (M+-18-15), 143 [base peak, C g H ^ *  (side chain)] and 
125 (side chain-18). The *H NMR spectrum shows eight methyl singlets [6r  0.84, 
0.86, 0.89, 0.94, 0.97, 1.11, 1.15 and 1.19] and two protons attached to oxygenated 
carbons [6H 3.40 (t, J 3.6 Hz, H-3) and 3.65 (dd, J 7.2, 5.8 Hz, H-24)]. The above 
data suggested a 3a-hydroxydammarane with a side chain containing a cyclic ether and a 
tertiary hydroxyl group. Comparison with published data22*23*24 revealed its identity as 
cabraleadiol (4).
The 13C NMR spectrum confirmed this deduction, showing signals for four 
oxygenated carbons [6c 76.2 (d, C-3), 70.2 (s, C-25), 86.6 (s, C-20) and 86.2 (d, C- 
24)], in addition to the expected eight methyl signals [8c 15.5, 16.0, 16.5, 22.1, 24.0,
27.1, 27.8 and 28.3], ten methylene, four methine and four quaternary carbons ( see 
Experimental). Comparison with published data24 again confirmed the identity .of AC-4 
as cabraleadiol (4).
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AC-5 was obtained as crystals, mp 182-184°, [a]o +70.4° (c, 1.00 in CHCI3) 
[lit.23 cabralealactone, mp 181-183°, [a]o  +70° (c, 0.57 in CHCI3)], vmax 1701 
(ketone), 1759 (y-lactone) cm-1. The mass spectrum exhibits a molecular ion [M+] peak 
at m/z 414 corresponding to C27H42O3 and peaks at m/z 399 (M+-15), 384 (M+-15-15) 
and 205 (base peak). The lH NMR spectrum of AC-5 shows six tertiary methyl signals 
[5h 0.88, 0.92, 0.98, 1.02, 1.06 and 1.37] including one (Me-21) which is deshielded 
with respect to (4). No downfield signals are observed. Comparison with published 
data22*23 led to the identification of AC-5 as cabralealactone (5).
22 23
The 13C NMR spectrum of AC-5 reveals a ketonic carbonyl [5c 218.1], a lactone 
carbonyl [5c 176.8], a quaternary oxygenated carbon [5c 90.1], six methyl groups [5c
15.1, 16.0, 16.1, 21.0, 25.4, 26.6], in addition to ten methylene, four methine and four 
quaternary carbons. The loss of three carbons , including two methyl groups , relative to 
a normal triterpenoid suggested oxidative cleavage of the end of the side chain with
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formation of a y-lac tone. This reasoning led to the cabralealactone structure (5) for AC-5. 
Comparison with published data26 confirmed its identity with cabralealactone.
AC-6 was obtained as crystals, mp 74°, [a]j) +3.2° (c, 0.10 in CHCI3) [lit.27 
viridiflorol, mp 74° , [a]o  +2.0° (in CHCI3)], vmax 3603, 3450 cm-1. The mass 
spectrum shows a molecular ion peak at m/z 222, corresponding to C15H26O. AC-6 is 
therefore a sesquiterpenoid. Its ^  NMR spectrum reveals the presence of a 
cyclopropane ring [8h  0.11 (1H, dd, J 9.1 Hz) and 0.61 (1H, m)], in addition to three 
tertiary methyl signals [8h  0.99, 1.01 and 1.14] and a secondary methyl [8h  0.93 (d, J
6.6 Hz)]. Comparison with published data27 led to the identification of AC-6 as 
viridiflorol (6).
PH
(6)
The 13C NMR spectrum of AC-6 exhibits four methyls [8c  16.1, 16.3, 28.7 and
32.1] and a quaternary oxygenated carbon [8c 74.6] and confirms the presence of the 
cyclopropane [8c 18.4 (s), 22.2 (d), 28.5 (d)]. AC-6 is therefore a tricyclic 
cyclopropane-containing sesquiterpenoid. The most obious conclusion is that it has an
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aromadendrane nucleus. The remaining carbon resonances, four methylenes [5c 18.8,
25.8, 29.0 and 37.7] and three methines [5c 38.4, 39.7 and 58.2], are consistent with 
this suggestion. Comparison with published data27 confirmed to the identification of AC- 
6 as viridiflorol (6).
AC-7, C30H50O3, was isolated as gum, [oc]d +33.0° (c, 1.00 in CHCI3) [lit.24 
isofouquierone, [cc]d  +34° (c, 0.10 in CHCI3)], v max 3607 (hydroxyl), 3453 
(hydroxyl), 1710 (ketone) cm-1 and is clearly a triterpenoid. The mass spectrum displays 
peaks at m/z 459 (M++1), 443 (M+-15), 425 (M+-15-18), 359 (M+-C6H11O) and 82 
[base peak, (C6Hio)+]. The !H NMR spectrum shows eight methyl singlets [5h  0.85, 
0.92, 0.97, 1.01, 1.05, 1.12, 1.32 (2)], two olefinic protons [5h  5.66 (m)] and two 
deshielded methylenes [5h  2.18 and 2.45 (both 2H, m)]. Consideration of the 13C NMR 
data (below) and comparison with published24 data reveals the identity of AC-7 as 
isofouquierone (7).
OH
OH
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The 13C NMR spectrum revealed a ketonic carbon [5c 218.3], two tertiary 
hydroxyl bearing carbons [5c 70.7 and 75.0], disubstituted olefinic carbons [5c 122.2 
(d) and 142.0 (d)] and eight tertiary methyl groups [5c 15.1, 16.0, 16.3, 21.0, 25.6, 
26.6, 29.8 and 29.9], in addition to nine methylene, four methine and four quaternary 
carbons. These data are consistent with a 3-ketodammarane structure (7), containing an 
unsaturated dihydroxy side chain. This structure belongs to the known compound 
isofouquierone and comparison with published data24 confirmed its identity with AC-7. 
There is a difference in chemical shift of one methylene signal [5c 24.8 for AC-7,27.4 in 
ref.(24)] which we assume is due to an error in the published value. This is the second 
report of the isolation of isofouquierone from a plant source.
AC-8 was also obtained as gum, [a]o +17.8° (c, 0.59 in CHCI3), vmax 3570 
(hydroxyl), 3452 (hydroxyl), 1698 (ketone) cm-1. The mass spectrum indicates that AC- 
8 is a triterpenoid, showing inter alia peaks at m/z 442 (M+-18), 427 (M+-18-15), 424 
(M+-2xl8) and 412 (M+-18-2x15). Other peaks associated with the side chain are 
observed at m/z 315 (M+-CgHi702), 145 [C8Hn02+ (side chain)], 127 [base peak, 
C8Hi50+ (side chain-18)] and 109 (CgHi3+). The *H NMR shows eight methyl singlets 
[5h  0.85, 0.91, 0.96, 1.00, 1.04, 1.12, 1.21 (2)] and a deshielded methylene [5h  2.45 
(m)] and suggested a close similarity to isofouquierone (7) but with a saturated dihydroxy 
side chain. Comparison of the chemical shifts of AC-8 with isofouquierone24 for the 
3-oxodammarane nucleus protons and with dammarane-20(S),25-diol28»29 for side chain 
protons suggests that AC-8 is 20S,25-dihydroxydammarane-3-one (8).
The 13C NMR spectrum of AC-8 confirmed the presence of a ketone 
[5c 218.3] and two tertiary alcohols [5c 70.9, 75.3] and shows, in addition, eight 
methyls [5c 15.1, 16.0, 16.3, 20.9, 25.4, 26.6, 29.2, 29.3], eleven methylenes, four
1 8 1
OH
(8) R = O; R' = OH
(9) R = O; R = H
(10) R = H,H; R’ = OH
methines and four fully substituted carbons. Comparison of the chemical shifts of 
AC-8 with those of 20S-hydroxydammarane-3-one17 (9) (for the carbon skeleton) and 
205, 25- dammaranediol17 (10) (for the side chain) are shown in Table 9. It is apparent 
that AC-8 is 205, 25-dihydroxydammaran-3-one (8), which is a new compound.
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TA BLE 9 : 13C NM R o f com pounds (8), (9) and (10)
Carbons
(8)
Compounds
(9) (10)
C-l 39.8 39.5
C-2 34.0 33.8
C-3 218.3 217.6
C-4 47.3 47.1
C-5 55.3 55.1
C-6 19.5 19.4
C-l 34.4 34.3
C-8 40.2 40.0
C-9 49.9 49.8
C-10 36.7 36.5
C -ll 21.9 21.8
C-12 27.4 27.3
C-13 42.3 42.1
C-14 50.2 50.0
C-15 31.1 31.0
C-16 24.7 24.5
C-17 49.7 49.3
C-18 16.0 15.8
C-19 15.1 15.0
C-20 75.3 75.4
C-21 25.4 25.6
C-22 40.9 41.1
C-23 18.3 18.5
C-24 44.3 44.6
C-25 70.9 71.1
C-26 29.2* 29.3*
C-27 29.3* 29.5*
C-28 26.6 26.5
C-29 20.9 20.8
C-30 16.3 16.2
* may be interchangeable
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EXPERIMENTAL
Isolation. The plant material of Amoora cucullata was collected from the coastal 
forest , Sundarban, Khulna district, Bangladesh. The ground stem bark (840g) was 
extracted in a Soxhlet apparatus with EtOAc. The EtOAc extract (19g) was concentrated 
in vacuo and a portion (12g) was fractionated by flash chromatography over silica gel. 
The column was first eluted with petroleum ether and increasing amounts of EtOAc in 
petroleum ether and finally with MeOH (100ml fraction). Fractions were monitored by 
analytical tic. The early fractions contained mainly fat while the later fractions showed 
many spots on analytical dc. Multiple preparative dc of fraction 5 using petroleum ether: 
EtOAc (94 : 6) gave AC-1 (90mg). Fraction 6 and 7 afforded AC-2 (3.0g) as crystals. 
Multiple preparative tic of fractions 6, 8, 9 using petroleum ether : EtOAc (85 : 15) 
afforded AC-3 (lOOmg), AC-4 (lOmg), AC-5 (16mg) and AC-6 (13mg). Preparative tic 
of fraction 17 using CH2CI2 : MeOH (98 : 2) afforded AC-7 (36mg) and AC-8 (50mg).
AC-1 (dammara-20,24-dien-3-one, 1), colourless crystals (MeOH), mp 76°, 
[oc]D +91.20 (C> Loo in CHCI3); IR vmax : 3050,1701,1630, 1222,1150, 1112, 1076, 
980, 895, 880 cm-1; EIMS m/z (rel. int.): 424 (M+) (42), 409 (M+-15) (6), 315 (M+- 
C8H i3) (9), 300 (8), 205 (54), 190 (10), 175 (13), 147 (28), 109 (C8H i3+) (100), 81 
(50), 43 (70); lH NMR : 5H 0.85, 0.94, 0.99, 1.02, 1.06 (Me-18, Me-19, Me-28, Me- 
29, Me-30), 1.60, 1.66 (Me-26, Me-27), 4.70 (2H, m, 2H-21), 5.12 (1H, m, H-24); 
13C NMR : 6C 40.0 (C-l), 34.0 (C-2), 218.1 (C-3), 47.3 (C-4), 55.2 (C-5), 19.6 ( C- 
6), 34.0 (C-7), 40.3 (C-8), 50.2 (C-9), 36.8 (C-10), 21.8 (C -ll), 27.0 ( C-12), 45.3 
(C-13), 49.3 (C-14), 31.3 (C-15), 28.8 (C-16), 47.7 (C-17), 15.7 (C-18), 15.3 (C-19),
152.5 (C-20), 107.5 (C-21), 39.9 (C-22), 24.9 (C-23), 124.4 (C-24), 131.4 (C-25),
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25.7 (C-26), 17.7 (C-27), 27.0 (C-28), 21.0 (C-29), 16.1 (C-30). HREIMS : Found 
424.3700; calculated for C30H48O 424.3705.
AC-2 (205-hydroxy -dammar-24-en-3-one, 2), white crystals (ether), mp 134- 
136°; [a]D +66° (c, 1.00 in CHCI3); IR vmax : 3600, 3020, 1698, 1520, 1425, 928 
cm-1; EIMS m/z (rel. int.) : 427 [M+-CH3] (2), 424 [M+-H20] (20), 315 (5), 205 (13), 
147 (9), 127 (15), 109 (100), 105 (12), 95 (54), 82 (20), 67 (43), 43 (94); iH NMR : 5H 
0.87, 0.93, 0.98, 1.02, 1.08 (Me-18, Me-19, Me-28, Me-29, Me-30), 1.13,1.61, 1.68 
(Me-21, Me-26, Me-27), 5.11 (1H, m, H-24); 13C NMR : 5c 39.8 (C-l), 34.1 (C-2),
218.1 (C-3), 47.8 (C-4), 55.3 (C-5), 19.6 (C-6), 34.5 (C-7), 40.2 (C-8), 49.9 (C-9),
36.8 (C-10), 22.0 (C-ll), 27.5 (C-12), 42.3 (C-13), 50.2 (C-14), 31.1 (C-15), 24.8 (C- 
16), 49.7 (C-l7), 16.0 (C-18), 15.2 (C-19), 75.3 (C-20), 25.4 (C-21), 40.4 (C-22),
22.5 (C-23), 124.6 (C-24), 131.6 (C-25), 25.7 (C-26), 17.7 (C-27), 26.6 (C-28), 21.0 
(C-29), 16.3 (C-30).
AC-3 (cabraleone, 3), needles (MeOH), mp 163°; [(x]d +60°  (c , 1.10 in CHCI3); 
IR Vmax : 3440, 1697, 1460, 1222, 1070 cm-1; EIMS m/z (rel. int.): 443 [M+-CH3] 
(10), 428 [M+-CH3-CH3] (4), 399 [M+-C3H7O] (4), 381 (12), 315 [M+-C8H i50 2 (side 
chain)], 143 [C8H i5C>2+ (side chain)] (35), 125 (C8Hi50 2+-18) (100), 59 (70), 43 (30); 
!H NMR: 5h 0.87, 0.93, 1.00, 1.03, 1.07 (Me-18, Me-19, Me-28, Me-29, Me-30),
1.10, 1.14, 1.18 (Me-21, Me-26, Me-27), 3.65 (1H, dd, J 7.0, 6.2 Hz, H-24); 13C 
NMR: 5C 40.1 (C-l), 33.9 (C-2), 218.1 (C-3), 47.2 (C-4), 55.1 (C-5), 19.3 (C-6),
34.4 (C-7), 39.7 (C-8), 50.0 (C-9), 36.7 (C-10), 22.1 (C -ll), 25.7 (C-12), 42.8 (C-
13), 49.8 (C-14), 31.3 (C-15), 26.8 (C-16), 49.6 (C-17), 16.0 (C-18), 15.0 (C-19),
86.2 (C-20), 23.9 (C-21), 34.5 (C-22), 26.2 (C-23), 86.3 (C-24), 70.1 (C-25), 26.6 (C- 
26), 27.0 (C-27), 27.6 (C-28), 20.8 (C-29), 16.1 (C-30).
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AC-4 (cabraleadiol, 4), needles (MeOH), mp 175°; [<x]d + 18.2°  (c, 1.00 in 
CHC13); IR Vmax: 3618, 3586, 2965, 1460, 1060 cm-1; EIMS m/z (rel. in t.): 460 [M+] 
(1), 445 [M+-CH3] (1), 427 [M+-CH3-H20] (1), 401 (2), 383 (8), 191 (5), 143 
[C8H i50 2+ (side chain)] (100), 125 (C8H i30+) (10), 59 (78); >H NMR: 8H 0.84,
0.86, 0.89, 0.94, 0.97 (Me-18, Me-19, Me-28, Me-29, Me-30), 1.11, 1.15, 1.19 (Me- 
21, Me-26, Me-27), 3.40 (1H, t, J 3.6 Hz, H0-3), 3.65 (1H, dd, J 7.2, 5.8 Hz, H-24); 
OC NMR : 8C 33.6 (C-l), 25.8 (C-2), 76.2 (C-3), 37.6 (C-4), 50.6 (C-5), 18.2 (C-6),
34.7 (C-7), 40.5 (C-8), 49.8 (C-9), 37.2 (C-10), 21.6 (C -ll), 25.3 (C-12), 42.7 (C-
13), 50.1 (C-14), 31.4 (C-15), 26.9 (C-16), 49.5 (C-17), 16.0 (C-18), 15.5 (C-19),
86.6 (C-20), 24.0 (C-21), 35.1 (C-22), 26.3 (C-23), 86.2 (C-24), 70.2 (C-25), 27.1 (C- 
26), 28.3 (C-27), 27.8 (C-28), 22.1 (C-29), 16.5 (C-30).
AC-5 (cabralealactone, 5), colourless crystals (MeOH), mp 182-184°; [a]D  
+70.4° (c, 1.00 in CHC13); IR vmax : 3020, 1759, 1701, 1560, 1223, 930, 850 cm -1; 
EIMS m /z ( rel. int.); 414 [M+] (65), 399 [M+-CH3] (9), 396 (7), 329 (11), 328 (9), 316 
(23), 315 (35), 205 (100), 195 (13), 135 (32), 121 (35), 109 (38), 107 (46), 99 (56), 95 
(70), 81 (64), 79 (36), 69 (38), 67 (49), 55 (63), 43 (30); !H NMR : 8H 0.88, 0.92,
0.98, 1.02, 1.06, 1.37 (Me-18, Me-19, Me-28, Me-29, Me-30, Me-21); 13C NMR ; 8c
39.8 (C-l), 34.0 (C-2), 218.1 (C-3), 47.4 (C-4), 55.2 (C-5), 19.6 (C-6), 34.4 (C-7),
40.2 (C-8), 49.8 (C-9), 36.8 (C-10), 21.9 (C -ll), 26.8 (C-12), 43.2 (C-13), 50.1 (C-
14), 31.1 (C-15), 29.2 (C-16), 49.2 (C-17), 16.0 (C-18), 15.1 (C-19), 90.1 (C-20),
25.4 (C-21), 25.0 (C-22), 31.0 (C-23), 176.8 (C-24), 21.0 (C-29), 16.1 (C-30); 
HREIMS : Found 414.3137; calculated for C27H420 3 414.3133.
AC-6 (viridiflorol, 6), crystals (MeOH), mp 74°, | cc]d  +3.2° (c, 0.10 in CHC13); 
Vmax : 3603, 3450, 3020, 2400, 1522, 1420, 1375, 1120, 1020, 985, 930 cm-1; EIMS 
m/z (rel. in t.): 222 [M+] (1), 204 [M+-H20] (10), 189 (13), 164 (9), 105 (40), 93 (48),
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91 (41), 83 (44), 81 (62), 69 (57), 55 (73), 43 (100); lH NMR : 8H 0.11 (dd, J 9.1 Hz, 
H-6), 0.61 (m, H-7), 0.99, 1.01, 1.14 (Me-12, Me-13, Me-14), 0.93 (d, J 6.6 Hz, Me-
15); 13C NMR : 8C 58.2 (C-l), 37.7 (C-2), 25.8 (C-3), 38.4 (C-4), 39.7 (C-5), 28.5 
(C-6), 22.2 (C-7), 18.8 (C-8), 29.0 (C-9), 74.6 (C-10), 18.3 (C-ll), 16.3 (C-12), 28.7 
(C-l3), 32.1 (C-14), 16.1 (C-15).
AC-7 (isofouquierone, 7), gum, [cx]d +33.0° (c, 1.00 in CHCI3); IR vmax : 
3607, 3453, 2964, 1710, 1522, 1460, 1030, 930 cm-1; EIMS m/z ( rel. int.) : 459 
[M++1] (1), 443 [M+-CH3] (1), 425 [M+-15-18], 359 [M+-C6H11O)] (26), 315 [M+- 
C8H15O2] (6), 205 (14), 159 (22), 143 (15), 135 (23), 127 (31), 125 (40), 95 (55), 82 
(100); lH NMR ; 8H 0.85, 0.92, 0.97, 1.01, 1.05 (Me-18, Me-19, Me-28, Me-29, Me-
30), 1.12 (Me-21), 1.32 (Me-26, Me-27), 2.18 (m, 2H-22), 2.45 (m, 2H-2), 5.66 (m, 
H-23, H-24); 13c NMR : 8C 39.8 (C-l), 34.1 (C-2), 218.3 (C-3), 47.4 (C-4), 55.2 (C- 
5), 19.6 (C-6), 34.4 (C-7), 40.2 (C-8), 49.9 (C-9), 36.7 (C-10), 21.9 (C -ll), 24.8 (C- 
12), 42.4 (C -l3), 50.2 (C-14), 31.1 (C-15), 27.4 (C-16), 49.7 (C-17), 16.0 (C-18),
15.1 (C-19), 75.0 (C-20), 25.6 (C-21), 43.3 (C-22), 122.2 (C-23), 142.0 (C-24), 70.7 
(C-25), 29.9 (C-26), 29.8 (C-27), 26.6 (C-28), 21.0 (C-29), 16.3 (C-30).
AC-8 (20.V, 25-dihydroxydammaran-3-one, 8), gum, [cc]d +17.8° (c , 0.59 in 
CHCI3); IR vmax : 3570 (OH), 3452 (OH), 2960, 1698 (C=0), 1522, 1460, 1030, 925 
cm-1; EIMS m/z (rel. int.) ; 442 [M+-H20] (1), 427 [M+-H20-CH3] (5), 424 [M+- 
2xH 20 ]  (3), 412 [M+-H20- 2xC H 3] (1), 315 [M+-C8H i70 2 ( side chain)] (5), 205 (9), 
163 (11), 145 [C8Hi70 2+ (side chain)] (15), 135 (11), 127 [CsHisO+l (100), 109 
[C8H i3+] (60), 95 (36), 82 (44), 43 (40); •H NMR SH 0.85 , 0.91, 0.96, 1.00, 1.04 
(Me-18, Me-19, Me-28, Me-29, Me-30), 1.12 (s, Me-21), 1.20 (s, Me-26, Me-27), 2.45 
(m, 2H-2); 13C NMR ( see Table 9). HREIMS : Found [M+-H20-Me] 427.3595; 
calculated for C2<)H470 2 427.3575.
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CHAPTER 10
CONSTITUENTS OF THE STEM BARK OF 
P I P E R  C H A B A  HUNTER (PIPERACEAE).
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INTRODUCTION
The genus Piper (Piperaceae) comprises 500 species which are distributed in 
tropical and subtropical regions. They are mostly shrubs and rarely herbs or trees1. 
Piper chaba Hunter is a much branched, rambling shrub which is cultivated in 
Bangladesh, India and Malay2. The fruit is used for treatment of coughs and common 
cold3 and the stem bark for asthma, cough, cold, indigestion, loss of appetite and piles4. 
The antitubercular properties of this plant have also been reported^. Preliminary 
pharmacological examination revealed a hypotensive and smooth muscle relaxant action6. 
Earlier phytochemical work on this plant resulted in the isolation of alkaloids7*8*9’10 , 
amino acids and monosaccharides11 and sterols8*9. Recently alkamides and a lignan have 
been isolated12.
RESULTS AND DISCUSSION
On chromatography over silica gel the ethyl acetate extract of the stem bark of P. 
chaba yielded four known compounds PC-1, PC-2, PC-3 and PC-4 which were 
subsequently identified as the known piperidine amide alkaloids piperanine (1) and 2,4- 
decadienoic acid piperidide (2), the alkamide alkaloid pellitorine (3) and the dibenzyl 
butyrolactone lignan , (-)-kusunokinin (4).
PC-1 (1), C17H21NO3, was obtained as white crystals, mp 80° [lit.13 piperanine, 
mp 79-80°]. It is UV active [^max 234, 290, 345 nm] and gave a single Dragendorff 
positive spot on tic (silica gel), indicating its alkaloidal nature. It has bands in the IR 
spectrum arising from amide [Vmax i670 cm-1] and aromatic and double bond [Vmax 
3020, 1624, 1600, 1580, 1446, 1022 cm-1] absorption. The mass spectrum displays a 
molecular ion [M+] at m/z 287 [C17H21NO3] and other fragments at m/z 286 [M+-1],
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203 [M+-84 (piperidine ring)], 201[M+-C5Hi2N], 175 [M+-C6Hi0NO], 135 [CgH702+ 
(base peak)], 112 [C6HioNO+] and 84 [CsHioN* (piperidine ring)], indicating its 
piperidine amide nature.
O
6 5
(1)
The iH NMR spectrum of PC-1 (1) shows signals at 8h  1-66 [6H, m, 2H-3, 
2H-4, 2H-5 ], 2.40-2.75 [4H, m, 2H-y, 2H-8], 3.55 [4H, br, 2H-2, 2H-6], 5.95 [2H, 
s, CH20 2], 6.35 [1H, d, J 14.6 Hz, H-a] and 6.60-6.90 [4H, m, H-0, H-2', H-5', H- 
6']. These data revealed a piperidine amide alkaloid with a,|5-unsaturation and a 
methylene dioxy group in the aromatic ring. Comparison with published data13 led to the 
identification of PC-1 as piperanine (1).
O
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The 13C NMR spectrum of PC-1 (1) is in accord with the proposed structure. 
Thus it has seven methylene signals [8c  46.9, 43.2, 34.5, 34.4, 26.7, 25.6, 24.9], five 
methines [8c 142.5, 122.5, 120.0, 108.8, 105.6], a methylenedioxy group [8c  101.7], 
an amide carbonyl [8c  165.4] and three aromatic quaternary carbons [8c  148.2, 148.1,
131.1]. The 13C data for (1) have not previously been reported. The assignments (see 
Experimental) were made by comparison with piperine (6)14 and pipemonaline (7)16. 
This alkaloid has been previously isolated from other Piper species16.
O
O
/
N
\
PC-2 (2), C15H25NO, was obtained as gum. It is UV active (^max 250 nm) and 
gave a Dragendorff positive spot on tic (silica gel), indicating its alkaloidal nature. It has 
bands in its IR spectrum at 1655 (amide C=0) and 1637, 1603, 1550 and 1016 
(CH=CH) cm-1. Its mass spectrum displays a molecular ion peak [M+] at m/z 235 
(C15H25NO) together with fragments corresponding to the loss of various alkyl groups at 
m/z 206 [M+-C2H5], 193 [M+-C3H6], 192 [M+-C3H7], 178 [M+-C4H9], 164 [M+- 
C5H11, base peak], 151 [M+-C5HioN (piperidine ring)] and 138 [M+-C7H i3]. A peak 
at m/z 84 [CsHioN4" (piperidine ring)] indicates the piperidine amide nature of the 
compound.
The NMR of PC-2 (2) has signals at 8H 6.13 (1H, d, J 14.8 Hz, H-2'), 7.22 
(1H, dd, J 14.8, 10.0 Hz, H-3'), 6.00-6.30 (2H, m, H-4', H-5'), 3.58 (4H, br, 2H-2, 
2H-6), 1.58 (6H, br, 2H-3, 2H-4, 2H-5), 2.13 (2H, dt, J 7.0, 6.0 Hz, 2H-6'), 1.27 
(6H, m, 2H-7', 2H-8', 2H-9’) and 0.87 (3H, t, J 7.0 Hz, Me-10'). These data revealed
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a piperidine amide alkaloid with an aliphatic chain having double bonds at 2' and 4' 
position. Comparison with published data17 led to the identification of PC-2 as 2,4- 
decadienoic acid piperidide (2).
N
10' 8’ 6' 4‘ 2'
2 3
(2)
The 13C NMR of PC-2 (2) readily accorded with the proposed structure. Thus it 
has five methylene signals for the piperidine ring [5c 43.2 (C-2), 26.6 (C-3), 24.7 (C- 
4), 25.6 (C-5), 46.9 (C-6)], an amide carbonyl [5c 165.7 (C-l'), four olefinic methines 
[5C 118.5 (C-2'), 142.7 (C-3'), 128.8 (C-4'), 142.9 (C-5')], another four methylene of 
the aliphatic chain [5c 32.9 (C-6'), 28.5 (C-7'), 31.4 (C-8'), 22.5 (C-9')] and a methyl 
carbon [5c 14.0 (C-101)]. The 13C data for (2) have not previously been reported. The 
assignments were made by comparison with pipeline (5)14 and pellitorine (3)18 (see 
Experimental). This is the first report of the occurrence of this alkaloid in Piper species.
PC-3 (3), C14H25NO, was obtained as colourless needles, mp 89° [lit.19 
pellitorine, mp 89-90°]. It is UV active [A.max 260 nm] and showed a single 
Dragendorff positive spot on tic (silica gel), indicating its alkaloidal nature. Its IR 
spectrum exhibits NH (vmax 3400 cm-1), amide (vmax 1665 cm-1) and double bond 
(Vmax 1620,1560, 1522, 1480, 1388, 1018 cm-l) absorption. The mass shows a parent 
ion [M+] at m/z 223 and fragments at m/z 222 [M+-1], 208 [M+-15], 180 [M+-15-28], 
167, 152 [M+-C4H 9N], 151 [M+-C4H i0N (base peak)] and 72 [C4H ioN +, 
isobutylamine], suggesting an isobutylamide alkaloid.
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The NMR of PC-3 (3) reveals a methyl [5h 0.89 (t, J 7.0 Hz, Me-10)], three 
methylenes [5h 1.30 (m, 2H-7, 2H-8, 2H- 9)], an allylic methylene [5h 2.14 (dt, J 7.0,
6.0 Hz, 2H-6)], four olefinic protons [5h 5.80 (1H, d, J 15.0 Hz); 5.95-6.20 (2H, 
complex m); 7.20 (1H, ddd, J 15.0, 8.8, 1.4 Hz)] and signals associated with an 
isobutylamide grouping [5h 0.92 (6H, d, J 6.7 Hz, Me-3', Me-4'); 1.77 (1H, m, H-21), 
3.15 (2H, t, J 6.7 Hz, 2H-1'); 5.88 (1H, br t, J 6.0 Hz, NH)]. These data are consistent 
with the presence of an isobutyryl alkamide alkaloid containing aliphatic acid chain (Cio) 
with double bonds at the 2 and 4 positions. Comparison with published data18*19 led to 
the identification of PC-3 as pellitorine (3).
4'
(3)
The 13C NMR spectrum of PC-3 (3) shows an amide carbonyl [5c 166.5 (C-l)], 
four olefinic methines [5C 121.8 (C-2), 141.1 (C-3), 128.1 (C-4), 143.0 (C-5)], five 
methylenes [5C 32.8 (C-6), 28.4 (C-7), 31.3 (C-8), 22.4 (C-9), 46.8 (C-l’)], one 
methine [5c 28.5 (C-2')] and three methyl carbons [5c 13.9 (C-10), 20.0 (C-3'), 20.0 
(C-4')]. These data are in agreement with published data18 and confirm the structure of 
pellitorine (3), which has been previously isolated from several Piper species16*20.
PC-4 (4), C21H22O6, was obtained as gum, [oc]d -34.2 (c, 0.50 in CHCI3) 
[lit.21 (-)-kusunokinin, [<x ]d  -34.5 (c, 0.52 in CHCI3)]. It is UV active and has 
absorption bands at Xmax 230, 282, 285 nm. Its IR spectrum shows bands at 1763 (y- 
lactone), 3020, 1601, 1577, 1560, 1504, 1442, 1018 (aromatic) and 1250 (C-0
195
streching) cm-1. Its mass spectrum has a molecular ion [M+] at m/z 370, together with 
fragments at m/z 235 [M+-135(C8H70 2)], 219 (Ci2H n 0 4+), 218 (Ci2H i0O4+), 192 
(CioHg04+), 151 (C9H n 0 2+) and a base peak at m/z 135 (CgHyC^4"), consistent with a 
lignan type structure.
O
O
OCH
(4)
The *H NMR of PC-4 (4) shows signals for two 3,4-disubstituted benzyl rings 
and a butyrolactone ring system . It has signals for the first benzyl ring at 8h [6.60 (br 
s, H-2'), 6.68 (m, H-5’), 6.58 (dd, J 8.2, 2.0 Hz, H-6'), 5.92, 5.94 (ABq, J 1.5 Hz, 
3’,4’- CH20 2), 2.83 (dd, J 14.0, 6.5 Hz, Ha-7') and 2.96 (dd, J 14.0, 5.0 Hz, Hb-7')] 
and for the second benzyl ring at 8h  [6.42 (d, 2.0 Hz, H-2"), 6.76 (d, J 8.2 Hz, H-5"), 
6.56 (dd, J 8.2, 2.0 Hz, H-6"), 3.83 (s, MeO), 3.85 (s, MeO) and 2.50 (m, 2H-7")]. 
For the butyrolactone ring it has signals at 8h [2.50 (m, H-2, H-3), 3.88 (m, Ha-4) and 
4.14 (dd, J 9.3, 6.9 Hz, Hb-4)]. Comparison with published data21 confirmed the 
identity of PC-4 as (-)-kusunokinin (4).
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The 13C NMR of PC-4 shows the expected features of a 3,4-disubstituted 
dibenzylbutyrolactone. Thus it has six aromatic methines [5c 109.4 (C-21), 111.5 (C- 
2"), 108.1 (C-5'), 111.2 (C-5"), 122.2 (C-6’), 120.5 (C-6")], six aromatic quaternary 
carbons [5C 131.3 (C-l'), 130.3 (C-l"), 147.8 (C-3'), 149.0 (C-3"), 146.4 (C-41),
147.8 (C-4")], two methylenes [5C 34.7 (C-7'), 38.2 (C-7")], a methylenedioxy [5C 
101.0] and two methoxyl groups [5c 55.8, 55.7]. There are also signals [5c 178.5 (s), 
(C-l), 46.4 (d), (C-2), 41.1 (d), (C-3), 71.2 (t), (C-4)] arising from a butyrolactone ring 
substituted at the 2 and 3 positions. These data (see Experimental) are in agreement with 
the published data22 for (-)-kusunokinin (4). This is the first report of the isolation of
(4) in Piperaceae.
In addition (3-sitosterol (5) and the alkaloid pipeline (6), previously reported 
constituents**’9, were also isolated from this plant.
HO
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EXPERIMENTAL
Isolation. The plant material of Piper chaba was collected from the district of 
Khulna, Bangladesh. The ground stem bark (450g) was extracted in a Soxhlet apparatus 
with EtOAc. The ethyl acetate extract (3g) was concentrated in vacuo and fractionated by 
flash column chromatography over silica gel. The column was first eluted with 
petroleum ether and then increasing amounts of EtOAc in petroleum ether and finally 
MeOH. Each of the fractions was monitored by analytical tic. The early fractions 
contained only fat. Multiple preparative tic of the later fractions gave the following 
results: fraction 16 [CH2CI2 : MeOH (99 : 1)] yielded PC-1 (1) (25mg); fraction 15 
[petroleum ether : EtOAc (65 : 35)] afforded PC-4 (4) (20.5mg); fraction 14 [petroleum 
ether : EtOAc (75 : 25)] afforded PC-2 (2) (17mg) and (3-sitosterol (5) (6.3mg); fraction 
12 [petroleum ether : EtOAc (85 : 15)] yielded PC-3 (3) (92 mg); fraction 18 [CH2CI2 : 
MeOH (99 : 1)] afforded pipeline (6) (12.8mg).
PC-1 (1), white crystals (EtOAc-hexane), mp 80°; UV A.max (log e) .* 234 
(4.35), 290 (3.76), 345 (3.18) nm; IR vmax : 3020, 1670, 1624, 1600, 1580, 1446, 
1040, 1022, 929, 852 cm-1 ; EIMS m/z (rel. int.): 287 (M+) (10), 286 (M+-1) (3), 285 
(10), 203 [M+-84 (piperidine ring)] (3), 201 (M+-86) (16), 176 (10), 175 (8), 174 (13), 
138 (6), 136 (11), 135 (100), 115 (25), 112 (10), 105 (8), 86 (31), 84 (79), 77 (17), 57 
(20); JH NM R: 8H 6.60-6.90 (4H, m, H-0, H-2', H-5’, H-6’), 6.35 (1H, d, J 14.6 
Hz, H-a), 5.95 (2H, s, CH2O2), 3.55 [4H, br, 2H-2, 2H-6), 1.66 (6H, m, 2H-3, 2H- 
4, 2H-5), 2.40-2.75 (4H, m, 2H-y, 2H-5); 13C NMR : 6C 131.1 (C-l'), 105.6 (C-2'),
148.1 (C-3'), 148.2 (C-4'), 108.8 (C-5’), 122.5 (C-6'), 101.7 (CH20 2), 120.0 (C-a),
142.5 (C-P), 34.4 (C-y), 34.5 (C-6), 165.4 (C=0), 43.2 (C-2), 26.7 (C-3), 24.9 (C-4),
25.6 (C-5), 46.9 (C-6). HREIMS : Found 287.1527; calculated for C i7H2iN 03 
287.1521.
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PC-2 (2), gum, UV A.max : 250 (log e 3.52) nm; IR vmax: 2940, 1655, 1637, 
1603, 1550, 1016, 952 cm-1; EIMS m/z (rel. int.) : 235 (M+) (54), 206 (M+-C2H5) 
(15), 193 (M+-C3H6) (18), 192 (M+-C3H7) (68), 178 (M+-C4H9) (15), 164 (M+- 
C5H n ) (58), 151 (M+-C5H i0N) (42), 138 (M+-C7H i3) (40), 112 (33), 95 (30), 84 
(C5H 10N+) (100); 'H  NMR : 6H 7.22 (1H, dd, J 14.8 , 10.0 Hz, H-3’), 6.13 (1H, d,
J 14.8 Hz, H-2'), 6.00-6.30 (2H, m. H-4’, H-5'), 3.58 (4H, br, 2H-2, 2H-6), 1.58 
(6H, br, 2H-3, 2H-4, 2H-5), 2.13 (2H, dt, J 7.0, 6.0 Hz, 2H-6'), 1.27 (6H, m, 2H-7', 
2H-8', 2H-9'), 0.87 (3H, t, J 7.0 Hz, Me-10’); 13C NM R: §c 165.7 (C-l’), 118.5 (C- 
2'), 142.7 (C-3'), 128.8 (C-4'), 142.9 (C-5’), 32.9 (C-6’), 28.5 (C-7’), 31.4 (C-8'),
22.5 (C-9’), 14.0 (C-10’), 43.2 (C-2), 26.6 (C-3), 24.7 (C-4), 25.6 (C-5), 46.9 (C-6). 
HREIMS : Found 235.1931; calculated for C15H25NO 235.1936.
PC-3 (3), colourless needles (pentane), mp 89°; UV X.max : 260 (log e 4.54) nm; 
IR vmax : 3400, 3020, 1665, 1620, 1560, 1522, 1480, 1388, 1018, 929, cm-1; EIMS 
m/z (rel. int.) : 223 (M+) (25), 222 (M+-1) (26), 208 (M+-15) (10), 180 (M+-15-28)
(5), 167 (10), 152 (M+-C4H i0N) (30), 151 (M+-C4H i0N) (100), 150 (M+-C4H nN ) 
(99), 137 (20), 135 (8), 113 (5), 112 (24), 111 (22), 109 (22), 96 (48), 81 (47), 78 
(30), 72 (C4H10N) (18), 57 (60), 43 (70); !H NMR : 5H 7.20 (1H, ddd, J 15.0, 8.8,
1.4 Hz), 5.95-6.20 (2H, complex m), 5.80 (1H, d, J 15.0), 2.14 (2H, dt, J 7.0, 6.0, 
2H-6), 1.30 (6H, m, 2H-7, 2H-8, 2H -9), 0.89 (3H, t, J 7.0 Hz, Me-10), 3.15 (2H, t, J
6.7 Hz, 2H-1'), 1.77 (1H, m, H-2’), 0.92 (6H, d, J 6.7 Hz, Me-3', Me-4'), 5.88 (1H, 
br t, J 6.0 Hz, NH); ^ C  NMR : 5c 166.5 (C-l), 121.8 (C-2), 141.1 (C-3), 128.1 (C- 
4), 143.0 (C-5), 32.8 (C-6), 28.4 (C-7), 31.3 (C-8), 22.4 (C-9), 13.9 (C-10), 46.8 (C- 
1’), 28.5 (C-2’), 20.0 (C-3’), 20.0 (C-4'). HREIMS : Found 223.1938; calculated for 
C14H25NO 223.1936.
PC-4 (4), gum, [a]D -34.20 (c, 0.50 in CHC13); UV Xmax (log e ) : 230 (3.68), 
282 (3.82), 285 (3.42) nm; IR vmax: 3020, 1763, 1601, 1577, 1560, 1504, 1442, 
1250, 1018, 930, 850 cm-1; EIMS m/z (rel. int.) : 370 (M+) (60), 235 (M+-135) (5),
199
219 (C12H 11O4+) (2), 218 (Ci2H io04+) (2), 192 (CioH80 4+) (5), 177 (16), 151 
(C9H ii0 2+) (85), 135 (C8H70 2+) (100), 107 (16), 91 (11), 77 (35); *H NMR : 8H 
6.60 (1H, br s, H-2'), 6.68 (1H, m, H-5'), 6.58 (1H, dd, J 8.2, 2.0 Hz, H-6’), 6.42 
(1H, d, J 2.0 Hz, H-2"), 6.76 (1H, d, J 8.2 Hz, H-5"), 6.56 (1H, dd, J 8.2, 2.0 Hz, H- 
6"), 5.92, 5.94 (2H, ABq, J 1.5 Hz, CH20 2), 3.83 and 3.85 (both s, 2xCH30), 2.83 
(1H, dd, J 14.0, 6.5 Hz, Ha-7'), 2.96 (lH,dd, J 14.0, 5.0 Hz, Hb-7'), 2.50 (4H, H-3, 
H-4, 2H-7"), 4.14 (1H, dd, J 9.3, 6.9 Hz, Hb-4), 3.88 (1H, m, Ha-4); 13C NMR : 6c
178.5 (C-l), 46.4 (C-2), 41.1 (C-3), 71.2 (C-4), 131.3 (C-l’), 109.4 (C-2’), 147.8 (C- 
3'), 146.4 (C-4'), 108.1 (C-5'), 122.2 (C-6'), 34.7 (C-7'), 130.3 (C-l"), 111.5 (C-2"),
149.0 (C-3"), 147.8 (C-4"), 111.2 (C-5"), 120.5 (C-6"), 38.2 (C-7"), 101.0 (CH20 2),
55.8 (CH3O), 55.7 (CH3O). HREIMS : Found 370.1415; calculated for C2iH220 6 
370.1416.
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